Accession	group	form	version	status	SampleID	aVisit	CSLRI_q1a	CSLRI_q1b1	CSLRI_q1b2	CSLRI_q1b3	CSLRI_q1b4	CSLRI_q1b5	CSLRI_q1b6	CSLRI_q1b7	CSLRI_q1c1	CSLRI_q1c2	CSLRI_q1c3	CSLRI_q1c4	CSLRI_q1c5	CSLRI_q1c6	CSLRI_q1c7	CSLRI_q1d1	CSLRI_q1d2	CSLRI_q1d3	CSLRI_q1d4	CSLRI_q1d5	CSLRI_q1d6	CSLRI_q1d7	CSLRI_q1e1	CSLRI_q1e2	CSLRI_q1e3	CSLRI_q1e4	CSLRI_q1e5	CSLRI_q1e6	CSLRI_q1e7	CSLRI_q1f1	CSLRI_q1f2	CSLRI_q1f3	CSLRI_q1f4	CSLRI_q1f5	CSLRI_q1f6	CSLRI_q1f7	CSLRI_q1g1	CSLRI_q1g2	CSLRI_q1g3	CSLRI_q1g4	CSLRI_q1g5	CSLRI_q1g6	CSLRI_q1g7	CSLRI_q1h1	CSLRI_q1h2	CSLRI_q1h3	CSLRI_q1h4	CSLRI_q1h5	CSLRI_q1h6	CSLRI_q1h7	CSLRI_q2a	CSLRI_q2b1	CSLRI_q2b2	CSLRI_q2b3	CSLRI_q2b4	CSLRI_q2b5	CSLRI_q2b6	CSLRI_q2b7	CSLRI_q2c1	CSLRI_q2c2	CSLRI_q2c3	CSLRI_q2c4	CSLRI_q2c5	CSLRI_q2c6	CSLRI_q2c7	CSLRI_q2d1	CSLRI_q2d2	CSLRI_q2d3	CSLRI_q2d4	CSLRI_q2d5	CSLRI_q2d6	CSLRI_q2d7	CSLRI_q2e1	CSLRI_q2e2	CSLRI_q2e3	CSLRI_q2e4	CSLRI_q2e5	CSLRI_q2e6	CSLRI_q2e7	CSLRI_q2f1	CSLRI_q2f2	CSLRI_q2f3	CSLRI_q2f4	CSLRI_q2f5	CSLRI_q2f6	CSLRI_q2f7	CSLRI_q2g1	CSLRI_q2g2	CSLRI_q2g3	CSLRI_q2g4	CSLRI_q2g5	CSLRI_q2g6	CSLRI_q2g7	CSLRI_q2h1	CSLRI_q2h2	CSLRI_q2h3	CSLRI_q2h4	CSLRI_q2h5	CSLRI_q2h6	CSLRI_q2h7	CSLRI_q3a	CSLRI_q3b1	CSLRI_q3b2	CSLRI_q3b3	CSLRI_q3b4	CSLRI_q3b5	CSLRI_q3b6	CSLRI_q3b7	CSLRI_q3c1	CSLRI_q3c2	CSLRI_q3c3	CSLRI_q3c4	CSLRI_q3c5	CSLRI_q3c6	CSLRI_q3c7	CSLRI_q3d1	CSLRI_q3d2	CSLRI_q3d3	CSLRI_q3d4	CSLRI_q3d5	CSLRI_q3d6	CSLRI_q3d7	CSLRI_q3e1	CSLRI_q3e2	CSLRI_q3e3	CSLRI_q3e4	CSLRI_q3e5	CSLRI_q3e6	CSLRI_q3e7	CSLRI_q3f1	CSLRI_q3f2	CSLRI_q3f3	CSLRI_q3f4	CSLRI_q3f5	CSLRI_q3f6	CSLRI_q3f7	CSLRI_q3g1	CSLRI_q3g2	CSLRI_q3g3	CSLRI_q3g4	CSLRI_q3g5	CSLRI_q3g6	CSLRI_q3g7	CSLRI_q3h1	CSLRI_q3h2	CSLRI_q3h3	CSLRI_q3h4	CSLRI_q3h5	CSLRI_q3h6	CSLRI_q3h7	CSLRI_q4a	CSLRI_q4b1	CSLRI_q4b2	CSLRI_q4b3	CSLRI_q4b4	CSLRI_q4b5	CSLRI_q4b6	CSLRI_q4b7	CSLRI_q4c1	CSLRI_q4c2	CSLRI_q4c3	CSLRI_q4c4	CSLRI_q4c5	CSLRI_q4c6	CSLRI_q4c7	CSLRI_q4d1	CSLRI_q4d2	CSLRI_q4d3	CSLRI_q4d4	CSLRI_q4d5	CSLRI_q4d6	CSLRI_q4d7	CSLRI_q4e1	CSLRI_q4e2	CSLRI_q4e3	CSLRI_q4e4	CSLRI_q4e5	CSLRI_q4e6	CSLRI_q4e7	CSLRI_q4f1	CSLRI_q4f2	CSLRI_q4f3	CSLRI_q4f4	CSLRI_q4f5	CSLRI_q4f6	CSLRI_q4f7	CSLRI_q4g1	CSLRI_q4g2	CSLRI_q4g3	CSLRI_q4g4	CSLRI_q4g5	CSLRI_q4g6	CSLRI_q4g7	CSLRI_q4h1	CSLRI_q4h2	CSLRI_q4h3	CSLRI_q4h4	CSLRI_q4h5	CSLRI_q4h6	CSLRI_q4h7	aProcDY
		CSLRI	1.0	expected	316242	b	246	6.17	4.18	351	658			2870	2.1	2.75	2.29	7.66			3.12	63.8	12.7	13.4	67.5			28	9.12	5.96	838	1680			1140	55.1	11.9	123	169			36.6	2.15			7.2			3.1	2.88	4.68	7.24	780			7.59	.m																																																		246	6.98	5.89	295	715			2810	1.7	2.31	2.27	14.5			6.12	71.4	16.3	13.7	82			31.1	7.38	5.07	617	1490			723	39.8	9.43	105	79.1			27.8	3.44	4.1	1.11	10.6			2.21	2.69	4.1	5.01	645			7.59	.m																																																		
		CSLRI	1.0	expected	127057	b	204	17.8	3.01	179	330			721				13.3				91.8	137	4.06	286			10.3	48.1	2.35	351	3320			15900	50.2	7.05	77.2	134			12.4		2.22		19.9					13.1	53.6	970			10.5	.m																																																		204	13.4	2.55	111	311			582		2.31		30.2				108	150	4.56	297			11.6	37.6	3.01	415	3320			13000	42.1	8.41	87.5	131			12.2		1.31		14.5					12.7	50	1320			14.3	.m																																																		
SUB230862	Atopic	CSLRI	1.0	expected	2699	b	57	60.99	13.3	472.28	172.57		314.68	1892.38	46.96	28.84		29.92	5.54	291.78		176.24	34.42		19.9	4.92			83.59	53.03	556.02	643.78		403.68	1888.39																						57	64.88		455.03	154.19		276.45	1995.88	29.15	6.31				280.2		159.28	16.65		7.03	8.11			66.79	88.5	559.54	714.67		406.15	1955.13																						57	48.46	22.51	514.62	228.43		258.65	2011		38.7		13.63		239.74		153.22	44.72			13.52	1048.19	11.79	73.59	38.7	677.11	967.81	5.54	472.71	3152.49																						57	64.88	20.57	536.85	267.21		324.42	2174.25		18.62		26.96	10.77	251.68		146.63	51.85		25.96	12.48	996.85	14.54	64.88	70.99	669.25	941.49	12.82	445.16	3340.7																						166
SUB230863	Atopic	CSLRI	1.0	expected	1885	b	57	49.93	126.31	164.85	180.04	8.76	297.1	1570.05	23.9	38.09		21.94		297.41		112.73	713.33	38.48	63.84	57.58	630.15	81.65	83.02	454.71	447.19	1256.62	12.82	638.37	3193.05																						57	66.79	148.23	177.12	195.72		290.23	1766.23	44.68	32.57		9.28	4.92	291.7		109.12	756.89	40.66	72.9	50.19	649.41	87.36	52.8	475.05	470.16	1337.2	17.76	844.19	3645.56																						.m																																																		.m																																																		173
SUB230864	Atopic	CSLRI	1.0	expected	4043	b	57	99.64	25.06	398.06	195.72	4.01	221.06	1895.24	53.5			40.57		533.06	5.9	443.42	3015.2	20.5	101.22	253.45	798.94	20.17	76.59	76.11	604.46	1247.17		481.39	1602.55																						57	69.92	13.98	338.29	233.3		198.29	1833.84	32.96	11.94		33.83		457.06		492.11	2984.51	18.81	120.25	260.87	574.97	19.73	96.94	62.37	542.55	1148.33	16.33	373.14	2738.29																						57	71.15		513.36	280.04		221.13	2297.09		38.09		8.17				487.86	9001	15.78	84.51	180.31	590.39	304.55	57.64	185.96	822.35	1704.1	8.76	498.47	3393																						57	77.18	26.32	452.18	251.1		156.45	2016.97		33.8				830.24		349.4	9001	13.47	85.4	154.94	420.84	247.86	98.56	209.14	769.36	1707.38		316.48	5001																						158
SUB230865	Atopic	CSLRI	1.0	expected	2375	b	57	90.92	21.22	96.88	187.48	4.31	208.69	1962.68	33.87	24.42			5.54	781.38		95.32	303.54	8.62	52.8	83.39	454.57	26.15	63.6	61.21	262.95	1015.89	8.76	331.53	2395.85																						57	41.52	35.65	104.99	184.18		221.78	2022.13		32.57		33.83		719.19		70.54	330.56	8.34	76.49	83.82	492.36	24.45	63.6	47.71	240.24	910.55	6.81	341.32	3549.87																						.m																																																		.m																																																		172
SUB230866	Atopic	CSLRI	1.0	expected	8411	b	58	119.79		2412.98	134.13		217.35	3867.95				32.92	13.94			295.31	3367.66	27.23	692.05	325.36	279.62	58.44	123.5	19.83	2955.1	971.4		334.9	5465.35	234.54	56.26	127.95	104.84		795.51	84.82	38.49			42.04				22.17	24.74	388.33	990.38			25.08	58	104.28		2250.52	148.03		227.54	5001	26.49	6.54		40.52				357.47	3394.62	26.62	753.49	337.71	286.81	63.48	164.35	20.44	2817.52	916.85		360.35	5001	208.8	30.2	122.56	67.23		703.02	81.13									48.65	380.62	1082.21			25.37	58	128.26	3.2	2361.15	188.27		218.79	3126.5	25.78	21.67	36.67	25.34			60.24	288.09	9001	57.53	720.4	535.72	277.33	606.47	190.24	30.8	2701.87	728.27	4.87	332.99	7510.75	407.1	486.98	247.97	59.59		655.59	90.46		5.88		4.32				27.88	19.21	123.5	1196.39			20.31	58	138.26		2037.43	157.3		196.97	5001	27.19	16.73	34.14	38.24	3.04		63.26	269.53	9001	54.45	816.57	546.19	266.71	592.81	163.32	2.51	2734.97	704.65	4.28	310.02	5001	403.43	419.61	235.7	91.77		581.88	105.72	53.26	40.96	121.12	1159.1			22.47	8.84	24.13		34.44				142
SUB230867	Atopic	CSLRI	1.0	expected	7963	b	57	101.24	13.98	82.47	47.19	5.86	197.94	1273.89		30.71			5.86	1034.51		143.78	44.72		67.48	22.13	390.6	67.98	94.23	47.11	256.48	679.24		297.46	4065.2								22.77	32.57		9.28	7.13	614.93		19.09	31.33		91.58	6.81	300.24	6.1	57	49.93	9001	436.77	106.44	30.41	137.94	1090.4	40.72	21.22	74.6	44.37	6.49	187.61	1117.54				54.65	4.92	836.9		107.56	22.51		29.92	7.46	387.79	50.91									4.83		84.51	4.31	303.67	6.46	81.29	38.7	237.96	646.87		317.83	5001	58	81.33		94.68	41.28		292.76	1986.06								141.93	39.18	5.22	81.79	21.86	653.3	128.13	160.2	15.48	300.95	747.18		416.27	3752.05								31.96			34.44		832.31					69.53		358.99		58	99.42		111.03	20.81		314.49	2259.5	9.82	2.51		25.34			4.19	111.26	14.22	6.98	31.4	27.67	673.03	135.91	174.73	5.22	330.46	712.52		495.04	5001									7.84		26.86		965.15			27.78		80.26		357.64		145
SUB230868	Atopic	CSLRI	1.0	expected	8523	b	58	89.61		217.2	228.61		395.28	2307.19								149.78	977.68	15.23	117.93	117.31	619.94	204.22	164.35	139.18	705.82	1333.82		524.91	4895.16	302.02	83.97	63.64	632.25			91.23				4.32		783.42		14.33	1499.97	22.83	690.47		832.06	62.65	58	93.44	13.59	197.97	188.27		401.92	2242.72								164.35	866.12	12.92	142.62	116.33	511.84	195.25	125.62	104.42	653.03	1302.81		579.92	4276.14	328.4	36.8	56.83	651.13			98.45	22.91			14.78				29.94	1538.29	25.73	675.52			74.63	58	109.65		188.75	245.7		375.96	2010.94				1.38	9.82	642.52		156.03	261.75	11.63	87.17	110.42	556.93	93.94	105.36	48.65	536.48	1289.3		580.43	4350.95	484.79	28.99	77.46	354.79			121.59	38.49	3.88		32.92		696.28		45.38	1282.7	19.9	644.05	22.84	809.95	77.08	58	106.97	22.9	216.08	194.47		462.43	2523.38				28.37		882.39		186.62	283.3	13.84	117.16	122.26	744.33	105.41	140.36	69.03	563.02	1290.1		791.53	5001	650.06	40.96	103.61	846.56			186.34	14.33	9.78		23.83		690.42		15.99	1181.81	14.31	704.65		770.19	69.16	140
SUB230869	Atopic	CSLRI	1.0	expected	2452	b	57	55.59	35.03	194.53	220.29		184.05	2655.92	16.35	13.3				207.85		266.06	2553.48	29.81	242.22	288.81	520.84	45.05	38.23	191.13	397.15	2739.3		338.29	6996.35																						57	84.17	42.32	171.47	208.85		170.8	2401.53		32.57		3.5	6.81	224.44		236.55	2527.14	29.85	213.76	298.87	778.26	48.14	63.6	216.81	396.67	2717.31	8.76	351.35	5001																						.m																																																		.m																																																		172
SUB230870	Atopic	CSLRI	1.0	expected	18622	b	69	14.87		223	91.03		601.55	1372.87	48.75			12.22		631.38		737.61	1713.98	38.45	135.28	145.17	630.13	139.15	28.77	42.59	521.79	542.64		962.69	4513.69	681.73		204.86	429.93	1.63		47.07				11.52		432.46		45.16	768.34	34.11	1310.01			80.77	69		5.25	221.39	101.11	1.63	613.55	1440.09						657.55		603.69	1544.58	33.62	119.47	124.82	659.09	123.71		39.79	563.52	598.43		1208.66	4223.17	581.31	20.67	199.27	439.46			45.08				12.93		442.96		63.48	727.28	33.81	1357.45			73.57	69			217.08	94.76		497.19	1269.05				8.73		1914.04		536.52	473.03	24.19	80.62	106.44	572.15	101.89	23.81	27.1	402.59	348.69		747.71	2544.05	687.34	0.97	135.14	515.31			49.29	5	5	5	25.89	5	154.47	5		2.95				251.01		69		1.37	234.99	97.37		561.44	1255.36	19.65			13.98		764.8		485.17	438.13	23.26	81.37	102.96	546.03	87.45	35.41	21.75	398.98	353.01		795.25	2719.58	588.9	3.72	118.09	433.11	8.44		44.64	5	5	5	25.89	5	173.4	5						220.17		118
SUB230871	Atopic	CSLRI	1.0	expected	10562	b	59	133.16	31.81	1168.39	747.29		391.1	7584.9					7.3	188.66		468.31	1336.41	18.5	154.87	186.9	431.56	139.84	151.28		414.66	675.45	5.76	954.24	4459.8	155.59		14.9	426.49		200.15	6.72	33.36			47.71		236.77				37.47	108	5	119.5	9.35	59	93.35	18.13	1067.13	680.4		425.97	5001	17.8	11.5		9.4		165.36		393.18	1286.06	17.01	116.03	165.39	442.64	127.97	108.02	25.89	387.33	589.53	1.34		5001	172.63		14.67	488.25	2.41	207.49			1.91		9.4		244.06		14.03		35.84	117.63		116.62	8.04	60	58.83	33.1	1002.81	674.53	10.88	526.52	8296.7	9.33	4			5.13	166.32		508.94	1737.42	19.93	148.56	160.95	426.73	136.67	222.9	4	383.73	493.02	7.78		5506.95	162.65	19	20.2	304.73		200.64	6.04		8.91			16.28	284.51			4.84	27.7	184.51	6.44	27.44	6.68	60	110.28	18.24	1044.79	688.83	3.86	556.52	5001		21.26			10.53	173.62		455.34	1759.08	21.06	100.11	152.83	470.83	133.3	217.3		392.62	493.02			5001	149.62	18.24	16.64	383.35	10.18	192.25	6.4		10.5				334.35		6.21	22.76	30.01	180.22	11.94	29.98	8.03	132
SUB230872	Atopic	CSLRI	1.0	expected	15903	b	62	330.9	102.53	331.31	453		342.06	2627.15		20.61		8.48		752.04	4.74	230.19	1862.23	35.67	198.99	199.35	493.5	93.12	284.97	83.41	381.32	662.88	29.52	508.65	2662.18	193.65	105.53	77.3	935.44	18.26	755.09	41.35		32.21		25.71		253.77	10.65		38.61		201.66		272.05	13.65	62	320.41	123.2	343.69	401.88		386.53	2612.38		29.39				886.6		219.89	1827.88	37.57	173.64	182.61	550.57	89.8	346.52	109.25	384.08	683.27		576.27	2792.44	184.07	123.2	81.45	1005.9		840.76	43.36		3.65				247.73	7.12	50.6	30.34	4.96	198.99		258.63	16.15	62	288.44	116.63	365.08	385.19	2.77	456.94	2915.09	3.16	20.61				626.51		188.44	1481.86	26.19	169.03	141.68	600.08	118.2	324.91	110.73	368.96	698.35		464.39	3097.55	214.05	117.36	85.05	492.65	20.02		138.69		6.29		38.49	13.35	178.91	10.97	26.75	38.61	16.34	244.45			21.78	62	283.81	100.27	327.79	334.48		431.04	2494.73		14.36			21.75	651.13		228.14	1583.02	29.92	144.6	158.67	440.89	122.65	340.21	89.61	369.25	742		431.67	3610.01	141.85	139.7	72.36	453.78	58.24		66.26		34.98				185.17	12.87	21.42		17.53	223.69			23.69	118
SUB230873	Atopic	CSLRI	1.0	expected	12029	b	60	23.34	0.46	73.61	30.95	7.78	461.01	252.29		15.18		23.06		877.77		8.08	462.19		23.06	3.86	750.25	17	77.45		141.89	89.6	5.78	902.13	674.82	71.07	27.23	33.94	180.94	9.83		55.53															60	41.8		74.28	7.61		652.51	258.36	7.46	13.63			8.12	805.13			463.41		12.76	11.94	806.88	19.87	73.97		141.45	70.51		1014.57	644.34	37.66	54.59	32.76	188.8			60.61															60	50.63	8.91	76.75	36.05		557.21	413.99		16.71		5.37		909.39		19.72	16.71			7.11	842.8	9.18	83.82		108.04	80.49			554.88	75.13	60.91	41.58	169.47			174.04															60	73.97		77.91	49.21	3.86	529.18	405.97		15.94			3.86		5.63	17.29	30.18			17.39	914.9	8.51	61.75	4	107.21	48.41	10.53		615.84	91.32	63.01	40.4	180.22	10.18		191.29															123
SUB230874	Atopic	CSLRI	1.0	expected	20789	b	69	546.92	759.33	34.83	99.61	262.95	1073.55	57.68	5	5	5	22.55	5	655.52	5	1477.06	68.84	133.5	936.47	17.98	517.43	55.58						190.78		63.48	21.39	8.51	293.25		301.4	14.22	5	5	5	6.03	5	476.11	5	53.05	1.77				269.88		69	548.92	713.89	31.13	96.63	231.82	1204.28	49.96	5	5	5	25.89	5	661.5	5	1192.86	44.33	118.36	816.55	13.33	471.82	47.4		8.26				166.6			24.25	8.84	318.96		287.21	15.67	5	5	5	2.53	5	483.44	5		1.37				257.28		69	537.72	537.81	35.91	127.74	220.63	1884.35	35.63	5	5	5	62.04	5		5	1161.04	53.36	103.56	770.76		675.36	38.64		9.37		17.17		142.46		11.08	9.74		190.71		246.63	27															69	456.95	489.5	30.49	73.95	234.16	1099.72	36.27	5	5	5	72.86	5		5	858.23	47.47	83.64	803.2	23.85	599.04	31.81						138.46			9		187.66		241.56	30.44															116
SUB230875	Atopic	CSLRI	1.0	expected	6395	b	86	85.14		163.27	220.46		617.29	2538.33				25.81		408.46		144.41	81.99		72.27	35.09		22.26	73.69	20.85	370.41	905.18			3610.41	199.83	20.02	28.52	790.73			158.69				20.47		195.28			1418.46	63.59	421.21			155.88	86	88.86		140.01	249.06		510.85	2300.87				36.11		368.41		153.48	74.25		69.02	35.44	849.91	29.07	83.27	25.87	389.7	959.03			3813.54	188.74	22.3	25.99	683.68			155.67				13.4		205.9			1332.57	56.74	401.02			141.53	86	61.03		119.28	276.47		490.95	2201.31				20.03		407.04		137.54	90.23		70.41	60.3		23.7	78.91	2.47	464.01	937.3			3531.43	165.57	16.52	32.93	826.97			158.17				20.47		185.59		11.26	1563.35	47.05	791.93			188.39	86	72.23		132.64	278.55		476.11	2451.42				16.05		414.82		143.8	94.37		68.56	63.86		22.9	93.8	7.73	433.05	977.11			3715.54	166.78	21.47	28.3	660.83			145.94				24.03		177.87			1484.38	37.33	816.07			163.6	195
SUB230876	Atopic	CSLRI	1.0	expected	21820	b	72	19.57		244.56	127.11		701.73	1136.39					0.89	281.12		221.92	1740.68	12.12	143.98	137.31	736.93	349.7	129.93		359.54	830.9			2929.23	527.15	39.6	102.39	523.81		619.56	96.05						109.12							105.7		72	92.23		211.52	108.75		1087.66	1097.88						273.35		176.01	1708.08	10.22	122.35	148.35	1013.2	375.13	95.93		334.07	778.6			3169.88	531.2	33.14	96.64	548.84	4.75	594	92.43					0.03	112.29							106.7		72			192.36	70.71		738.98	1278.67					4.52	463.75	34.94	133.87	345.7		82.25	102.35	984.73	35.44	115.11		326.35	656.82	0.67		3715.7	625.1	44.31	85.91	473.99	0.67	666.94	94.17						94.7			19.44	5.62	594.98	5.92		31.05	72			189.61	77.98		701.29	1298.16					4.52	487.78	41.86	145.44	331.72		69.22	112.7		45.14	89.98		290.69	681.03	3.37		2918.46	483.56	39.12	81.94	532.7		637.74	86.88				4.92	4.29	95.06			10.38	6.8	578.72			33.31	112
SUB230877	Atopic	CSLRI	1.0	expected	21369	b	71			177.34	237.97		630.76	965.04				6.52				49.86	62.16		13.71	14.04			26.91	7.6	101.4	462.94			1542.9	324.11	50.11	34.33	591.13	7.8		27.01				14.91		596.29			450.94		444.68			6.94	71	17.48		156.22	246.87		524.96	931.43	7.31				4.82			54.95	42.07		17.94	14.56	783		28.14		98.35	532.41			1517.51	250.25	29.71	26.77	542.21			20.05						594.38			445.29		418.96			7.24	71	30.57	4	164.78	211.69		500.35	1038.94				13.1			6.68	21.94	33.75		17.64	9.98	628.11		30.57		111.75	613.45		752.34	1777.9	238.56	25.92	21.84	393.71			7.7	1.93			11.9					254.95		355.06			7.9	71			145.73	194.37		573.48	884.55	9.44			9.2	4.82		6.74	21.31	8.11		8.31	13	675.83		14.86		84.97	499.99		1146.11	1360.97	118.31	13.22	16.78	456.04							11.3					238.65		351.01	4.38		8.18	105
SUB230878	Atopic	CSLRI	1.0	expected	26602	b	82	8.72	14.7	156.19	448.35			6316.05						963.4		70.87	1448.36	7.05	208.19	48.89	930.18	190.82			65.33	393.13			2942.55	11.26		37.66	158.15			10.49						540.25			2.26	95.87	43.16		188.96	3.69	82		5.57	152.59	453.74			5001				10.14		847.83		78.69	1504.19		252.53	53.54		209.76	4.8	1.83	63.72	429.16			5001	25.95		39.26	175.27			15.37						571.21			7.86	109.22	53.18		206.78	3.69	82			108.1	288.25		965.22	5321.75						840.9		47.03	693.79	4.62	280.99	43.36	967.28	188.63	9.14		70.19	375.69			2984.4	67.12		41	36.87			16.86						586.21		3	14.22	90.87	48.18		248.22		82		2.47	140.7	254.35		904.86	5001						890.86		64.5	735.28	4.26	351.01	46.32		233.42	0.09		65.18	391.93			5001	86.09		48.09	60.68			15.92						577.25		1.12	18.57	92.42	63.17		265.08		109
SUB230879	Atopic	CSLRI	1.0	expected	8747	b	86	80.99	2.65	241.27	340.17		628.1	4007.6				30.28		321.71		337.94	1863.19	18.56	155.53	86.9	649.73	51.95	89.06	7.34	534.57	1813.15			3002.75	1844.96	25.87	121.21	623.01			48.93				21.36		345.02			106.41	44.17	1122.54			53.11	86	88.86	3.01	221.47	350.85		553.43	3895.43				27.59		309.39		369.24	1851.87	13.13	168.34	82.93	695.45	52.57	110.57	10.08	526.8	1744.28			5050.77	1758.39	15.09	111.13	357.27			47.87				24.03		349.52			102.69	48.38	1128.94			58.05	86	94.83	6.38	185.83	267.64		478.47	3689.95				20.92		338.4	19.26	347.04	1351.93	8.21	138.91	81.63	556.97	68.84	111.79	5.24	485.55	1772.32			3036.6	2065.28	24.61	148.95	482			76.29				37.46		503.25			123.22	44.84	1214.15			44.98	86	85.34		209.45	311.55		457.16	4258.09				50.16		363.58	18.32	378.2	1291.42	11.17	136.96	83.65	473.08	80.81	91.54		473.11	1704.48			5001	2019.72	24.19	151.44	551.84			78.93				30.28		458.7			122.28	49.27	1161.08			47.17	149
SUB230880	Atopic	CSLRI	1.0	expected	33166	b	84	26.49		155.4	315.13		510.04	2908.53						534.46		130.4	378.06	6.34	107.85	24.26	624.72	99.05	17.76	26.59	542.53	1368.18		580.12	5597.6	1584.48	327.51	114.17	530.16		932.04	184.11						197.27		13.18	326.95	34.36	940.28			894.04	84	33.82	8.16	170.15	322.35		510.84	3675.72				22.19		573.92		132.41	384.26	7.82	81.44	24.2	565.55	90.07		27.1	524.1	1302.51		559.29	5001	1632.21	316.69	120.38	600.44		998.25	183.06						199.07			312.59	33.6	925.46			874.19	84	30.36		169.47	244.74		482.86	2708.78						606.52		127.53	680.35	10.54	152.55	34.29	576.69	196.07	24.35	48.34	517.45	1522.56		613.78	6197	1735.54	20.48	52.45	592.3		884.9	112.09						339.38			202.3	52.33	839.71			421.96	84	25.78		153.79	224.96		478.65	2874.24				2.1		592.43		132.41	692.43	7.38	146.2	38.09	540.35	203.42	5.83	32.41	477.52	1503.04		571.61	5001	1651.06	13.6	52.33	599.42		920.27	101.29						338.09			189.1	40.64	840.73			350.8	99
SUB230881	Atopic	CSLRI	1.0	expected	34671	b	95a			274.07	406.34			1211.53				4.11			55.12	106.39	353.98	14.22	97.27			63.68		4.34	765.63	1743.35			4194.99	1018.7	72.8	321.65	408.01			116.57				5.33					1530.27	20.13	628.74			75.19	.m																																																		95a			333.19	468.15			1430.28							5.31	120.62	253.9	12.16	100.7			44.41		52.06	550.68	1533.59			4028.31	872.96	89.8	257.64	312.46			100.43									1610.55	20.48	541.48			51.3	.m																																																		178
SUB230882	Atopic	CSLRI	1.0	expected	40578	b	96a	27.79		417.49	534.01			2118.73								615.43	700.75	21.08	103.29			61.07	67.51		754.06	2493.77			4979.7	622.56		273.84	402.79			49.75									3.43	61.77	1495.43			31.76	.m																																																		96a	35.51		441.48	607.56			2583.56				22.51			10	698.69	538.17	45.44	106.25			44.52	63.07		721.06	1819.8			5150.9	755.95	20.37	172.92	411.42			28.68									8.49	54.26	1731.83			23.29	.m																																																		169
SUB230883	Atopic	CSLRI	1.0	expected	38030	b	95a	10	1225.3	304.9	928.6			9698.8	10.95						4.35	231.62	3966.22	18.87	523.16			304.03	16.13	53.8	547.5	4207.07			5460.55	671.52	52.06	79.02	411.36			35.75							4.12		2.25	15.85	1929.08			55.25	.m																																																		95a	53.9	857.3	257.7	861.8			7223.3	11.76							135.25	2424.54	17.29	518.17			114.87	16.41	415.58	475.09	3621.85			5106	607.86	64.21	76.09	489.84			52.04										24.68	1718.89			42.39	.m																																																		171
SUB230884	Atopic	CSLRI	1.0	expected	42070	b	96a			310.79	134.26			892.74								41.82			160.68			24	34.18		276.48	915.01			3707.88	558.1	13.33	60.39	415.73			57.53				7.12						20.37	333.62			6.87	.m																																																		96a	24.67		341.36	205.99			1368.3				46.71					21.52		89.23			22.67	25.47		242.37	738.52			3882.38	531.64		57.9	343.73			33.37				8.68						7.74	81.06				.m																																																		167
SUB230885	Atopic	CSLRI	1.0	expected	41956	b	96a			699.52	295.32			878.05				1.59				182.79			11.78				47.12	11.53	753.93	2113.93			3219	501.56		94.33	307.61			18.08				31.63					1107.63	72.38	963.79			611.89	.m																																																		96a			747.74	284.46			675.18								173.75			45.21				62.57		805.14	1990.64			3369.9	614.25		106.24	306.89			23.08									573.86	82.92	1041.45			332.95	.m																																																		167
SUB230886	Atopic	CSLRI	1.0	expected	46134	b	96b			138.95	132.05			932.57								324.12	720.08	11.95	137.2			87.19	62.07		635.62	890.25			3667.73	189.33		33.41	332.9			19.17										6.47	33.9			25.13	.m																																																		96b	17.6		131.54	198.7			1193.52								378.99	812.22	9.65	169.47			85.57	36.82		502.67	812.33			3469.44	270.5		36.84	290.97			16.52									4.73	94.55	595.43			10.18	.m																																																		154
SUB230887	Atopic	CSLRI	1.0	expected	41153	b	96a			42.93	33.14			374.32									1056.13	21.96	122.48			21.46			68.81	282.28			1106.89	68.96		94.76	137.2			32.08									9.72	7.28	245.29			10.72	.m																																																		96a			27.78	42.95			226.62								14.47	1321.49	34.38	99.6			13.29			67.54	242.38			1062.56	83.27		82.36	207.45			19.76									3.43		195.78			6.87	.m																																																		168
SUB230888	Atopic	CSLRI	1.0	expected	46558	b	96b			499.6	307.61			737.54								901.42	1379.92	31.28	189.94			72.61	48.82	124.68	496.1	3311.34			9355.2	52.68	18.05	43.55	310.51			25.13				7.9					81.87	39.31	420.05			47.47	.m																																																		96b			429.22	350.22			784.14				8.68				718.35	1331.38	29.17	216.92			90.59	48.82	220.7	565.64	3732.44			8827.9	44.21		42.36	348.06			14.99				24.04					36.21	47.22	343.73			24.82	.m																																																		152
SUB230889	Atopic	CSLRI	1.0	expected	47493	b	96b	32.81		269.93	576.88			2539.66								207.29	996.12	5.65	72.14			28.26	5.99	30.62	355.44	2336.61			4510.7	75.1	491.71	92.99	173.13			65.84		67.63		27.08					553.75	57.25	944.71			75.05	.m																																																		96b	18.57		218.04	567.6			2432.9								248.39	1276.25	8.21	52.72			44.97	30	133.81	399.93	2951.59			6764.6	74.16	29.5	89.05	129.11			78.12		90.75		5.55					1043.45	16.29	751.31			149.12	.m																																																		149
SUB230890	Atopic	CSLRI	1.0	expected	47629	b	96b		2.1	301.85	64.68			1346.6								183.83	51.55	7.4				20.16	28.53	51.55	383.71	724.31			4067.61	24.67	4.73	36.71	187.02			49.75									3259.78	15.36	365.36			111.36	.m																																																		96b			235.18	37.68			931.04								137.3	37.31	8.03	3.98			34.56	61.57	16.88	412.43	734.26			4790.14	54.3	52.09	38.75	132.05			47.81									1863.08	16	493.93			90.46	.m																																																		149
SUB230891	Atopic	CSLRI	1.0	expected	25249	b	96b			37.33	149.68			248.99				11.78				33.5	164.95		41.45			12.64	3.57		32.31	265.61			406.5			38.81	64.68			51.94									842.02	24.09	1384.68			16.72	.m																																																		96b			38.81	142.34			250.32								56.42	405.76	6.47	42.2			10.81			39.68	399.92			480.35	71.34		42.18	79.58			38.16				15.63					825.57	20.26	1472.31			17.01	.m																																																		148
SUB230892	Atopic	CSLRI	1.0	expected	32133	b	96b	34.18		120.94	240.2			2075.1								379.29	717.83	10.05	175.32			61.78	49.94		432.56	1819.1			6497.5	1087.59		35.12	384.81			27.94										27.96	428.67			29.52	.m																																																		96b			100.82	198.7			1532.6								275.27	688.59	6.82	156.29			64.76	45.97		320.57	1440.78			5899.7	878.15		27.72	418.61			10.72				7.12						34.75	418.61			6.87	.m																																																		150
SUB230893	Atopic	CSLRI	1.0	expected	52503	b	102			214.49	326.23			1818.43								1059.16	216.31	8.81	36.55			99.28		31.12	502.79	1545.28			2816.1	25.66	59.87	27.78	460.74			95.75									145.3	27	527.75			101.39	.m																																																		102		13.15	217.85	343.96			1818.43								1076.5	183.52	8.61				89.05		22.48	384.24	1247.21				21.86	60.36	28.85	524.42			2358		9.98							281.2	34.49	524.42			60.2	.m																																																		151
SUB230894	Atopic	CSLRI	1.0	expected	44505	b	102			494.52	294.05			1445.21		17.33						52.86	117.51		52.28			27.53		22.48	571.11	2199.07			2684.55	528.36	70.59	19.6	438.05			54.73		23.5							147.18	42.23	1691.91			28.86	.m																																																		102		1.17	431.09	285.16			1257.86		11.04						54.34	91.32		66.55			18.48		33.64	419.77	2118.9			2494.05	520.53	102.79	27.3	480.11			69.13		23.5							110.4	38.64	1247.8			39.81	.m																																																		143
SUB230895	Atopic	CSLRI	1.0	expected	46670	b	102		253.42	389.05	558.81			3260.45								177.4	4854.44	15.84	134.25			113.72		312.47	608.71	2381.84			4518.7	47.4	366.95	225.76	495.61			72.26									3260.27	120.62	1088.92			126.98	.m																																																		102		249.31	403.31	495.61			2766.17								138.28	4497.12	12.16	106.75			191.89		232.38	557.77	1751.31			3774	57.33	1943.07	254.45	399.32			88.41									2713.97	127.35	1135.07			80.35	.m																																																		144
SUB230896	Atopic	CSLRI	1.0	expected	56701	b	102			239.19	92.87			1246.95								76.19	235.13		59.44			7.52		21.46	198.52	438.05			2543.61	169.63	14.2	9.14	658.35					45.61		15.27					29.6		92.29			11.96	.m																																																		102			234.74	110.78			1218.39		19.4						65.01	182.6		46.27			11.96		22.48	298.6	626.04			2331.78	160.89	12.1	9	616.58			9.74		1.17							24.53		34.72			9.46	.m																																																		141
SUB230897	Atopic	CSLRI	1.0	expected	27770	b	102			294.37	264.59			1857.68								76.34	413.02	13.38	31.64			106.17		5.67	227.28	755.06			2021.45	805.06	129.32	60.33	366.11			236.45									1195.87	35.47	2431.9			69.73	.m																																																		102			269.09	203.72			1569.82								57.93	572.74	27.87	105.02			635.44	25.39	358.42	125.14	455.2			3155.35	723.29	79.3	40.96	480.66			118.92		5.12							1620.12	31.23	2256.57			54.85	.m																																																		128
SUB230898	Atopic	CSLRI	1.0	expected	39550	b	102		355.73	143.3	321.24			1249.74		7.84						582.72	15170	25.35	573.79			286.59		1436.51	400.92	2423.32			1193.7	1786.59	306.14	301.37	431.41			150.46									1019.22	30.5	627.71			68.65	.m																																																		102		339.54	101.2	424.21			1236.06								569.22	13796.3	34.39	584.34			330.31		2418.95	420.13	2454.38			1500.7	1596.81	255.25	267.82	26.05			199.09									1782.77	24.2	1285.25			74.69	.m																																																		131
SUB230899	Atopic	CSLRI	1.0	expected	29867	b	107			350.61	761.81			702.76		5.73							17.21	318.36	2607.58			1999.44	237.23	1881.88	8.03	119.81				1366.09	65.68	74.8	369.53					16.77							331.93	18.35	400.1			28.3	.m																																																		107			340.18	580.08			609.77		2.24		17.45					50.35	349.04	2483.72			2306.73	312.43	2008.61	7.82	166.38				1253.22	64.33	78.89	406.58					17.66							570.63	18.86	430.12			6.06	.m																																																		-226
SUB230900	Atopic	CSLRI	1.0	expected	30432	b	107			36.87	31.8			51.15		35.97		26.05				48.21	72.46							284.04	47.13	448.97			252.17	93.17	68.39	30.84	434.83			7.76		34.17		31.8					1635.78	9.71	378.35				.m																																																		107		17.21	33.83	69.91			55.86		3.11						51.27	69.3	6.03	52.56					341.15	36.13	379.52			207.73	92.24	79.25	30.78	368.94			7.08		31.49		16.3					1767.48	8.11	363.07				.m																																																		-229
SUB230901	Atopic	CSLRI	1.0	expected	58584	b	102			166.75	243.98			1909.89		16.29						397.18	347.19	34.77	77.13			129.78		22.99	252.19	616.58			2633.19	41.01	19.91	318.83	426.98			117.14		6.76							49.56	77.56	685.13			18.06	.m																																																		102			146.27	96.93			1554.76		9.45						493.9	210.32	32.91	145.06			147.54			328.75	675.64			2424.7	62.89	54.48	295.5	732.65			146.09		28.59							52.52	75.16	719.22			13.34	.m																																																		135
SUB230902	Atopic	CSLRI	1.0	expected	54376	b	107		194.99	315.95	686.23			2926.21		20.77						95.33	781.73	6.89	160.56					26.12	217	1785.26			1752.03	511.09	48.55	63.32	298.51					13.66							227.08	65.03	535.13			132.1	.m																																																		107		136.51	335.88	514.45			1675.93		12.78						107.57	1052.43	6.64	187.96					11.89	223.63	1306.09			1435.92	457.07	27.91	51.29	327.84												172.12	45.81	433.65			139.64	.m																																																		-228
SUB230903	Atopic	CSLRI	1.0	expected	25697	b	107		5.73	335.25	41.02			546.32		27.02		52.56				15.72	30.59							6.6	412.82	509.72			1475.57	181.06	45.4	18.81	603.17			15.66									43.15	7.35	262.2			16.19	.m																																																		107		12.33	291.21	89.61			579.2		46.75		32.95					14.55							28.8	301.98	490.25			3610.53	148.2	9.68	21.47	447.79			21.45		37.76		16.87					47.65	11.76	243.47			8.27	.m																																																		-232
SUB230904	Atopic	CSLRI	1.0	expected	30096	b	107		37.76	115.79	280.93			570.86		3.98						65.69	336.54	6.19	178.63			25.14		2411.13	293.68	3721.73			3390.05	142.13	55.75	51.99	213.07			17.73		23.44		27.78					6648	5.79	1516.12			95.85	.m																																																		107		27.91	126.74	245.22			599.81		18.55		25.48				78.08	395.14		150.07			33.18		445.99	337.28	3742.86			5005	159.86	58.46	54.1	293.82			27.74		20.77		18.59					1700.21	11.33	1284.68			53.99	.m																																																		-232
SUB230905	Atopic	CSLRI	1.0	expected	61405	b	107		15.44	983.66	345.45			3969.85								576.03	1824.91	92.21	664.85			652.05		33.28	752.66	2311.67			6392.65	111.36	31.04	296.81	157.64			1095.57				31.8					242.68	44.73	1911.66			327.88	.m																																																		107		60.26	1138.99	353.08			2083		37.31						561.2	2439	98.97	675.54			884.85		54.4	786.96	1900.17			4133	107.57		294.14	130.28			990.35		25.68		24.9					76.99	38.02	1362.49			88.33	.m																																																		-234
SUB230906	Atopic	CSLRI	1.0	expected	31455	b	107		13.22	983.17	371.88			1216.1		41.35		51.41				226.68	386.37	32.62	68.17			31.86		22.55	737.42	1299.36			1746.14	25.32	35.97	245.91	260.44			99.89		43.15		43.33					94.66	73.7	2011.65			17.09	.m																																																		107		18.1	1123.8	313.17			1218.12		26.12		71.07				150.86	327.32	28.28	80.34			40.79		32.38	568.13	1230.97			1838.81	23.14	44.95	227.62	93.09			74.09		39.11		15.16					178.52	77.77	1796.64			22.19	.m																																																		-243
SUB230907	Atopic	CSLRI	1.0	expected	25473	b	107		22.55	492.25	354.84			1506.98		25.68		60.65				251.09	50.35	50.59	130.86			27.18		31.04	705.7	1751.17			1450.8		35.97	430.03	52.56			38.02		35.97		40.44					123.75	173.43	4131.2			19.45	.m																																																		107			491.57	327.84			1329.86		38.66		76.28				197.42	73.82	33.83	83.23			15.48		77.44	472.1	1529.15			2476.8		35.97	364.33	87.29			36.4		15.44		44.48					384.98	92.84	5261.14			63.47	.m																																																		-245
SUB230908	Atopic	CSLRI	1.0	expected	68508	b	107		68.39	644.11	436.01			1804.49		4.85						293.69	676.54		67.6			29.79		108.74	571.15	2368.7			2500.5	23.38	64.78	40.29	380.11			17.73		27.46		17.45					184.01	75.15	1964.11			7.25	.m																																																		107		67.49	641.09	395.99			1398.51		31.94		45.63				449.39	375.75		80.34			26.71		180.35	574.92	2851.25			1942.45	37.79	44.5	35.1	340.75			46.39		16.32		24.9					106.47	38.19	1053.87			11.31	.m																																																		-238
SUB230909	Atopic	CSLRI	1.0	expected	49921	b	107		3.98	539.35	324.9			2012		11.01						302.36	184.92	32.89	58.92			108.03		39.56	1131.69	2771.15			4356	90.84	35.07	257.96	562.91			109.5		35.97							88.76	66.74	2378.01			8.62	.m																																																		.m																																																		.m																																																		-251
SUB230910	Atopic	CSLRI	1.0	expected	70829	b	107		5.73	394.98	393.63			1114.18		26.12		40.44				54.1	154.76	7.99	88.45			36.69		47.65	755.95	2029.69				196.68	152.93	325.38	93.67			151.05		39.56		15.73					51.25	68.96	2380.67			235.25	.m																																																		107		17.66	351.98	380.11			1191.56		30.59		25.48				50.19	48.1	6.15	73.38			10.79		103.74	755.95	3453.98			7089.25	185.48	32.38	270.25	72.23			133.07		45.4		57.18					91.49	61.47	3329.16			325.85	.m																																																		-237
SUB230911	Atopic	CSLRI	1.0	expected	48666	b	107			10.42						6.6							51.25								12.74	18.59			10.35		13.66		401.87					17.66							19.88		496.15				.m																																																		107		11.01	7.31	39.87					3.98							62.97		36.41						20.28	35.26			15.21			6.27	436.6					24.78							8.36		521.54				.m																																																		-219
SUB230912	Atopic	CSLRI	1.0	expected	54264	b	107		11.45	428.38	236.45			3840.09		35.52		19.17				54.8	83.78	11.18	53.72			52.72		35.52	574.31	1804.86			3246.45	65.03	3.98	109.49	142.5			13.43		40.9						10.04	53.95	52.25	3522.86				.m																																																		107	13.09	11.45	444.84	253.42			4836.04		23.89		35.83				55.5	41.35	14.89	95.41			41.95		15.44	788.68	1759.37			2969.7	62.01	32.38	103.89	180.96			15.21		43.15		38.71					47.65	46.44	2713.78				.m																																																		-254
SUB230913	Atopic	CSLRI	1.0	expected	45791	b	112		3.95	275.31	170.84			428.67		19.08						154.67	743.78		121.6			25.96	5.64	23.79	643.66	913.14			1513.49	256.44	48.74	126.09	431.01			27.82		75.52					4.89		247.32	29.79	1165.81			135.1	.m																																																		112			254.51	207.74			534.2		14.41						199.14	874.4		145.18			30.21		19.75	534.43	761.79			1403.21	259.62	36.71	83.91	524.09			34.09		52.54		8.54					140.98	21.38	858.35			31.42	.m																																																		123
SUB230914	Atopic	CSLRI	1.0	expected	49361	b	112		0.82	227.04	172.7			1674								130.86	130.64	14.02	56.34			18.93		9.78	678.72	927.81			2268.3	47.78	47.02	395.37	117.73			162.05		19.75							480.13	34.78	1043.08			59.88	.m																																																		112		9.78	225.61	193.05			1355.49		0.82						91.54	99.78	11.91	79.34			18.57		2.68	675.05	1170.23			2435.2	35.53	62.95	307.31	194.89			148.28		21.77		12.37					375.07	32.71	945.58			46.78	.m																																																		122
SUB230915	Atopic	CSLRI	1.0	expected	65262	b	113	23.48		326.7	876.97			3943.54								41.02	16.04	25.31	241.42			51.37			585.4	3270.87			6260.95	436.63		78.66	98.2			16.69										83.97	520.93				.m																																																		113	16.55		338.9	973.51			3307.72								38.27		22.1	215.77			36.91	18.67		750.76	2737.01			4899.6	401.54		89.67	117.54			10.48										44.95	378.96				.m																																																		123
SUB230916	Atopic	CSLRI	1.0	expected	46896	b	96b			231.77	223.47			1103.91								232.78	200.6		126.9			40.15	54.3		426.41	1256.9			7175.4	172	32.86	78.78	322.07			43.39									252.29	63.95	1107.72			45.54	.m																																																		96b			214.45	220.56			965.11				41.45				220.28	206.5		119.53			38.83	59.53		384.11	1004.75			5812	173.4	122.13	69.01	270.69			108.89				5.55					419.32	39.06	1034.39			94.25	.m																																																		151
SUB230917	Atopic	CSLRI	1.0	expected	25585	b	112			532.95	1077.93			3065.3		3.31						26.51	25.82		19.48					6.52	667.97	1124.25			2612.2	149.6	19.75	122.65	167.73			43.47		7.17		16.88						104.17	512.89				.m																																																		112		7.17	526.64	1053.02			3365.45								19.1	19.42					7.81		20.76	443.38	1204.43			2559.5	115.29	11.1	105.72	187.52			18.93									11.76	50.62	569.55			6.1	.m																																																		120
SUB230918	Atopic	CSLRI	1.0	expected	30659	b	112		15.74	342.88	153.99			2248.77		0.82						118.78	130.64	8.72	11.44			36.38		15.07	277.72	905.21			2164.2	80.41		17.06	175.18			13.54		0.22							702.69	9.95	1139.33			53.35	.m																																																		112		18.08	282.79	124.82			1751.71		0.22						117.44	122.81	8.2	38.68			21.96		0.22	439.47	1017.04			2827.05	73.6	18.41	18.15	285.45			11.98		0.52							1075.97		1279.1			48.01	.m																																																		117
SUB230919	Atopic	CSLRI	1.0	expected	53586	b	112			234.04	403.31			1348.23		9.78						59.91	22.78					6.31		10.11	226.07	1039.97			2025.65	380.42	30.57	31.61	341.3			13.38		6.85							213.24	24.54	1157.6			26.25	.m																																																		112		1.43	219.46	254.92			960.89								67.59	11.1						0.68	44.95	249.26	1043.08			2035.45	316.56	31.25	44.28	361.41			18.75		15.07							321.42	15.3	1195.55			44.89	.m																																																		117
SUB230920	Atopic	CSLRI	1.0	expected	81506	b	113			322.59	1604.66			3077.8							7.16	87.82	229.2	11.05	76.44			40.23	17.5		220.84	2614.86			5297.9	858.4		132.53	486.02			62.31										243.76	840.87				.m																																																		113	18.44		281.93	1411.18			3320.75				16.42			13.13	76.78	164.05	14.12	84.75			35.63	13.13		522.97	3547.81			5556.65	968.8		119.51	310.4			44.96	15.59							13.13		145.99	1024.27				.m																																																		117
SUB230921	Atopic	CSLRI	1.0	expected	84337	b	113			397.02	26.71			557.48				14.52				63.66		9.21	20.29				19.37		245.38	64.95			2254.1	67.36		11.8	501.14					9.78		14.52					239.05	12.23	404.68			19.81	.m																																																		113			362.27	23.23			460.6								61.19		9.36				13.5	18.67		523.68	361.7			1521.55	59.55		16.63	369.36			7.82									98.81	10.83	387.94			17.49	.m																																																		115
SUB230922	Atopic	CSLRI	1.0	expected	66721	b	107		11.89	292.4	590.73			2894.53		23		45.06				102.4	183.09	9.71	60.07			48.33		35.07	331.6	1154.35			2228.6	292.93	64.78	251.06	360.72			64.97		36.86							595.23	228.97	3245.09			75.2	.m																																																		107			245.78	599.02			2397.61		35.07						77.28	69.3	8.11	65.28			35.55		18.55	264.57	956.89			1747.05	307.08	61.17	232.01	348.97			68.46		35.07		36.41					440.9	190.18	2764.22			52.03	.m																																																		-239
SUB230923	Atopic	CSLRI	1.0	expected	93240	b	113	15.59		119.47				819.91								32.71	10.25					9.3	16.55		434.03	396.3			1457.04	115.04			30.73													50.45	1001.68			10.13	.m																																																		.m																																																		.m																																																		110
SUB230924	Atopic	CSLRI	1.0	expected	88964	b	113	17.02		308.62	624.3			2206.52				15.47				99.68	142.73	17.65	68.22			70.83		136.98	842.9	2131.32			3201.95	261.61		372.45	27.71			202.75		9.09							56.28	32.28	1192.42			40.64	.m																																																		113			351.07	592.1			2532.42				32.77				94.77	24.93	15.65	40.49			51.8	17.97	38.86	967.47	2035.36			3384.8	247.94		293.55	47.82			155.96									17.78	23.31	1063.94			30.25	.m																																																		110
SUB230925	Atopic	CSLRI	1.0	expected	89514	b	125			253.23	543.93			3522.84								161.27	33.52	8.38	105.8			22.58		27.29	486.63	1945.94			3670	54.88		246.42	157.59			93.78									3.93	148.59	3572.08			103.01	.m																																																		125	14.58		239.65	496.17			3897.76				52.54				111.92		5.41	44.15			16.73		10.69	549.98	1798.11			3125	9.55		218.73	161.19			86.73				17						151.99	2648.76			24.88	.m																																																		158
SUB230926	Atopic	CSLRI	1.0	expected	98365	b	125	10.62		582.64	1119.45			2189.19								147.05	361.3	6.15	104.81			13.25		161.35	1299.29	5356.12			7451	473.47		171.43	435.9			16.24									127.62	456.47	2585.37			98.04	.m																																																		125		12.14	661.55	1103.8			2480.21				23.02				146.56	352.94	4.35	162.99			12.92		68.51	1297.14	4919.49			6807	442.95	5.04	159.15	369.74			10.15				8.5					67.41	349.24	3340.68			91.52	.m																																																		151
SUB230927	Atopic	CSLRI	1.0	expected	95887	b	127	21.63	20.15	224.31	23.11			772.56								3.04	8.26	14.35				32.31	23.05	9.91	246.39	175.15			1261.17	37.3	34.95	89.62	126.6			38.82									1201.89	11.65	334.21			15.69	.m																																																		127	13.99	7.26	202	11.06			730.63								20.18	4.89	13.19	13.97			39.38	24.09	40.7	161.12	138.78			1105.88	36.99	43.1	111.22	260.79			36.77		1.36							1247.15	8.86	221.97			9.47	.m																																																		146
SUB230928	Atopic	CSLRI	1.0	expected	94993	b	127	27.15	7.26	348.92	352.29			1151.26		6.93						94	512	18.03	47.12			65.45	33.29	3.51	307.03	671.8			1984.62	15.61	1.36	50.39	64.79			8.41									263.11	87.16	1547.1			75.5	.m																																																		127	17.18		290.79	215.64			1006.54								86.52	433.48	13.63				43.78	46.69	2.45	470.69	913.95			2196.97	5.54	2.09	47.4	96.79			8.33							3.17		496.77	90.57	1518.31			98.59	.m																																																		143
SUB230929	Atopic	CSLRI	1.0	expected	90570	b	127	24.09	8.92	516.15	175.8			1255.01								298.98	85.86	94.22	13.01			87.73	30.1	10.24	729.39	898.41			1892.91	36.08	5.58	293.12	53.36			42.93									8.26	36.12	1200.5			6.76	.m																																																		127	27.15	25.45	612.9	188.12			1394.18		4.55						323.92	108.98	86.95	25.74			104.04	32.03	14.12	559.26	988.27			2328.63	24.78	7.59	334.82	111.49			48.19			6.47						45.49	54.32	1538.7			9.29	.m																																																		143
SUB230930	Atopic	CSLRI	1.0	expected	102056	b	127		1674.47	81.99	629.11			1073.36								128.66	1237.61					19.93	20.91	1182.78	63.13	1288.88			1237.63	87.25	37.68	16.04	276.87			10.44		6.93		13.01					176.19		785.15			11.76	.m																																																		127	19.45	1712.02	81.31	594.41			1066.05							14.53	112.98	1991.53		20.44			100.14																													.m																																																		140
SUB230931	Atopic	CSLRI	1.0	expected	97809	b	127		9.91	180.52	98.91			791.58								76.39	122.25	32.21	90.39			38.63	24.78	64.41	363.08	495.54			1754.11	54.76	29.77	100.8	304.46			48.95				20.44				4.35	1060.81	64.14	755.83			364.19	.m																																																		127			169.68	115.64			827.2								66.71	156.31	29.59	125.24			30.28	24.44	64.7	382.39	419.67			1679.06	32.66		121.02	167.97			51.59				34.2					1135.9	54.99	935.82			328.89	.m																																																		130
SUB230932	Atopic	CSLRI	1.0	expected	90196	b	142	66.6	2.44	482	497			5500	6.69						1.32	287	6.83	12.8	52			145	78.5	1.08	571	2850			8540	70		58.4	104			47.3	2.06		8.38							213	761			6.15	.m																																																		142	63.2		491	902			4880								272	13.3	11.2	39.5			113	87.6	9.41	499	2350			8860	58.7		60	65.1			49.4			9.26	4.64					5.56	185	841			11.5	.m																																																		212
SUB230933	Atopic	CSLRI	1.0	expected	90020	b	142	63.5	4.42	673	153			2290	4.57	2.56		33.5			2.44	62.5		23.8	58.6			17.1	71.8	13.8	735	537			2030	61.2	46.1	124	69.7			112	3.75	6.64		5.42				16.1	35.4	262	2080			49.5	.m																																																		142	61.7	5.68	891	205			2050	2.93	12.5		12.3				43.7	26.4	20.5	68.7			22.4	67.1	16.1	772	485			1490	46.1	20.1	97	50.5			77.7	7.44	14.8		42.5			4.98	15	62.8	302	1710			97.9	.m																																																		204
SUB230934	Atopic	CSLRI	1.0	expected	89734	b	142	23.8	44.6	279	381			994								73.6	35	12.2	11.7			29.6	62.8	192	332	1620			1670	67.2	114	249	168			71.8	1.49	10.5		26.5			1.59	17	4170	103	2630			257	.m																																																		142	31	69.4	289	380			1120				9.39				66.4	50.7	15.4	21.4			23.8	64.9	315	327	1680			1920	113	93.8	303	173			118	2.45	5.68		21.4				16.1	2600	74.2	2020			188	.m																																																		203
SUB230935	Atopic	CSLRI	1.0	expected	90482	b	142	31.2	83.4	150	573			1550				6.15				95.5	420	20	139			52.3	55.8	1280	101	3090			1570			57.2	48.5			27									366	81	3800			76.9	.m																																																		142	45.6	20.6	208	455			1700				16.1			2.17	75.9	144	24.3	107			54	76.4	1240	109	2150			2260		3.05		19.8						37.7	45.5			18.1		61.7	92.3	2580			34.2	.m																																																		205
SUB230936	Atopic	CSLRI	1.0	expected	89624	b	142	45.7	10.2	442	491			1340	6.76	7.6		19.3				133	43.4	12.3	85.2			23	71.1	13.5	404	1610			1150	147	27.4	132	64.6			48.4	8.64	7.6		23.9			3.97	12.8	791	113	1910			46.1	.m																																																		142	33.6	12.2	384	497			1070	1.81	11.2		14				126	37.4	8.16	75.9			18	54.6	16.1	307	1370			947	99.2	23.1	119	71.2			41.3	3.75	5.05		36			3.16	12.7	582	120	1650			54.2	.m																																																		200
SUB230937	Atopic	CSLRI	1.0	expected	100459	b	142	95.2	32.1	568	1800			11300	3.26	17.4		36.5			1.35	910	258	5.7	249			94.9	84.2	32.8	1350	4770			13800	319	30.8	70.5	114			37.4	5.41	7.6		47				4.41	19.8	45.9	752			3.97	.m																																																		142	89	15.5	547	1600			10400	8.29	10.2		9.39			3.64	1010	322	6.81	260			78.9	97.4	37.4	871	5320			16800	225	41.4	67.1	217			39.2		16.1		26.5				1.32	20.1	76.6	1080			6.44	.m																																																		198
SUB230938	Atopic	CSLRI	1.0	expected	105629	b	142	56.3	75.5	173	545			2120	5.24	8.57		25.5			3.81	1130	3030	43.2	122			184	90.6	229	342	3940			3660	27	22.4	98.8	77.9			52.3		9.54		22.4			1.74	23.3	2050	77.4	7560			320	.m																																																		.m																																																		.m																																																		193
SUB230939	Atopic	CSLRI	1.0	expected	90108	b	142	42.9	20.8	705	234			816	7.78	11.5		26.5			3.48	281	54.1	61.2	72.3			61.6	73.9	8.89	860	676			2090	21	8.25	516	133			79.8	4.41	5.68	3.48	22.4			2.68	12	3.8	39.7	772			11.6	.m																																																		142	38.9	4.42	671	148			752	3.26	3.18		23.4			5.58	207	25.4	45.1	72.8			48.6	83.4	7.92	1570	573			1680	12.3	10.5	390	128			50.3	3.75	10.2	7.76	18.3				6.08	9.87	41.8	1080			12	.m																																																		191
SUB230940	Atopic	CSLRI	1.0	expected	90746	b	134	33.9	4.47	433.7	155.48			488.2								75.82	428.98	31.16	39.44			16.27	91.27	46.72	275.43	788.85			1062.83	23.68	13.01	169.04	168.98			51.7									613.81	40.89	722.11			17.79	.m																																																		134	42.46		323.89	150.99			450.18																																											.m																																																		98
SUB230941	Atopic	CSLRI	1.0	expected	116675	b	134	115.8		358.27	468.61			1417.88								110.53	2.8		3.47			37.47	214.65	6.94	165.13	938.96			2974.19	69.12		14.52	175			21.88									176.68	36.92	1544.09			73.66	.m																																																		134	112.79		337.2	387.71			1373.11								119.56			32.35			46.46	234.77		183.17	1049.72			2977.7	56.5		17.05	118.2			28.66									132	57.99	1222.34			41.67	.m																																																		94
SUB230942	Atopic	CSLRI	1.0	expected	96474	b	142	21.2	9.54	175	132			507	2.93	4.42		40.5			2.2	37.7	22.1	21.3	56.5			23.2	46.3	16.1	171	617			1450	16.4	10.8	231	90.4			53.4	4.41	5.68		33.5					38.8	47.5	759			20.1	.m																																																		142	26.9	4.42	216	113			476	1.97	8.89		11.7				45.9	21.1	27.4	49			36.2	42.5	3.8	176	607			1210	5.91	11.5	237	80			52.4	3.42	12.8		33.5			2.92	5.41	30.8	43.6	638			10.1	.m																																																		187
SUB230943	Atopic	CSLRI	1.0	expected	117049	b	134	146.49		621.51	386.16			1768.91								244.72	45.56		6.1			10.1	261.83	0.66	901.01	2092.36			6890	5.03	0.21	52.19	301.29			13.9										26.21	263.76				.m																																																		134	125.34		510.15	279.82			1336.66								244.72	28.06		18.35			4.7	254.67	7.35	642.77	2053.59			7520	1.79		37	230.98			11.19										24.52	322.05			4.7	.m																																																		92
SUB230944	Atopic	CSLRI	1.0	expected	91076	b	134	197.12	14.21	35.17	611.4			2889.86		12.2		19.74			5.49	86.28	54.81	6.97	65.34			45.08	270.52	51.73	119	1918.53			3469.64	444.94	33.53	7.77	173.5			9.74		4.47		29.53				0	206.27	38.96	465.49			89.49	.m																																																		134	227.64		29.83	606.67			3078.6								65.4	9.38		34.47			41.94	267.96	56.35	107.57	1822.38			3944.58	331.52	24.52		178.01			9.62		5.29		19.74					218.44	32.08	355.21			85.29	.m																																																		91
SUB230945	Atopic	CSLRI	1.0	expected	107117	b	134	128.36		452.68	827.08			1489.75				8.78				77.32	49.81	7.57	80.63			26.04	191.79	45.56	499.82	1855.23			2699.7	292.53	11.8	114.13	237.07			70.67								25.13	581.29	73.13	863.78			199.51	.m																																																		134	139.68		483.55	724.49			1620.31				6.77				69.86	56.35	8.59	66.79			31.84	196.86	186.31	425.56	1902.9			2677.81	326.9	11	133.07	323.59			87.75								41.97	511.77	115.91	749.1			212.27	.m																																																		88
SUB230946	Atopic	CSLRI	1.0	expected	89074	b	145	27.3		610	83.9			471				5.43			2.87	51.5	25.2	16.2	56.2			8.89	86.5		922	526			568			61.3	225			14									222	35.7	765			75.9	.m																																																		145	38.5		642	108			529							3.02	67.5	56.3	18.2	99.8			6.33	89.6		1010	640			716			80.7	340			10.2									187	22.9	593			51.9	.m																																																		192
SUB230947	Atopic	CSLRI	1.0	expected	108379	b	145	126		1400	78.8			4490			3.2	25.4			2.23	65.8	6.98	31.1	172			33.6	68.7		590	435			344	36.2		69.1	53.3			12.1			7.64												.m																																																		145	151		1070	76.6			2580		3.91	4.01	56.2			3.5	55.4		22.1	174			17.1	89.3		377	526			661	15.2		57.5	34.2			8.74			4.71												.m																																																		189
SUB230948	Atopic	CSLRI	1.0	expected	90284	b	145	34		291	185			661							5.36	27	1.5	3.27	11.8			8.28	65.2		197	196			241	147		47.4	160			30.1				19.6			3.76			5.05	165			10.3	.m																																																		145	35.1		276	137			582				6.84																																							.m																																																		186
SUB230949	Atopic	CSLRI	1.0	expected	116201	b	145														4.8	214		19.5				45.6	114	158	1500	2190			1140	187	10.8	228				35.6			3.64	6.84			1.81	7.68	240	178	1060			148	.m																																																		145											3.99			2.57	185	3.53	18.7	16.7			34.6	97.3	50.4	1300	1960			1070	173	5.77	154	21.1			21									220	117	1190			83.1	.m																																																		185
SUB230950	Atopic	CSLRI	1.0	expected	120186	b	145	50.3		120	285			284								127	9.71	9.71	72.2			31.2	114		590	828			481	49.4		73.7	25.4			36.6				35.7			3.61		6.89	25.1	1460			18	.m																																																		145	59.8		112	243			326								117	15.8	10.1	103			24.1	110		393	1070			1150	54.5		58.9	81			42.2							6.52		6.05	24.2	1230			18.1	.m																																																		182
SUB230951	Atopic	CSLRI	1.0	expected	90658	b	145	129		146	2130			1850				21.8			2.34	31.3		5.28	20.3			5.62	96.3	3.53	277	3540			9930	514		49	32			13.3							3.58			23.1	1020			9.62	.m																																																		145	114		134	1640			1800								17.7		3.64	64.2			4.28	110		238	3330			7050	579	11.9	56.3	33.5			19.8				14.6			2.91			25.9	1110			12	.m																																																		181
SUB230952	Atopic	CSLRI	1.0	expected	118260	b	145	113		667	795			1160							3.02	49.4		23	92.5			42.6	119		725	1570			1020	32.4		137	63.5			57.1			5.28	3.99			1.77		13.9	97	995			60.5	.m																																																		145	97.3		717	1520			1750				34.9			3.69	58.7		25.1	105			41.5	119		751	1420			1610	33.8		123	77.3			63.8			6.5	7.54			4.02			100	551			30.1	.m																																																		179
SUB230953	Atopic	CSLRI	1.0	expected	120523	b	145	84.7		441	253			565				3.23			3.35	139		11.6	30.5			25.6	138		527	1650			2770	61.1	2.77	68.4	199			82.1			5.05	11.8			4.39		6.8	95.4	379			36.5	.m																																																		145	85.6		520	208			626			3.52	4.72			5.58	128		8.39	81.7			18.1	144		450	1470			18.1	52.9		71.6	283			47.1			7.1				5.32			88.7	330			25.3	.m																																																		179
SUB230954	Atopic	CSLRI	1.0	expected	127167	b	145	63.2	11.9	587	133			1680		1.63	2.45	14.6			4.47	116	28.1	63.3	99.8			43.4	124	45.2	361	1580			1650	130	34.8	391	206			175			4.94	29.8			3.91		136	79.4	1550			70.1	.m																																																		145	64.9	14	565	122			1590			3.58				3.17	133	48.4	64.7	106			65.1	119	30.8	526	1920			1530	121	29.5	413	172			150			6.17	23.2			3.99		134	60.9	1240			76.3	.m																																																		171
SUB230955	Atopic	CSLRI	1.0	expected	126836	b	145	102	18.9	496	106			832			3.01	49.6			6.03	132	29.3	25.9	65.7			42.2	106	2.28	304	886			756		5.86	74	424			14.7			5.95	40.8			4.88			53.3	307			5.17	.m																																																		145	89.7	17	459	96.2			570			3.14	26.2			3.65	93.4	23.8	24.6	39.3			37.7	79.6		295	809			425			72.2	424			21.9			4.71	49.6			4.06			66.6	366			4.8	.m																																																		169
SUB230956	Atopic	CSLRI	1.0	expected	125421	b	157	101	24.5	321	103			509	1.51	20.7		28.9			1.05	141	22.2	13.9	111			43.6	125	20.7	336	884			3570	119	24.9	233	412			46.6	3.47	14.1		30			1.59	15.9	290	21.9	720			89.7	.m																																																		157	96.4	14.1	257	92.1			631	4.63	16.8		56.5			2.29	123	24.9	12.5	97.4			35.7	134	16.8	440	718			3770	118	26.8	151	492			41	3.72	8.05		28.3			4.8	5.48	39.9	20.2	545			32.3	.m																																																		245
SUB230957	Atopic	CSLRI	1.0	expected	88788	b	156	45.3	86.2	263	731			1380	2.13	30.1		35.8			1.71	115	46.7	2.05	35.8			8.57	54.7	177	272	2100			4010	185	79.8	23.7	627			13.1	1.47	31.7		56.4			3.76	12.1	2430	9.01	2080			171	.m																																																		156	53.9	116	312	740			1650	2.57	25.3		63			1.66	116	67.9	2.24	60.5			14.6	54.8	43.8	420	3220			2600	188	92.5	32.8	587			11.5	3.67	51.9		70.5			4.5	12.1	2430	12.9	2290			202	.m																																																		228
SUB230958	Atopic	CSLRI	1.0	expected	126726	b	157	107	5.49	375	314			456		14.8		34.8				180	99.2	7.89	161			18.9	138	8.46	484	873			3830	128	19.9	54.9	118			71.3		8.05		21.8			2.49	2.44	80.8	99.2	669			1.96	.m																																																		157	114	18.3	344	224			453	1.51	24.1		47.1				173	93.9	8.49	155			14.9	142	6.79	511	750			3980	164	23	45.9	152			79.2	1.89	11.3		27.7			1.54	3.47	91	60	644			2.38	.m																																																		232
SUB230959	Atopic	CSLRI	1.0	expected	113904	b	157	123	5.49	123	220			942	1.89	14.1		28.9			1.73	145	15.2	2.62	10.7			10.4	128	21.8	210	1120			1690	6.87	13.7	31.2	172			20.3	1.74	11.3		11.7				44.3	364	23.2	2230			436	.m																																																		157	123	27.1	125	235			813	6	17.6		33.6			1.39	125	24.1	1.89	49			10.6	114	27.1	163	995			2070	11.2	21.4	22.4	126			19.2	3.8	17.2		27.7				35.5	194	37.9	1780			270	.m																																																		231
SUB230960	Atopic	CSLRI	1.0	expected	108709	b	157	54	13.1	785	153			255				20.1				216	139	363	118			188	136	161	677	3620			1370	21.5	3.89	45.3	33.6			18.5				4.47				29.7	1010	28.1	6400			183	.m																																																		157	58.8	9.93	856	147			259				24.7				219	137	325	117			190	112	150	698	4120			1090	28.9		53.8	30.6			15.7	1.35			3.03				21.1	1430	17	5520			123	.m																																																		228
SUB230961	Atopic	CSLRI	1.0	expected	91296	b	157	45.9		404	96.7			307				3.99				51.1	35.2	17.6	68.6			21.5	61.3	35.2	217	647			354	11.8		31.1	34.2			13.7				11.2				7.49	4660	16.3	1190			80.1	.m																																																		157	53.6		354	80.9			264				1.15			2.17	50.3	22.4	14	56.5			15.4	71	3.89	236	776			407	10.1	11.5	25.9	42.8			10.8				14.5				7.13	5180	7.34	877			50.8	.m																																																		227
SUB230962	Atopic	CSLRI	1.0	expected	138655	b	157	87.4	16	273	486			298	3.39	10.9		42.2			1.96	167	297	13.8	71.2			84.4	121	48.7	273	3290			1180	116	28.3	146	85.5			118				25.3				15.1	328	108	2720			45.8	.m																																																		157	63.5	26	231	350			264	1.82	13.7		36.7			2.26	163	148	15.1	88.8			87.5	121	31.7	349	2770			1030	111	16.8	117	77.7			91.2	2.2	12.1		16.7				9.47	165	30.7	2730			35.4	.m																																																		218
SUB230963	Atopic	CSLRI	1.0	expected	108599	b	157	67.2	15.5	288	129			314				16.1				146	131	85.8	130			92.9	96.2	9.12	252	1790			734	17.8	3.89	147	69.2			44.7				10.1				9.56	423	34.1	2400			42.3	.m																																																		157	65.3	13.9	284	114			317								138	83.1	61.8	103			87.6	85		410	1590			482	28.5	19.4	165	62.8			50.2	2.05			15				11.8	553	23.3	2160			40.5	.m																																																		216
SUB230964	Atopic	CSLRI	1.0	expected	112211	b	157	64.9		165	227			389		4.86		13.4				265	304	53	33			70.4	93.8	18.6	443	873			964	86.9	18.6	432	312			105	3.47	11.3		17.3				47.4	266	78.9	817			428	.m																																																		157	61.3		162	234			392	1.35			14.5			3.26	228	200	38	34.8			66.7	102		302	791			837	89.5	27.7	291	269			112	2.59	7.22		16.1				32.8	198	78.1	708			209	.m																																																		214
SUB230965	Atopic	CSLRI	1.0	expected	148320	b	157	110	48	169	386			413	2.75	24.5		25.3			3.18	244	445	8.97	65.4			74.6	139	44.7	224	953			1170	148	87.5	46.3	174			30.8															.m																																																		.m																																																		.m																																																		214
SUB230966	Atopic	CSLRI	1.0	expected	104465	b	157	98.6		312	221			877				9.06				243	30	27.7	52.7			20.7	89.3		274	660			784	4.46		21.6	222			12.5				11.7				11.2	96.9	49.1	4530			67.1	.m																																																		157	78.6		300	163			761		4.86		25.3				113	7.05		24.7			22.2	96.1		306	746			644	2.83		22.5	174			10.5				21.8				2.99	20.1	47.5	2440			18.6	.m																																																		211
SUB230967	Atopic	CSLRI	1.0	expected	107807	b	157	95.8	27.7	123	445			901				9.06				91.2			9.06			49.7	102	27.4	539	2180			2610	26	7.88	22.8	643			52.9				11.2				6.34	184	13.4	673			66.8	.m																																																		157	106	48.5	138	489			951				13.9				212	7.88	25.1	37.9			19.1	122	13.1	334	1800			2220	19.8		25	509			61.3				4.96				6	90.9	16.2	680			33.1	.m																																																		210
SUB230968	Atopic	CSLRI	1.0	expected	119686	b	181		31.8	181	113			1020		5.82		32.7			15	75.1	145		7.14			19.9	7.89	19.5	71.1	339			823	366	191	37.5	284			21		38.3		21.9			25.6								.m																																																		.m																																																		.m																																																		333
SUB230969	Atopic	CSLRI	1.0	expected	131858	b	181		324	385	579			937		19.5		17.6			15.1	242	2730	42.9	160			63.9		9.48	446	1310			761	12.6	28.9	40.2	34.7			45.7									1170	133	3180			264	.m																																																		181		336	409	507			1190		17.8		39.7			15.1	291	3280	54.9	261			112		33	306	1790			925	48.5	123	52.9	139			70.5		19.3		50.9			10.3		929	134	5010			230	.m																																																		327
SUB230970	Atopic	CSLRI	1.0	expected	108819	b	181		1.96	634	181			1340		12	5.56	19.8			1.29	352	39.5	36.1	109			48.2		36.3	557	878			848	6.1	9.77	198	62.5			35.5		8.35	4.37	12.6			2.52								.m																																																		.m																																																		.m																																																		320
SUB230971	Atopic	CSLRI	1.0	expected	163583	b	181		17.2	502	129			3090		17.8		30.2			6.53	145	77.7	30.7	113			116		55.9	460	1820			2950	31.4	37.2	35.1	149			46.4	5.32	19.5		37.7			16.3		131	84.8	2300			155	.m																																																		181	3.16	27.7	559	132			3300		12.9		28.1			8.01	131	30.7	32.6	104			95.2	5.11	32.1	746	1180			2430																						.m																																																		319
SUB230972	Atopic	CSLRI	1.0	expected	162867	b	182		16.9	260	253			1550		5.32						66.7	7.63	2.3	10.7			12.4		14.2	455	1210			2800	8.07	17.9	96.8	54.7			21.1			4.25						128	281	1000			17.8	.m																																																		182		2.17	308	368			1640		1.69						63	3.69	2.15	45.1			7.58	4.05	13.3	485	1350			1920	21.8	42.4	126	409			59		3.17	2.45						247	227	1000			77.3	.m																																																		311
SUB230973	Atopic	CSLRI	1.0	expected	155095	b	181		18.1	461	235			2160		11.5		45.6			13.8	151	39.5	30.3	89.7			65.8		9.2	324	879			503	8.06	30.7	137	234			45.3		16.4		23.5			14.6	5.91	158	53.2	1770			35.1	.m																																																		181		28.3	461	248			2050		17.8		18.2			15.7	157	35.1	34.4	89.2			76.9		16.1	392	1110			687	5.32	26	86.5	220			55.3		16.7		36.7			6.75		288	45	1770			48	.m																																																		310
SUB230974	Atopic	CSLRI	1.0	expected	167576	b	182		12.6	42.7	156			939		1.2						5.21	36.8					11.7	3.82	11	36	251			1080	28.6	52.2	4.66	733			10.2		6.17		24.7					696	1.38	690			51.6	.m																																																		182		19.3	27.3	110			880								19.4	44.6		13				2.24	47.7	45.9	339			989	30.6	27.7	2.29	326					7.04													.m																																																		310
SUB230975	Atopic	CSLRI	1.0	expected	112541	b	182		57.6	393	265			2060		4.22						131	59.2	11.9	25.4			84.3	3.27	69.3	450	2280			3870	139	146	74.3	324			134									118	66.4	1820			93.5	.m																																																		182	1.52	70.1	385	248			1650		11						121	47.3	11.5	39.5			83		44.6	400	2450			3280	165	122	96.1	277			145		7.63		4.09				3.27	425	78.2	1110			141	.m																																																		308
SUB230976	Atopic	CSLRI	1.0	expected	126946	b	182	1.52		333	407			1120		15.2		22.6				178	78	32.1	170			111		40.9	276	1770			1120	35.9	27.3	121	148			81.5		7.04							594	134	5350			194	.m																																																		182		3.17	347	463			1410		2.66		22.6				171	48.4	31.9	159			128		1.2	268	1810			995	16.5	14.2	91	195			87.4		4.49							384	163	5060			145	.m																																																		307
SUB230977	Atopic	CSLRI	1.0	expected	167686	b	188	12.4	14.2	425	481			3810		4.59						210	25.8	5.93	23.7			29.4	15	10.9	475	2130			5420	75.2	9.14	59.8	385			41.2								7.37	170	81.5	3290			203	.m																																																		188	11.3	19.3	446	417			3490		4.25						296	552	15.4	57.9			98.6	14.5	4.48	454	1900			4820	87.1	11.3	59.3	466			43.9		4.48					1.36	15.9	211	66.9	3460			238	.m																																																		344
SUB230978	Atopic	CSLRI	1.0	expected	168235	b	188	15.8	18	509	1000			4550		5.72		6.56			1.36	107	12.9		52			20.7	12.3	13.4	556	2910			1640	46.2	5.15		425			6.93		3.6					2.24		14.1	81	3080			48.7	.m																																																		188	8.59	10.2	505	1130			4000		10.6						99.6	10.6		65.6			22	12.9	25.9	497	2880			1860	28.2	3.38		362			6.42		3.17					6.03		54.9	120	3250			245	.m																																																		341
SUB230979	Atopic	CSLRI	1.0	expected	109174	b	188	8.24	14	469	1500			3500		5.37		19.8			3.79	166	10.9	12.7	33.1			85.9	17.4	100	416	1710			998	23.9	15.1	88	601			80		4.92							104	33.6	4220			337	.m																																																		188	10.8	9.99	530	1790			4100		5.72					2.95	118	13.6	12.5	49.1			70.3	15.5	59.2	472	2040			1130	30.9	15.1	85	665			53.4				13.1					57.1	42.9	3680			185	.m																																																		340
SUB230980	Atopic	CSLRI	1.0	expected	162640	b	182		623	576	530			1770		340	2.97	26.2			99	122	1140	50.5	110			64		903	416	2210			3870	129	352	271	557			89.4		4580	15.6	324			78.4		3670	19.1	978			133	.m																																																		182	2.17	713	686	604			2200		167	1.87				30.9	85.9	1110	56.4	116			105	3.27	707	430	2160			3500																						.m																																																		301
SUB230981	Atopic	CSLRI	1.0	expected	112431	b	189	18.9	4.54	227	137			1770		5.51					16	141		22.1	42.6			32.7	31.9		308	804			5660	58.9	3.96	60.1	499			46.9		7.51	4.92	64.9			17.3		16.4	25.3	355			16.4	.m																																																		189	24.2	2.64	219	132			1700		2.27					3.09	120	9.56	17.5				32	30.3	13.8	316	709			5480	56.7	113	87.7	412			56.5		7.51	6.7	48			7.96	3.91	7.3	26.9	417			32.9	.m																																																		328
SUB230982	Atopic	CSLRI	1.0	expected	124977	b	189	20.1	11.2	238	306			1710		4.15		18.7			2.03	176	123	15.6	112			46.9	34.1	23.3	517	1550			4360	18.8	19.9	32.5	595			30.7		3.21	2.43	15.3			2.46	11.5	185	90.6	1460			51	.m																																																		189	12.6		205	256			1440							4.15	170	104	14.1	126			45	29	16	509	1600			4240	21.1	31.8	31.8	817			15.2		2.45	3.88					6.79	261	89.8	1310			45.2	.m																																																		326
SUB230983	Atopic	CSLRI	1.0	expected	221697	b	189	12.3		87.8	153			906		3.96					4.79	83.4	12.1					14.7	37.2	11	109	494			4460	57.9	47.3	9.73	1250			48.4		3.96		15.3			1.11		578	11.5	446			134	.m																																																		189	11.6		73.6	116			1060		3.96		3.74				66.5	13.1					11.8	32.5	13.4	195	754			5060	57.3	61.9	11.4	1490			48.7		7.91		16.2			3.52		322	6.92	248			82.6	.m																																																		326
SUB230984	Atopic	CSLRI	1.0	expected	168455	b	189	28.9	9.35	678	645			3120	7.3	5.51		20.7			9.65	172	80.7	2.91	136			12	32.3	13.8	942	1920			4060	240	52.6	67.9	622			19	10.9	2.08	2.49	40.1			8.59	15.9	136	200	771			17.7	.m																																																		189	30.9	1.24	725	646			3290	8.87	6.5		45.6			6.48	141	48.8	2.8	87.4				36.8	13.8	1070	1210			969	237	27.6	63.8	573			20.5	10.9	2.45	1.89	49.6			7.11	3.22	88.7	148	607			17.7	.m																																																		323
SUB230985	Atopic	CSLRI	1.0	expected	223572	b	189	35.1	7.91	160	382			3260	14			7.96			7.11	137	26.5	6.15	146			42.8	41.3	21.3	455	1980			5460	74.6	14.7	15.3	531			42.6	10.6	1.24	2.36	34.4			1.11	9.86	162	17.9	1010			18.6	.m																																																		189	33.6	5.91	149	400			2980	6.51	4.54		31.5				131	143	7.18	115			109	43.9	20.6	474	1890			5730	79.1	7.91	18.8	493			25.6	3.91	12.9	1.34	28.5			3.52	9.47	296	15.6	929			16.4	.m																																																		321
SUB230986	Atopic	CSLRI	1.0	expected	168125	b	189	29	7.1	433	184			3270	7.3	6.3		31.2			10.9	373	26.2	8.41	64.9			28	29.6	4.15	669	362			4030	127	3.58	27.9	29.7			9.02		4.73					7.54		6.5	25.3	404			13	.m																																																		189	29.6		412	195			2990		8.12		22			6.69	219	33.9	7.73	77.4			23.3	36.8	8.73	620	361			5050	141	20.4	22.2	433			13		10.4		5.15					9.97	20.7	371			16.7	.m																																																		320
SUB230987	Atopic	CSLRI	1.0	expected	163095	b	189	35.9	400	1120	733			794							8.38	323	352	26.6	74.9			39.1	27.7	26.9	1630	3440			1330	697	13.1	176	280			64.6		2.83	6.19				9.86	17.7	1430	49.6	4000			311	.m																																																		189	30	273	1090	535			495		3.96					5.42	249	212	26.5	76.1			53.7	35.9	52.9	1470	3950			1740	574	36	137	426			64.6	7.3	7.1	6.55	25.9				22.3	1020	49.4	2000			84.6	.m																																																		312
SUB230988	Atopic	CSLRI	1.0	expected	126109	b	191	5.18	1.01	178	71.8			1290	1.55			17.7				144	4.04		30.6				11		219	589			1010	7.09	8.82		1430			21.1	1.06	2.04		17.7				6.63	64.1	12.6	733			311	.m																																																		191	6.29	2.28	152	89.9			1200	1.14			16				156	4.36		15.7			6.62	10.2	1.3	251	649			622	5.57	11.9		1470			15.3	1.55			4.53				2.77	9.4	19	851			216	.m																																																		321
SUB230989	Atopic	CSLRI	1.0	expected	227208	b	191	10.1		1120	578			742				18.8				217	47.5	15.7	38.4			10.8	8.86	7.21	728	3290			3070	8.03	3.22	2.89	425				1.3			9.18					2.28	2.96	3220			29.1	.m																																																		191	7.91	2.97	1030	470			684	1.14	1.81		19.9				215	64.6	14.3	63.9			2.92	6.46	5.32	899	3600			3040	5.73	2.14	3.53	505							11.7				1.02	2.72	12.9	1200				.m																																																		297
SUB230990	Atopic	CSLRI	1.0	expected	267233	b	191	6.75	27.8	107	2490			2500				9.18				96.8	234		74.5			4.38	10.9	215	339	4560			2110	30.3	52.7	38.6	648			10.5		2.72		12.4				3.36	1320	26.8	6200			213	.m																																																		191	4.86	26.3	117	2170			2330	4.07	1.81		19.9				88.3	115		49				13.3	389	305	3900			1550	15.7	39.4	26.7	457			6.76															.m																																																		299
SUB230991	Atopic	CSLRI	1.0	expected	267453	b	193	12	16.2	1170	751			1730								680	10.9	10.8	86.5			31.7	15.5		374	3080			2900	21.5	1.19	67.1	456			7.51			3.28					37.3	22.4	120	2400			38.6	.m																																																		193	10.3	16.2	1110	597			1290							5.84	530	16.8	10.2	84.1			23.8	13.4		402	3010			2180	20.2	1.58	74.3	679			9.32		2.57	1.05				3.04		1.93	161	2560			10.9	.m																																																		297
SUB230992	Atopic	CSLRI	1.0	expected	135463	b	193			169				303								55.5	3.92	12.1	37			16.3	2.94		227	252			799	80.7	2.39	31.1	423			11.9							2.91								.m																																																		193			163	12.4			315				4.25				43.6	2.39	11.8	32.4			21.8		5.81	218	278			944	51	2.39	33.8	442			8.91							5.75		1.32					3.75	.m																																																		293
SUB230993	Atopic	CSLRI	1.0	expected	113123	b	193	6.74	4.82	1970	150			1180			1.23				4.99	299	9.6	47	104			41.3	14.3	3.33	383	1800			4100	172	3.72	219	712			67.8			3.2	3.65				4.25	93.1	53.3	1230			78.5	.m																																																		193	9.21	5.03	2270	98.8			691			1.07					299	4.52	41.5	90.2			34.4	15.5	1.49	546	1670			3310	124	3.38	226	542			56.6			2.74	5.43			4.18	2.94	133	26.1	1420			124	.m																																																		292
SUB230994	Atopic	CSLRI	1.0	expected	267343	b	203	29.2	8.16	360	356			2680		13.9	1.49	37.1				88	19.9	5.36	132			2.97	38.9	13.2	801	1560			3560	963	24.3	63.5	274			3.54	4.47	9	2.29	22.3			1.83	4.39	28.7	41.2	547			4.33	.m																																																		203	25.6	9.27	359	346			2080		9.27	1.27	36.5				101	16	5.91	101			2.87	35.4	10.5	641	1590			2690	960	21.5	56	263			3.04	5.1	16.3	1.46	55.3					30.1	34.4	737			4.09	.m																																																		333
SUB230995	Atopic	CSLRI	1.0	expected	273182	b	203	47.6	10.6	320	589			5050	1.77	12.1	1.85	20.5			1.31	195	14.8	6.05	70.1			31.7	50.9	14	538	2200			2450	594	19.5	64.2	284			23.8	3.61	11.3	9.27	4.7			1.63	2.59	13.5	76	4090			70.5	.m																																																		203	55.1	12.6	348	564			5080		7.4	1.92	22.3				220	13.7	6.02	68.9			39.1	48.9	14.7	913	3330			4180	579	19.8	67.1	290			23.6	1.77	8.31	8.56	53.5				4.55	13.8	83.5	3970			71.2	.m																																																		331
SUB230996	Atopic	CSLRI	1.0	expected	127879	b	203	34.4	13.5	488	580			2380	5.64	15.7	2.97	68.2				771	36.3	72	258			34.3	63.6	15.4	610	1490			4610	52.2	14.8	356	111			46.3	3.38	12.3	4.97	40.8				6.43	26.8	94.9	878			5.76	.m																																																		203	29	16.4	399	410			1820	6.27	12.9	2.67	42			1.96	621	30.4	50.8	346			30.4	49.9	14.4	560	1390			4370	50.2	16.9	353	173			44.4	5.1	11.9	4.75	31.2				4.55	37.6	111	751			11.4	.m																																																		330
SUB230997	Atopic	CSLRI	1.0	expected	230482	b	203	11.9	42.5	211	958			915	4.39	14.1	2.13	34.7				226	66.8	20.6	38.3			5.86	27.2	43.5	244	2700			2910	239	51.3	576	121			24.9	2.9	11.5	2.59	38.3			1.39	5.17	415	29.8	2840			57.6	.m																																																		203	17.1	28.8	189	1070			895	2.83	6.18	1.56	9.12			2.47	230	36.7	19.4	44.4			5.83	32	42	409	3290			4060	384	47.5	378	430			17.4	4.55	8.73	2.17	25.2				5.41	1210	23.3	1510			61	.m																																																		324
SUB230998	Atopic	CSLRI	1.0	expected	299592	b	203	54.3	15.6	410	515			4270	1.18	15.3	3.4	45.6			2.8	171	12.8	19.7	130			46.1	43.6	16.9	538	1880			1950	16.9	14.1	197	68.2			49.3	1.85	13.1	5.99	38.3			1.53	4.71	30.3	98.5	4140			183	.m																																																		203	53.7	14.7	392	522			4530		12.6	2.8	44.4				180	13.3	20.2	158			32.7	56.7	19.4	544	1760			1850	16	14.2	173	101			45.4															.m																																																		323
SUB230999	Non-atopic	CSLRI	1.0	expected	268497	b	203	32.1	21.4	314	1330			3320	3.77	16.3	2.1	43.8				958	306	17.7	376			170	52.2	15.4	346	3950			2840	96.9	14.5	66.7	212			8.51	3.92	11.9	5.52	47.4				4.24	243	36.3	5690			29.9	.m																																																		.m																																																		.m																																																		322
SUB231000	Atopic	CSLRI	1.0	expected	209198	b	204	20.1		505	222			891								157	18	14.8	69.7			16.6	25.3		536	1750			3500	34.1	4.28	109	150			12									43.5	27.4	2260			2.96	.m																																																		204	19.8		521	192			888								139	10.3	11.1	54.9			12.2	28.9		753	1850			4430	25.6	4.64	99	182			10.8				13.3					10.4	11.8	3150			1.1	.m																																																		320
SUB231001	Atopic	CSLRI	1.0	expected	162530	b	204	27.7	17.7	474	3400			3290				8.34				379	484	10.8	225			76.1	38.5	3.08	374	5160			4050	2020	14.2	89	178			16.8															.m																																																		204	30.2	24.3	550	4010			4350								291	457	11.2	224			75.7	37.9	3.12	302	4680			4040	1410	9.15	95.7	40.7			15									14.4	34.2	2620			1.07	.m																																																		317
SUB231002	Atopic	CSLRI	1.0	expected	311655	b	204	10.1		549	764			745				2.69				308	16.3	36.9	302			21.4	29.9	2.25	675	2130			4640	34.7	1.37	224	155			59.7	3.21								1.29	26.5	2460			9.69	.m																																																		204	9.62	1.61	564	632			799								305	8.81	33.9	314			19.1	36.8	7.17	675	2550			5400	25.6		182	128			48.9				6.34						20.9	2300			19.1	.m																																																		313
SUB231003	Atopic	CSLRI	1.0	expected	265736	b	204	29.4		177	787			2490				8.34				72.4	47	10.7	963			50.6	42.8		589	3620			2630		1.92	49.1	54.4			17										148	4860			4.34	.m																																																		204	27.1		167	836			2570								45.9	32.8	7.5	810			33.9																													.m																																																		311
SUB231004	Atopic	CSLRI	1.0	expected	276925	b	215		35.7	363	497			3530	14.9	4.69		9.61				268	2040	23.6	279			40		284	883	4870			2890	570	314	358	605			102		3.12		5.01					171	34.5	1010			33.6	.m																																																		215	21.9	66.3	267	564			4570	30	9.09		17.4				278	2500	28.3	204			36		193	683	3420			1750	540	144	305	461			33.9		3.12		16.5				6.25	68.8	46.3	937			12.7	.m																																																		360
SUB231005	Atopic	CSLRI	1.0	expected	299482	b	215	15.4	23.6	1370	547			334	11.9	1.7		9.88				381	91.1	120	416			100	9.29	11	1870	3810			608	10.6	2.24	220	83.9			8.04	6.25	4.13		13.7					3.57	232	8810			21.6	.m																																																		.m																																																		.m																																																		358
SUB231006	Atopic	CSLRI	1.0	expected	163473	b	215	6.25	36.9	1060	492			6480		2.13		26.4				153	6.75	6.25	32				14.3	6.99	521	1610			7070	96	16	82.9	275			14.4		6.29		12.3				7.86	103	89.7	1300			606	.m																																																		215	9.29	28	899	373			3720	4.14	1.38		9.88				109	9.32		42.4				33.3	5.37	503	1320			4050	124	13.4	99.4	262			21.1	17.7	2.57		16.2				11.9	171	88.1	1290			533	.m																																																		355
SUB231007	Atopic	CSLRI	1.0	expected	276217	b	215	11.9	6.06	395	206			2560	13.7	2.46		12				64.4	1.81	10.8	33.9			49.2	26	3.9	559	623			4460	15.4	4.92	128	38.5			33.7	17.1			18					5.49	19.9	898			3.4	.m																																																		215	21.9	2.68	336	132			1700		4.46		11.8				52.8	6.75	9.14	47.5			48.6	23	3.79	479	455			3520	27	5.49	119	36.8			32.7	31.9	2.13		3.11					3.68	20.2	790				.m																																																		356
SUB231008	Atopic	CSLRI	1.0	expected	254433	b	216		74.6	486	422			811								268	454	9.11	183			15.1		5.5	313	1610			1560	147		113	195			7.73			1.53						19.6	97.9	2190			12.5	.m																																																		216		76.3	514	415			757								257	255	9.35	126			11.2		1.85	408	1670			1430	157		105	116			8.3			1.16						10.3	134	2260			4.94	.m																																																		354
SUB231009	Atopic	CSLRI	1.0	expected	307342	b	216		4.39	284	194			711			1.13					257	23.3	12.5	50			21	2.45		711	1280			1950	30.6		143	10.9			39.8			2.45						5.14	90	776			13.5	.m																																																		216			318	169			621								243	21.9	13	80.8			23.7			730	1470			2310	47.9		142				42			3.04						13.9	68.8	802			23.9	.m																																																		351
SUB231010	Non-atopic	CSLRI	1.0	expected	314114	b	216			156	42.5			275	66.4	43.8	4.09	131			10.6	23.9		4.8	25.3			4.71			652	182			559			137	147			27										24.3	355			6.43	.m																																																		216			189	32.7			273			1.56	6.68				17.5		5.48	8.07			3.58			694	190			494	30		132	80			19.6										26.2	671			3.52	.m																																																		348
SUB231011	Atopic	CSLRI	1.0	expected	314224	b	216		19.7	198	740			399								85.4	1760	1.87	237			13.6		116	500	2040			2720	31.7	2.58	3.81	328			4.09									73.1	38.8	939			52.3	.m																																																		216		13.9	196	752			384								77	1650	2.44	282			24.2		60.8	475	1840			1830		2.58	4.51	312			20.5									34	39.8	665			19.7	.m																																																		346
SUB231012	Atopic	CSLRI	1.0	expected	230592	b	217	7.61		416				636		2.62						125	15.4	7.11				12.7	19.3		662				657	31.5	6.86	89.4				25.2							3.83		17.3	72				18.8	.m																																																		217	5.91		389				606								139	16.2	7.17				12.8	23.8		823				608	34.5	7.59	97.2				23.2							1.39		8.62	62.4				5.75	.m																																																		372
SUB231013	Atopic	CSLRI	1.0	expected	219542	b	217	34.1		605	1220			3250				10.3			2.6	122	1.57	25.8	158			66.1	40.8		1320	2710			1400	27.2		143	41.6			11.8			3.72	15.7											.m																																																		.m																																																		.m																																																		365
SUB231014	Atopic	CSLRI	1.0	expected	303040	b	231	14.3	2.39	272	538			1410	2.32	4.38		27.5			1.75	93.3	6.11	5.1	72			9.73	15.4	5.81	684	2180			356	246	7.22	59.1	236			9.03	3.76	4.38		35.8			1.6	3.49	3.27	144	1230			3.74	.m																																																		231	12.8	4.01	221	478			1280	4.57	4.68		19.4			2.8	83.8	4.07	4.85	78.6			12.4	14.5	3.52	672	2340			400	192	7.97	62.7	324			6.79	3.94	3.89		20.4			2.16	3.3	8.15	146	1000			2.88	.m																																																		386
SUB231015	Non-atopic	CSLRI	1.0	expected	284349	b	231	11.4	5.34	545	319			237	3.3	4.01		31.6			1.4	272	199	18.1	104			49.3	13	7.22	669	1870			1030	105	9.06	133	349			42.2	2.93	2.65	2.62	22.9			1.28	7.06	213	40.7	3530			105	.m																																																		231	10.6	4.44	520	402			317	3.03	3.89		32.7			2.47	12.4	20.1	169	35.8			942	11.8	6.52	578	2130			941	78.9	8.83	123	346			45.9	3.99	4.98	6.57	54			2.23	15.6	287	36.4	3370			155	.m																																																		384
SUB231016	Atopic	CSLRI	1.0	expected	235142	b	234	13.1	1.23	147	641			1160		2.47		6.22				148	170	3.66	138			16.6	15.7	13.3	454	1670			3240	263	3.39	7.95	208			2.06	2.02	2.76	1.28	369			6.85								.m																																																		.m																																																		.m																																																		392
SUB231017	Non-atopic	CSLRI	1.0	expected	270809	b	252	14.2	2.93	521	221			2270	8.69	3.63	1.15	24.8			11.6	241	10.9	19.7	259			256	27.1	6.22	1060	1810			5260	81	4.63	91.4	85.6			46.8	1.66	3.05	4.82	22.8			10.6								.m																																																		.m																																																		.m																																																		418
SUB231018	Atopic	CSLRI	1.0	expected	204570	b	234	13.8	44.8	876	499			4270								209	192	7.19	161			49.8	16.6	27.9	1150	2660			7520	42.3	24.3	62.9	143			16.8	6.92	1.55	12.1					2.94	16.1	304	921				.m																																																		234	13.1	36.7	792	479			3690		2.03						172	106	7.55	154			42.1	18.7	9.61	1100	2190			4830	29.7	45.8	70.8	124			48.5	5.92		14.1					5.73	14.3	262	817			1.64	.m																																																		388
SUB231019	Atopic	CSLRI	1.0	expected	214886	b	234	13	2.81	274	198			1090								73.3	215	55.8	96.4			54	14.6	2.76	645	1270			1950	20.3	4.41	228	82.6			31.6	1.37	1.82	8.91					3.12	25.7	115	1420			18.5	.m																																																		234	15.3	2.64	321	168			1050	1.28	2.31						85.2	83.9	50.1	60.1			43.6	14	5.52	779	1510			2690	22.1	4.22	232	78.5			25.5			4.39					2.39	36.8	114	1180			20.4	.m																																																		380
SUB231020	Atopic	CSLRI	1.0	expected	309577	b	234	9.97	35.5	73	480			593	2.2	2.2						42.4	54.3	5.88	24.3			5.87	15.7	101	188	1820			1670																						.m																																																		.m																																																		.m																																																		372
SUB231021	Atopic	CSLRI	1.0	expected	268276	b	234	8.56	1.34	372	148			438				2.69				188	38.1	44.2	81.3			45	16.8	3.39	475	2480			1410	9.29	1.87	95.5	51.3			31.2								3.77	98.2	121	5160			12.9	.m																																																		234	8.9	2.64	345	142			410		1.44						173	17	44.6	106			45	17.6	2.47	388	2170			1270	9.09	1.12	106	58.1			32.6				6.78				2.39	169	117	5880			20.1	.m																																																		370
SUB231022	Non-atopic	CSLRI	1.0	expected	293830	b	237	1.52	13.3	209	500			933				19.7				476	3290	51.5	1400			769	2.9	318	158	1980			944	11.5	19.1	146	86.9			6.4									17.8	135	1690			4.47	.m																																																		237	8.03	18.7	118	1910			1.09																																											.m																																																		372
SUB231023	Non-atopic	CSLRI	1.0	expected	395871	b	237		32.7	628	571			1930		2.13		5.32											3.84	21.7	472	1000			1690	121	17.8	187	221			116				13.2					36	18.7	3020			15.5	.m																																																		237	2.06	8.79	423	327			1790				9.98				92.7	7.28	2.06	58.4			25.2	6.88	7.28	651	1430			2550	92.2	10.6	130	235			99.2									60.3	16.6	2770			15.8	.m																																																		340
SUB231024	Non-atopic	CSLRI	1.0	expected	363810	b	246	13.6	4.14	404	121			2610	4.77	2.07		2.85			2.94	819	112	6.74	427			276	11.4	6.62	322	65.3			2410	5.72	3.42	60.3	41.4			47.5	5.81	3.18					4.66	9.21	10.7	276	1380			20.7	.m																																																		246	16.6	4.06	381	69.7			2220	7.74	4.22	1.48	10.4			4.9	767	149	7.55	484			258	15.4	5.89	282	73.5			1770	6.89	3.67	71.1	26.8			26	4.91	4.53		5.84			3.49	8.94	10.6	215	1360			19.4	.m																																																		325
SUB231025	Atopic	CSLRI	1.0	expected	400596	b	247	6.62	1.36	714	199			2620								50.6	31.2	16.6	316			83.1	4.19	3.03	824	369			1040	63.2	1.5	36	20.1			12.4	1.52		5.99						3.21	87	814			6.72	.m																																																		247	9.5	2.65	761	202			2800								49.3	29.3	16.4	290			77.2	5.61	2.7	827	367			1150	81.4	2.1	33.1	15.7			7.66	2.91	1.28	5.36						5.36	68.4	883			7.9	.m																																																		316
SUB231026	Atopic	CSLRI	1.0	expected	421027	b	250	1.61	2.71	687	262			1490							1.05	129	121	34.3	265			101	8.18	5.31	410	4360			3920	4.47	1.4	169	47.7			47.9				6.28				3.53	7.31	180	3490			55	.m																																																		250	4.03	2.35	662	358			1590		1.33					1.13	110	83.7	31.1	248			98.3	3.18	5.56	428	4610			3770	6.19	2.51	173	45.6			42.5				7.91			1.33	16.6	11.8	220	3950			166	.m																																																		318
SUB231028	Atopic	CSLRI	1.0	expected	13595	b	81		256.11	385.16	53.86			1176.79	96.33		31.01	258.34		272.73	10.65	72.03			21.52		910.13	8.82		10.71	239	496.86			742.58			66.03	206.97			115.82						30.37			516.6	7.05	509.43		720.87	46.48	81	2.3	270.63	369.8	40.16			1134.27	84.08		28.6	228.26		249.96	6.96	28.39		6.77			809.14	11.67			215.45	457.91			681.93			60.46	191.94			108.28		5.61				29.14			527.72	5.71	525.77		714.58	43.74	.m																																																		.m																																																		142
SUB231029	Atopic	CSLRI	1.0	expected	16690	b	82			82.39	139.77			34						777.07		3.91		56.94	138.54			191.85	50.48	65.52	4.98	22.95	15.67			167.55	7.16	20.92	193.57		977.21	7.65				3.62		599.47			49.08		289.46			18.17	82		4.45	85.45	121.34			26.42			2.64			555.06			1.83	61.69	125.64		934.09	175.56	46.65	79.83	2.97	26.12	14.34			108.07		30.27	150.8		839.65	11.47						386.18			69.74		271.92			19.31	82	1.12		60.53	112.72			33.28		2.26				768.97		87.2	59.75	8.34	58.81	15.38		5.34	17.48	8.32	239.86	1425.69			760.51	157.27	8.32	20.68	102.85			3.39						576.68		1.6	7.16		244.04			7.23	82			65.18	110.25			34		2.47				692.8		52	60.79	9.35		9.82					237.82	1303.75			697.28	143.02		9.35	115.8		786.53							434.7		1.12	3.12		261.62			4.7	123
SUB231030	Atopic	CSLRI	1.0	expected	31003	b	87			252.21	16.89		613.49	376.65				8.43		501.46		105.28			92.41	28.58		17.48			562.18	220.59			1412.04	467.5	5.03	54.02	459.87			9.91						209.99			216.89	45.42	373.52		344.09	62.56	87			270.22	14.3		612.51	356.59						472.31		98.77		9.18	135.68	31.32		19.44			520.08	236.15		1001.09	1454	375.69		37.73	523.64			11.4				5.12		208.12		3.82	204.05	42.95	403.12		330.56	61.33	87	12.33		240.38	23.3		551.8	442.17						414.27		112.3	8.68	6.38	55.38	26.56		25.4			518.47	237.94			1526.16	414.94		45.71	479.37				23.54					267.54		1.13	48.15	101.58	224.78		291.25	12.91	87	4.65		224.8			542.68	383.32	2.52			19.46		402.95		94.5	1.79		95.47	24.18	990.64	23.5			487.81	235.55			1524.73	361.62		39.76	413.18			6.68				1.74		236.94			44.55	80.69	200.81		269.08	10.9	146
SUB231031	Atopic	CSLRI	1.0	expected	27506	b	81			38.45	130.63			1993.07				9.74		328.12		15.08			15.94	6.12		14.64			90.69	255.83			2739.12	41.48	22.23	10.66	431.52		808.17	48.29						187.39			194.58		71.94		686.3	34.54	81			35.44	120.63			1936.42						332.66						6.12	1491.09	14.82			87.71	283.42			2834.14	73.98	46.73	9.97	253.33		749.53	27.08						181.92			203.65	6.06	44.52		650.92	32.73	81			51.48	186.3			2281.57				1.72		403.7		14.62			7.27	8.85		16.43			91.88	259.59			2958.21	99.37	49.06	30.77	361.2	7.1	1048.14	44.68						216.34			147.54	5.27	104.39		728.97	32.73	81			44.35	176.92			2208.74						361.5						6.23		15.89			69.41	240.79			2719.09	13.7	40.51		177.54	9.02	967.95	39.25						231.38			138.24		83.16		763.68	26.2	120
SUB231032	Atopic	CSLRI	1.0	expected	31679	b	81			833.18	283.42		1285.3	3603.5				16.56		318.93		168.93	4.49		12.22	6.12		13.32			1076.87	1698.13			5732	1552.64	77.71	98.21	1180.03			107.07			6.24			340.71				30.53	252.07			56.94	81			715.57	288.43		1048.89	5001						308.63		110.3		4.85				13.23			1143.08	1633.72			5001	1254.85	49.06	93.68	1131.48			88.98						341.96				29.8	235.15			54.32	81			836.16	348.65		846.18	4266.85				13.46		406.1		153.05	11.72					8.98			1118.5	1675.39			5174.05	1525.15	63.7	109.87	1078.52			99.39						238.85				42.54	230.77			34.95	81			882.79	343.63		1766.74	5001				0.5		365.99		145.41	11.51		35.81			10.57			1075.42	1597.1			5001	1328.9	67.54	70.84	892.01			90.39						168.24				28.25	214.48		893.63	21.04	108
SUB231033	Atopic	CSLRI	1.0	expected	129141	b	95b	14.76		246.05	107.55			702.55				61.11				47.64	89.8	10.82	118.67			9.43		8.34	1486.8	600.51			2058.87	283.64		130.71	19.27			9.07	12.03			6.82						73.33	948.71			13.43	.m																																																		95b								14.21			93.83			4.04	39.55	147.91	9.57	139.15			9.25	12.85		1137.08	410.52			1854.49	316.04		141.63	10.4			8.01									23.46	102.39	1054.92			23.79	.m																																																		171
SUB231034	Atopic	CSLRI	1.0	expected	33515	b	95b	16.41		304.05	14.85			320.88	9.87						4.12	125.49	472.04	19.04	12.18			9.79	17.79		1004.41	379.56			1274.33	178.01	4.34	62.83	41.16			18.98		10.29		8.61					41.49	27.54	958.6			7.31	.m																																																		.m																																																		.m																																																		172
SUB231035	Atopic	CSLRI	1.0	expected	46246	b	95b			271.67	290.6			1207.83	10.68			35.06				88.36	2.25		26.3			8.71	17.79	2.25	993.15	1045.87			3293.43	743.79		13.68	98.98			5.8	18.34									157.84	700.05			21.99	.m																																																		95b			230.28	199.46			1097.35	13.67	16.02		20.15			6.97	99.16	34.35		66.29			6.38	17.23		764.78	923.99			2874.14	775.73	11.26	14.22	153.63			9.34	12.58			42.03						148.24	606.32			27.78	.m																																																		169
SUB231036	Atopic	CSLRI	1.0	expected	29390	b	95b			209.48	88.68			1802.85	24.2			10.4				130.67			33.31			7.66			907.65	710.82			2820.14	99.16		31.17	29.81			14.59	10.41			3.21						131.06	445.62			8.53	.m																																																		95b	20.84	23.46	180.47	118.67			2418.74				38.55				93.15			45.51			11.07			1218.28	881.1			3389.81	152.1		31.68	57.65			19.5									41.49	136.76	459.81				.m																																																		183
SUB231037	Atopic	CSLRI	1.0	expected	44644	b	95b	20		62.75	134.03			581.72	18.89							29.84	367.89	10.87	196.07			17.76	12.03		302.01	2088.5			3094.05	35.82		157.65	6.82			31.55	12.85							24.2		28.04	607.98			51.3	.m																																																		95b	20.28		52.91	125.5			577.53	17.51			13.96				49.96	512.98	12.1	234.97			22.2			348.08	2478.93			3966.8	42.72		158.29	16.62			29.55	12.58							16.13		22.83	791.91			62.15	.m																																																		153
SUB231038	Atopic	CSLRI	1.0	expected	30891	b	96a	9.4		294	168.01			1192.5								319.78	155.96	12.59	22.51			11.72	47.12	321.35	328.32	1472.31			3346.05	496.79	51.55	55.69	46.71			20.86									39.53	41.3	658.87			19.66	.m																																																		96a			277.76	91.45			892.55				25.56				318.85	140.89	11.32	57.21			13.48	49.94	193.71	301.85	1328.54			3713.5	648.41	53.71	61.7	67.67			19.46										36.35	521.85			21.36	.m																																																		154
SUB231039	Atopic	CSLRI	1.0	expected	35609	b	102			383.71	279.61			2413.72								82.39	1081.09		27.3			103.77	9.32	10.51	966.73	2266.95			2752.75	2685.11	15.25	45.39	27.92			24.75		3.46							17.33	68.75	862.56			11.81	.m																																																		102			423.35	320.13			2496.73								70.96	728.16		17.2			88.92		3.46	1161.32	2690.39			3145.7	2471.57	17.85	31.95	31.64			17.72		1.17								42.18	588.79				.m																																																		160
SUB231040	Atopic	CSLRI	1.0	expected	34311	b	103			191.79	136.24			763.59				49.16				55.87	261.33		30.11			8.15			349.91	576.97			1072.71	41.17		31.52	157.47			55.72									88.43	38.02	888.25				.m																																																		103			174.11	242.2			779.12								67.02	192.19		49.69			6.57			351.89	465.01			980.73	34.73		27.73	84.79			47.53									140.42	40.79	1013.64				.m																																																		164
SUB231041	Atopic	CSLRI	1.0	expected	45563	b	103			155.51	569.62			3165.86								12.1	57.81		38.6			12.99			372.23	1139.74			5857.7	184.66	12.44	22.15	42.83			6.57										68.89	1080.33			40.69	.m																																																		103			164.08	685.72			3584.74								37.03	52.67		22.63			21.9			318.58	1147.54			4510.7	504.7		52.44				13.41										75.17	1183.31			38.85	.m																																																		147
SUB231042	Atopic	CSLRI	1.0	expected	57588	b	103			121.06	211.22			407.2														6.47		56.53	168.71	1030.13			1106.79	110.59		78.11	15.1			111.92									361.26	71.64	238.07			18.17	.m																																																		103			108.33	219.48			409.08								5.16	16.12					13.83			153.66	950.18			984.45	79.06		69.71	14.02			103.45									217.53	49.19	164.71			11.51	.m																																																		140
SUB231043	Atopic	CSLRI	1.0	expected	53810	b	103		74.22	116.66	150.23			739.68								179.03	477.1	22.95	73.3			27.66		1235.46	143.32	2131.68			4209.86			72.7	34.89			49.49									836.66	35.3	1512.03			79.53	.m																																																		103		61.63	115.1	151.78			739.31								151.1	315.2	19.97	43.89			27.55		1261.76	124.72	1869.61			3196.82			54.04	20.49			39.71									490.53	25.57	1133.05			58.36	.m																																																		137
SUB231044	Atopic	CSLRI	1.0	expected	50033	b	103			138.07	285.59			971.57								75.7	0.19	3.85				22.64		293.01	353.88	1764.38			3489.66	74.18		42.49				36.04									360.19	6.67	645.48			48.4	.m																																																		103			166.9	221.55			775.32								84.06	2.11					25.42		265.72	337.38	1991.34			3310.91	67.54		40.39	19.41			32.38									608.35	8.88	509.37			51.02	.m																																																		137
SUB231045	Atopic	CSLRI	1.0	expected	60015	b	103			96.33	266.99			926.82								23.14	728.87		44.94			36.69			327.09	1253.06			3171.33	9.41	12.44		105.1			28.73									540.83	29.88	1194.52			108.71	.m																																																		103			121.56	472.83			882.16								6.27	600.27		48.64			43.18			206.2	966.55			2759.64	17.58	11.69		79.58			21.26									410.4	37.22	1356.54			75.51	.m																																																		138
SUB231046	Atopic	CSLRI	1.0	expected	57476	b	103			200.79	799.34			1494.62								54.27	1306.71		157.47			73.06			119.3	1158.7			1724.34	19.11		23.92	50.22			24.99									160.74	100.1	1971.43			60.89	.m																																																		103			183.11	806.85			1747.89								59.04	1241.1		134.69			75.95			162.48	1638.62			2355	22.52		21.69	40.19			20.62									183.1	98.76	1918.18			64.09	.m																																																		138
SUB231047	Atopic	CSLRI	1.0	expected	60239	b	103		14.66	427.24	384.96			1945.32								107.87	785.16	13.66	40.72			56.6		206.87	381.52	1091.95			4411.85	245.86	10.94	55.02	140.91			76.4									217.53	69.54	689.44			69.51	.m																																																		103		42.89	533.03	482.74			1976.6								91.82	921.79	10.81	62.83			74.17		193.32	443.51	1186.67			4243	280.26	93.93	56.68	113.94			98									637.56	49.13	892.58			116.05	.m																																																		140
SUB231048	Atopic	CSLRI	1.0	expected	40008	b	103		214.73	296.06	933.3			3455.66								258.44	841.55		56.53			128.55		207.99	287.43	993.9			4664.1	108.99	21.84	50.96	21.56			124.83									940.17	48.28	1309.18			1031.21	.m																																																		103		511.12	338.11	821.89			3639.37								198.62	350.6		48.11			95.05		203.49	325.8	1334.82			5027.05	37.22	34.23	44.92	55.48			140									952.24	45.72	1056.02			574.18	.m																																																		129
SUB231049	Atopic	CSLRI	1.0	expected	39664	b	115			325.6	170.25			959.81				17.51				42.02	281.35	9.69	63.03			20.3	13.48		829.31	177.44			1965.15	8.13		16.75														144.07	791.67			34.52	.m																																																		115	9.78		246.31	105.39			636.34				29.38				63.24	154.29		62.47			9.52	22.9		869.12	201.75			2090.05	14.1		17.47								0.35						157.31	766.64			100.89	.m																																																		152
SUB231050	Atopic	CSLRI	1.0	expected	54500	b	122	63.57		151.01	309.34			1128.59								28.85	4.44		14.8			9.83	162.42		324.72	1209.69			3117.9	4.78	4.44	43.39	57			19.51				8.5					21.79	31.56	1216.77			13.72	.m																																																		122	73.98		126.66	281.5			940.3		23.65		32.41				4.96			82.62			19.84	128.42		357.5	1267.85			3356.4			31.85	49.6			20.88									23.65	27.91	1543.69			26.55	.m																																																		176
SUB231051	Atopic	CSLRI	1.0	expected	60127	b	115			69.89	20.34			307.68								10.19							14.31		291.63	299.81			1922.08	15.13			129.82											11.43	163.96	26.9	314.65			88.81	.m																																																		115	8.95		68.49	16.95			305											3.26						324.2	322.89			2070.99	7.09			110.39							6.7					13.28	15.76	280.01			26.31	.m																																																		153
SUB231052	Atopic	CSLRI	1.0	expected	95641	b	122	19.7	2.06		5.29			166.63		8.22		78.98							13.24				24.64	28.76		15.58			367.75	16.3						6.53									27.83						.m																																																		122	11.42						140.35									27.83		56.26			4.89	32.49			19.45			366.94							5.29									30.62		27.11				.m																																																		134
SUB231053	Atopic	CSLRI	1.0	expected	97029	b	122	75.56		326.31	496.81			1139.88								234.03	45.44	17.5	63.63			10.06	141.87		674.42	2285.04			1465.6	28.08		140.36	10.09			20.95			6.23					5.33	25.04	86.48	1209.69			55.25	.m																																																		122	55.36		394.95	410.51			1349.89								206.24	62.05	15.22	38.42			10.81	144.08		886.31	3146.42			1801.55	18.19		143.19	36.17			23.08			6.61					16.11	151.83	79.48	1680.38			127.36	.m																																																		136
SUB231054	Atopic	CSLRI	1.0	expected	85442	b	122	74.96		189.1	81.89			1120.11				31.65				62.79	67.57		194.67			17.71	112.43		282.85	187.62			1901.94	32.3		37				6.37									28.76	33.98	350.3			5.29	.m																																																		122	79.7		188.85	80.44			1337.97															123.42		312.85	206.63			2220.14	59.66		44.28				21.08				4.47					3.49	32.88	242.4			4.3	.m																																																		145
SUB231055	Atopic	CSLRI	1.0	expected	87400	b	122	141.67	4.44	1299.89	40.67			2523.57				1.12				14.23		12.44	29.38			6.32	42.52		473.53	142.27			614.14			119.86	2.82			12.27										52.23	1503.8				.m																																																		122	121.02		1500.17	38.42			3649.79				6.9				18.75	7.75	11.61	78.98				81.27		695.4	212.96			1387.19			125.33	45.15			12.04									7.75	65.47	2886.9				.m																																																		144
SUB231056	Atopic	CSLRI	1.0	expected	85046	b	122	117.62	30.62	528.13	275.23			1514.79				1.98				457.36	402.55	16.91	68.76			48.05	134.44	13.85	618.05	788.79			3041.49	146.69	21.32	244.57	112.24			205.46								15.17	84.12	63.22	1159.51			86.07	.m																																																		122	66.12		305.45	214.36			981.06				1.12				394.14	341.56	16.56	50.35			54.38	150.52	47.29	552.34	879.63			4363.32	142.87	18.52	254.02	64.36			204.54								16.11	103.38	58.92	1144			84.69	.m																																																		128
SUB231057	Atopic	CSLRI	1.0	expected	105519	b	127	8.18	6.93	399.21	108.71			727.69		1.36		50.25				58.81	4.89	23.81	57.97			20.48	15.61		323.83	416.12			1447.13			54.63	184.89												16.68		133.39			4.44	.m																																																		127	11.88		374.48	122.51			704.28				51.81				108.59	13.48	23.71	23.99			17.67	43.23	19.84	320.3	447.42			1434.9	2.3		58.73	374.47			3.76		14.12							17.31		133.39				.m																																																		135
SUB231058	Atopic	CSLRI	1.0	expected	84452	b	127	48.67	97.32	240.35	816.76			3264.73	7.67	13.48						106.27	254.24	18	115.64			315.54	43.23	144.08	181.26	1760.81			6071	61.21	7.93	18.32	271.94			116.54		12.19						25.13	368.31	75.83	774.8			174.78	.m																																																		127	38.8	15.4	188.14	480.91			2274.31	6.64							117.57	208.5	6.64	54.91			170.58	26.48	188.28	207.91	1714.26			6591	29.78		13.88	398.91			115.17		4.21		15.86				3.72	337.44	72.57	754.68			160.01	.m																																																		131
SUB231059	Atopic	CSLRI	1.0	expected	85816	b	127	42.06		673.15	150.81			2163.71								170.66	38.28	29.27	57.97			28.81	43.23	23.59	635.31	708.66			1998.8	88.46	1.36	243.1	9.04			13.1				6.95				17.95	361.99	141.11	1941.28			530.52	.m																																																		127	8.18	14.76	645.13	180.35			2409.27	13.58			1.02				137.36	37.68	24.33	43.94			26.41																													.m																																																		117
SUB231060	Atopic	CSLRI	1.0	expected	86696	b	129	15.49		56.77	30.77			199.33				15.99				15.49		19.26	24.33			8.67	17.49	14.06	21.69	132.97			474.88	14.99	10.41	29.39	19			7.76	20.16	19.27		26.14				20.66	14.06	18.75	64.64			9.13	.m																																																		129	18.15		54.36	39.36			164.61				40.33				15.99	10.13	23.12	32.65			13.29	23.51		29.86	121.97			429.34		12.64	35.1	16.41							17.27					15.78	15.58	55.84				.m																																																		126
SUB231061	Atopic	CSLRI	1.0	expected	87114	b	127	33.6	14.44	1045.24	86.09			703		1.36						31.71	9.58	8.86	23.99			15.06	21.99		738.58	625.64			595.5		6.25	59.01				3.76										119.33	312.38				.m																																																		127	8.67		1053.17	127.96			914.92		15.08						30.43	6.59	9.07	51.81			9.64	21.27	3.86	866.41	850.68			859.7	9.15	10.89	49.84	34.2			3.33		1.36		18.63					10.24	120.56	174.5				.m																																																		121
SUB231062	Atopic	CSLRI	1.0	expected	84936	b	129	28.23	8.49	99.62	339.46			1017.86				29.84				84.2	95.45		30.3			8.73	51.92		252.96	1054.16			3714.91	26.38	32.53	9.7	388.24				14.16	13.49							14.06	25.69	581.11			17.29	.m																																																		129	32.3		124.13	315.45			1067.43	17.49			27.98				93.26	151.5		30.3				49.49		211.6	856.93			3204.89	27.9	32.22	11.53	289.74				14.82	10.69							18.68	13.75	507			19.4	.m																																																		122
SUB231063	Atopic	CSLRI	1.0	expected	84562	b	127	27.81		443.45	56.44			1232.09								106.27	24.21		10.06			14.08	29.78	24.21	715.46	1075.54			3584.53	280.8	12.19	91.26	112.18			107.35								27.48	1526.34	40.81	2487.84			516.4	.m																																																		127	37.9	4.21	434.24	88.96			1079.48								97.57	12.51					12.39	35.15	15.72	509.99	867.35			2745.6	299.38	29.15	83.52	123.88			106.38		4.21						16.4	197.04	83.74	2591.11			414.79	.m																																																		128
SUB231064	Atopic	CSLRI	1.0	expected	84650	b	122	62.98		91.24	72.42			1095.53				1.98				6.42			30.9			7.82	141.87		422.5	1430.18			4828.12			11.3	439.53												58.36	10.07	739.67			22.14	.m																																																		122	95.13		91.56	142.27			1361.88								4.23	11.04		24.82			4.69	170.3		391.93	1269.27			3989.15			10.99	479.57											9.19	96.05	10.77	690.62			25.79	.m																																																		125
SUB231065	Atopic	CSLRI	1.0	expected	86212	b	134	62.68		377.1				633.22								59.46	8.57	9.43	16.97			9.74	188.99		591.9	509.26			2177.07				262.99			6.77									2.8		308.97				.m																																																		134	53.04		320.4	2.18			538.77								29.99		5.71	18.35			6.89	199.91		634.85	456.12			2291.1				83.56			7.12		8.97								5.59	221.87			3.35	.m																																																		100
SUB231066	Atopic	CSLRI	1.0	expected	87752	b	134	134.65	86.08	509.39	847.82			1716.77								55.51	44.02		149.49				187.98	13.41	400.9	2054.42			2635.56			15.7				19.82			13.75						80.77	137.32	1615.96			45.77	.m																																																		134	126.34	57.88	595.98	994.28			1605.88								52.05	111.75		136.05				181.13	7.75	428.72	1796.12			2574.37	107.52	0.21	143.97	187.05			4.24		8.16							15.01	21.45	1212.64			5.38	.m																																																		100
SUB231067	Atopic	CSLRI	1.0	expected	94663	b	134	238.6		804.86	118.2			1390								167.97	54.81		21.13			42.9	247.01	4.47	1067.38	714.18			2790	192.8		14.75	471.73													23.58	476.41				.m																																																		134	187.22		785.7	110.79			1530				0.92				140.69	89.87		28.82			43.03	223.05	10.59	817.39	631.91			2110	108.27	10.19	13.06	379.96												11.8	39.32	641.38			9.14	.m																																																		103
SUB231068	Atopic	CSLRI	1.0	expected	107919	b	134	142.71		354.25	1396.69			1537.03								21.74	22.16	16.39	181.78			34.24	189.76	0.21	484.86	1876.6			2185.63	63.42	15.01	149.78	269.11													22.93	861.39				.m																																																		134	132.89		337.37	1059.38			1445.71							9.26	30.73	25.31	12.13	187.81			37.47	161.64	7.35	449.1	1723.97			1866.84			22.17	29.53			70.81			7.99					12.61	385.23	136.42	1852.77			163.18	.m																																																		92
SUB231069	Atopic	CSLRI	1.0	expected	116533	b	156	43.3	238	212	2310			1260	1.8	2.24					2.36	37.8	111	3.98	151			15.8	43	335	312	4830			1860	64	52.3	43.2	86.3			46.1	1.21	11.4		26.9				17.8	38.2	32.9	5740			469	.m																																																		156	43.4	462	208	3150			1670	1.62	1.85		20.5			1.09	43.3	89.4	4.44	98.8			15.4	56.9	194	324	5090			2350	48.2	42.2	47.5	58			46.1				2.06				13.7	55.1	28.7	5440			508	.m																																																		248
SUB231070	Atopic	CSLRI	1.0	expected	113352	b	156	52.5	272	237	2200			945		2.63					1.35	53.1	438	4.23	184			73.2	44.4	1570	407	4090			1840	93.2	9.82	28	15.8			31.1	1.51			4.68				6.3	6.59	9.13	3840			151	.m																																																		156	47.3	143	235	2050			836				4			1.11	82	551	4.13	225			79	30.4	366	422	5430			3060	147	25.3	30.3	15			34.6	1.68							6.82	55.1	4.75	2970			125	.m																																																		248
SUB231071	Atopic	CSLRI	1.0	expected	108931	b	156	29.1	5.39	294	136			969				36.6				4.18			49.8			1.85	20.6		298	140			899	5.23		33.9				26.2	2.11			1.4				10.9		33.2	610			373	.m																																																		156	22.4		300	100			983				17.3				7.26			78			2.8	27.9		455	177			1290	9.56	3.41	32.4	4.68			22.2	3.51							12.8		38.5	673			398	.m																																																		250
SUB231072	Atopic	CSLRI	1.0	expected	120868	b	146	102		321	455			617				7.23				343	53.7	7.51	209			31.3	133		374	1250			717	2.93		34.5	19			25.5				2.3											.m																																																		146	123		336	464			884				17.5			5.42	294	52.1	9.2	216			25.7	159	3.87	384	1660			1280	3.66		31.1	52.6			26.2				24.4				13.1		336	2490			183	.m																																																		175
SUB231073	Atopic	CSLRI	1.0	expected	121433	b	134	86.78	65.54	477.29	366.03			1080.7								12.37	95.92		113.75			14.52	120.31	8.57	464.1	1139.14			1238.47							14.27		8.57		12.85				2.71	24.92	104.09	2052.77			65.7	.m																																																		134	119.31	90.63	552.96	376.09			1261.28								1.79	129		110.79			6.07	103.77		520.16	1109.3			1126.57				4.78													122.81	2089.89			49.35	.m																																																		80
SUB231074	Atopic	CSLRI	1.0	expected	114128	b	146	92.5		425	318			1880				9.38			3.25	113	93.3	18	102			46.4	163	9.34	1070	3010			877	81.1	7	103	102			68				3.7			8.06								.m																																																		146	85.3	2.94	514	267			1640		3.57		22.4			4.47	92	96.6	18.5	155			38.5	170	5.7	1020	1260			851	96.8	10.8	71.6	123			82.8		3.42		42.1			3.25	8.95	148	47.5	2280			72.2	.m																																																		170
SUB231075	Atopic	CSLRI	1.0	expected	87576	b	146	119		608	363			627				24.4				15.6	3.87	17.4	132			25.4	158		310	1160			1040	43.9	5.2	568	159			211				37.2			1.58								.m																																																		146	126		437	386			822				36.2			10.2	21.4	5.7	17.2	115			40.2	155	7.35	380	2440			1250	39		423	116			196				18.5			1.97	12.5		27	259			66.9	.m																																																		162
SUB231076	Atopic	CSLRI	1.0	expected	88280	b	165	7.36	7.41	325	119			746		16.1		15.4			2.94	9.86	12.6	3.54	12.6			20.9	18.8	15.4	187	1350			636	24.5	11.6	28	14			2.2	5.39	12.6		9.87					6.22	13.2	3810			26.6	.m																																																		165	4.15	3.02	396	142			822	2.94	6.22		15.4				7.01	4.55		5.29				17.8	17.6	172	1150			615	11.7	9.91	23.6					3.6	8.63		3.04					4.55	12.6	3640			30.1	.m																																																		267
SUB231077	Atopic	CSLRI	1.0	expected	95441	b	165	7.36	4.03	221	75.2			1320		16.8		4.15			1.88	15.2	5.65		28.7			2.12	11.3	10.6	332	185			486	10.3	11.6	38.4	12.6			24.7	5.62	11.6		9.87			1.13	7.48	8.01	25.3	150			439	.m																																																		165	10.8	8.01	241	94.6			1160	1.08	3.02		17.3				18.3	9.91		42.2			2.44	20	12.9	457	217			628	2.06	1.15	33.1	4.91			24.8				10.3				9.62	16.1	25.8	144			486	.m																																																		271
SUB231078	Atopic	CSLRI	1.0	expected	110661	b	167	122		266	773			1440	5.18	12.3	5.48					100	25	21.7	1530			42.2	114	4.12	511	3340			7840	30.6		197	3.5			87.7			3.89					20.4		36.4	1070			261	.m																																																		167	152		318	925			1610			4.79					80.1	34.7	20.5	1520			13.7	138	2.87	271	3570			7050	39.2		155				61	1.53		3.25					20.7	9.43	46.3	1190			354	.m																																																		267
SUB231079	Atopic	CSLRI	1.0	expected	95217	b	165	9.38	197	576	236			1030	1.37	3.02		10.8				84.1	68.4	18.5	75.2			25.5	13.1	17.6	857	1810			1030	188	21.3	113	37.1			33.6	2.17	1.15		12.1				3.05	23.7	193	1170			6.73	.m																																																		165	8.19	122	622	178			1020		7.41		4.52			1.72	110	115	19.3	76.4			37.4	11.8	18.7	443	1600			620	183	20.6	107	17.8			42.4	1.37	1.85		10.8					19.8	203	1130			6.06	.m																																																		262
SUB231080	Atopic	CSLRI	1.0	expected	88016	b	165	8.42		58.8	16.4			450		1.15		12.6				25.2	5.94	1.63	32			3.11	15	6.22	267	365			342	127	3.51	134	11.7			21	8.66	13.3		5.29			1.22	2.28	6.51	7.15	232			26.6	.m																																																		165		26.8		28.7			3.8	15	8.63	1.08	29.8			1.64	58.1	2.54	105	25.5			27.4	13.4	6.22	235	421			378		14.7		17.3				2.72	2.08	7.14	290			18.9	2.72		61.8	60.2			546	.m																																																		260
SUB231081	Atopic	CSLRI	1.0	expected	95329	b	165	16	11.2	314	3620			1520	3.38	6.81		12.6				98.9	42.1	1.79	182			4.86	19.7	78.5	683	13400			2360	155	11.2	233	54.1			19.2	1.5	9.91		13.5				12	49.2	242	6470			1320	.m																																																		165	16.7	5.1	325	3840			1660	1.61	8.63		11.7				113	67.9	2.32	211			5.5	22.3	36.9	843	9420			3470	150	8.63	160	23.4			21		3.02		12.6				11.1	177	187	6400			1690	.m																																																		258
SUB231082	Atopic	CSLRI	1.0	expected	100238	b	167	46.9	2.87	255	2.93			857	4.46							36.7		15.3	113			17	84.2	3.29	342	258			333	92.3		40.2	10.1			9.13	1.33			4.07						23.2	282			4.52	.m																																																		167	50.9		308	19.6			918		3.29	1.53	6.41				26.1	5.36	15.2	158			13.4	94.3		449	411			305	103		36.8	8.24			8.16								4.46		24.9	264			8.86	.m																																																		265
SUB231083	Atopic	CSLRI	1.0	expected	95777	b	167			98	910			1420				19.6				74.4	524	4.63	198			44.1	145	21	570	7190			2700	760	14.7	159	270			211	5.71							6.95	9.43	13.7	802			21.5	.m																																																		167	125		84.5	1260			1300								84.6	337	3.95	215			33.8	160	22.6	305	7130			3000	712	13.9	152	125			208	5.71									11	727			18.9	.m																																																		262
SUB231084	Atopic	CSLRI	1.0	expected	103225	b	168	95	29.5	310	185			734								87.4			33.6				187		518	1050			1710	128		44.4	8.3			5.04									139	51.6	897			23	.m																																																		168	122		136	68			1330								87.7	2.3		39.1				140		241	809			1560	133	3.05	52.5	7.06			17.7		3.79							130	53.4	1060			13.7	.m																																																		256
SUB231085	Atopic	CSLRI	1.0	expected	163331	b	168															99.8	178	3.97	78.4				210	13.2	314	1510			2740	60.3	11.1	36.9	141			2.77				1.15				3.59	35.6	26.9	618			196	.m																																																		168	119	18.3	352	239			993								79.2	232	3.67	44.8			4.82	217	30.6	357	1670			3210	77.2	25.5	46.4	236			9.96								2.96	80	32.6	788			135	.m																																																		253
SUB231086	Atopic	CSLRI	1.0	expected	95105	b	180	25.7		50.7	82.1			1650								15.1	1.06	2.14	55.4			15.4	44.7		215	648			3310	13.3		7.88	139			44.5									1.73	22.2	712			81.9	.m																																																		180	21.9		42.1	54.3			1700								21.9		2.62	45.8			19.8	44.7		157	515			3310	26.7	12.9	8.85	179			41.9		3.27	1.04	9.72				5.23	9.61	18.1	569			66.9	.m																																																		310
SUB231087	Atopic	CSLRI	1.0	expected	156180	b	180	31.1		371	388			2310			1.21	34.3				57.6	30.7	38.3	53.1			236	55.3		390	869			3690	138	4.03	110	146			48.2	5.48	1.73		2.5			7.6		7.97	14.1	690			22.2	.m																																																		180	31		366	408			2410			1.11	22.7			6.07	133	41.5	7.15	103			31.4	41.7	6.37	357	1070			3550	105		113	174			42.1		1.73		5.12			4.41		11.8	16.4	766			14.6	.m																																																		308
SUB231088	Atopic	CSLRI	1.0	expected	99048	b	180	3.44		123	15.5			383		2.25		7.84					2.51	2.27	31.1			8.77	28.2		255	288			1470	25.7		9.83	18.6													47.5	239			132	.m																																																		180	5.48		109				352	1.93			33.2			1.92			1.68	6.92				15.5		174	335			1190	16.5		10.4	4.23				1.28							2.28		40.9	200			105	.m																																																		314
SUB231089	Atopic	CSLRI	1.0	expected	136655	b	180	65.4	9.61	416	1990			15800	2.67	13.5	1.43	38.3			2.35	53.7	12.9	2.6	102			79.3	62.7	16.1	460	1830			10500		11.3	12.3	72.9			8.85	1.97	7.97	2.05	36.2			9.24	7.64	12.4	171	3010			41.5	.m																																																		180	68.8	15.5	363	1820			15700	2.21	8.52	1.07	23.4			21.8	84.1	7.44	2.62	152			113	70.4	7.97	331	968			8970	1.48	9.33	18.7	75.9			5.96	9.93	9.61	1.87	24.4				7.51	5.84	101	3110			104	.m																																																		308
SUB231090	Atopic	CSLRI	1.0	expected	92698	b	165	9.86	912	421	617			1420	2.06	8.01		10.8				35.7	52	2.31	23.4			1.13	32.5	180	547	3910			948	34.2	33.4	49.6	12.6			14.6	5.51	10.2		3.41				3.16	11.2	19.4	1470			196	.m																																																		165	4.26	627	375	571			1340		12.6		11.7				37.6	71.7	3.41	42.2			8.48	23.1	179	454	3390			883	26.9	39	43.5	27.7			21	4.26	6.22		4.15				5.62	29.7	16.3	1730			356	.m																																																		256
SUB231091	Atopic	CSLRI	1.0	expected	103897	b	180	45.3		228	500			3370								47.5	3.27	1.97	84.5			22.2	63.5		460	1540			5470	1.56		20.3	6.01			9.76				8.77				1.81		12	1610			298	.m																																																		180	50.1		340	432			4200								40.1		2.11	74.5			18.8	59.5		414	1540			5380	10.7		18.7	32.2			8.96							2.28			12.5	1830			248	.m																																																		320
SUB231092	Atopic	CSLRI	1.0	expected	108031	b	188	8.24		214	38.5			3170							9.46	41.9	5.6	10.7	64.4			246	6.86		459	502			559	67.2	8.17	28.4	910			152		3.17							11.8	6.35	539			74.5	.m																																																		188	7.63		198	19.6			2860							2.24	50.2	5.6	10.8	56.7			299	10.5		382	448			414	89.3	4.25	31.5	839			156		2.1							10.6	6.18	518			77.6	.m																																																		353
SUB231093	Atopic	CSLRI	1.0	expected	103561	b	180	21.6		479	1460			1480			1.08	2.5			5.88	38.9	3.01	4.45	123			13.8	51.5		948	2950			1300	4.75		67.6	7.84			21.1							4.23		17.5	36.6	6370			251	.m																																																		180	27.7		484	1540			1710			1.04	4.23				33.5	12.4	5.47	89.3			25.6	44.7	8.52	900	2930			1390	1.81		48.7	7.84			9.76		1.44	1.07						7.97	32.4	5930			186	.m																																																		319
SUB231094	Atopic	CSLRI	1.0	expected	100798	b	188	11.3	55.9	916	823			3430								1080	557	16.6	191			211	11.4	7.82	706	3340			578	114	23.3	160	545			376		3.17		14.2			5.77		10.7	25.9	4260			9.06	.m																																																		188	12	82.9	1020	1300			4500							3.67	1130	1000	18.6	240			276	20.8	7.46	796	3260			461	135	22.7	163	718			341							2.24		7.46	26.6	4280			5.77	.m																																																		342
SUB231095	Atopic	CSLRI	1.0	expected	115844	b	189	35.9		141	101			3660	14.5	12.9		58.8			13	507	55.8	8.27	111			45.6	40.6	13.8	413	626			1070	22.4	11.9	7.5	828			21.1	22.2	2.83		32.2				11.3	11.9	57.9	737			18.6	.m																																																		189	30.7	12.3	124	67			2820	13.2	19.9		28.5			10.5	535	69.2	8.13	129			31.2	43.1	6.5	469	595			1990	28.9	20.8	5.74	144			21.8	20.1	3.96		38			5	20.3	19	55.8	769			35.3	.m																																																		326
SUB231096	Atopic	CSLRI	1.0	expected	136543	b	192	15.6	26.3	273	1260			4830		2.84						312	533	16	263			143	20.4	12.3	468	2680				5.92	9.15	58.5	1010			84.8		1.45					1.89		9.7	24.6	971			40	.m																																																		192	16.5	28.2	295	862			3350		1.24						336	640	13.6	237			98.8	17.8	21.3	850	4140				5.92	8.6	44.7	559			74.6		4.17							3.6	16.8	1180			42.9	.m																																																		335
SUB231097	Atopic	CSLRI	1.0	expected	131262	b	192	8.27	8.23	308	164			1250				52.4				98.8	108	60.8	281			61.4	10.8	2.65	447				2940	12.5	8.97	950	445			129		2.26		13				2.8		63.3	659			397	.m																																																		192	7.54	7.13	306	129			1170	8.46	7.4		10.4				94.1	120	53.1	313			65.6	9.49	2.84	420				3010	13.8	7.5	914	432			110		1.66		17				2.88		61.1	646			398	.m																																																		331
SUB231098	Atopic	CSLRI	1.0	expected	167464	b	188	8.85	9.38	357	516			2290		3.6		19.2				45.9	126	1.26	167			10.8	18.3	5.6	325	3270			5260	21	6.52	72.9	60.8			49.4		1.56						6.52	8.53	60.8	616			618	.m																																																		188	10	8.41	379	897			2470		4.48					1.88	51.2	143		173			12.4	15.6	9.02	329	3530			5390	16	11.6	66.6	34.2			42.7	17.7	5.72					1.88	7.11	6.99	40.1	538			266	.m																																																		327
SUB231099	Atopic	CSLRI	1.0	expected	147082	b	188		4.14	301	128			717		2.53						31.7	58.9		238			9.33	12.9	4.03	524	592			4500	17.6	5.04	46.4	148			48.5	1.2	3.71						1.43	15.1	36.8	335			74.2	.m																																																		188	3.08		240	98			542								40.7	35.2		243			9.19	18.3	5.49	678	762			5380	4.52	5.37	45.6	236			70.2	8.06	7.11							7.34	37.3	256			88.2	.m																																																		328
SUB231100	Atopic	CSLRI	1.0	expected	139116	b	188	7.54	14.6	608	108			2000		3.27						14	7.94		19.2			19.2	9.64	9.87	1000	1230			3860	7.03	10.2	8.45	701			13.3		3.17		8.63					153	15.3	1590			263	.m																																																		188	9.82	4.59	537	67.5			1790		3.81		11.8			3.07	15.7	2.31		30.1			9.6	14.2	11.2	1160	1790			4590	6.09	12.6	7.58	745			21.7		3.38					4.27		129	22.2	1520			216	.m																																																		332
SUB231101	Atopic	CSLRI	1.0	expected	131498	b	188	3.96		76.7	1420			1830								39.5	35.8		58.2			11.8	5.18	3.06	71.8	1220			3260	70		7.1	60.1			11.7										7.22	920			23.2	.m																																																		188	1.43	1.89	80	1530			1780								53.3	44.6		82.1			7.33	2.76		43	492			1560	66.9		6.74	69.7			23.3									2.95	9.87	775			33.6	.m																																																		335
SUB231102	Atopic	CSLRI	1.0	expected	120756	b	192	12	4.45	342	1140			2840		3.32		30.7				756	14	1.75	97.9			174	13.9	1.14	305	2820			4000	89	3.79	36.9	211			172	2.88	2.46						17	123	26.7	2000			160	.m																																																		192	16.8	4.07	324	1130			1590		4.45		21.1				608	17.7	2.52	113			154	12.3		439	3130			4250	86.6	3.42	36.7	238			184	3.69							2.56	10.3	9.23	1430			4.51	.m																																																		326
SUB231103	Atopic	CSLRI	1.0	expected	121545	b	192	13.9	3.79	995				534		2.26		22.4				158	162	28.3	1900			80.1	12.5	2.75	547				938	137	6.39	313	308			57.3	6.9	4.54						2.8	3.6	34	349			5.97	.m																																																		192	12.7	4.17	927				553		2.75		4.29				133	67.4	27.5	1530			62.8	9.39	2.84	625				1310	112	3.42	350	540			98.5	11.9	1.66						4.62	6.21	38.1	369			40	.m																																																		322
SUB231104	Atopic	CSLRI	1.0	expected	130572	b	189	36.6	17.1	371	2130			4420	5.6	15.5		30.8			8.17	366	296	8.23	104			64.6	39.6	109	637	3770			7480	130	40.9	119	409			144	12.3	9.56	1.43	35.8			10.5	15.2	50.2	17.3	2350			55.6	.m																																																		189	38	30.8	365	1950			4240	19.2	9.77		27.8			6.48	360	327	8.05	114			61.1	37.9	84.7	496	3400			6920	125	63.3	154	377			119	17.8	7.51	1.08	35.8			5	13.9	58.9	19.4	2500			38.3	.m																																																		310
SUB231105	Atopic	CSLRI	1.0	expected	120635	b	189	39.8	12.1	409	1700			2410	12.3	5.71		58.8			7.11	56.1	18.6	4.63	153			65.2	30	17.3	456	2240			1200	79.9	11.2	80	401			198	14.5	9.77	4.38	49.6			8.38	18.6	29	21.3	1820			34.4	.m																																																		189	40.8	3.96	423	1540			1080	8.66			80.1			9.23	55.7	53.4	4.53	161			78.6	34.2	12.5	656	2610			3240	94.1	24	80	482			233	15.6	2.83	5.15	48.9			9.23	17.7	60.2	25.1	2460			47.4	.m																																																		310
SUB231106	Atopic	CSLRI	1.0	expected	114016	b	189	30.7	6.7	349	249			2570	7.3			63.9			11.3	28.2	42.8	2.69	191			13	38.9	2.08	1100	1660			5320	40.6	17.1	19.6	824			17.9	10.2	7.1		37.3			5.21	12.9	18.4	28.8	1030			60.6	.m																																																		189	32.9		375	234			2570	9.47	6.5		40.8			7.54	23.4	45.2	2.49	162			4.58	32.9	7.71	733	1060			4550	39.9	13.1	20.9	628			13	10.9	8.73		30			1.36	9.86	11.2	33.1	1170			55.2	.m																																																		323
SUB231107	Atopic	CSLRI	1.0	expected	222698	b	193	19.3	53.8	271	2150			2350		3.87	1.05	35.3			8.78	234	50.2	8.03	93.8			22.4	34.1	235	330	4260			1960	101	54.8	226	939			95.4		2.66	1.32	75			9.91		50.4	33.8	2390			84.3	.m																																																		193	17.2	67.7	250	2260			2810		3.67	1.07	53.5			8.78	303	117	10.7	104			27.2	32.9	182	402	3070			1860	112	62.8	226	1030			88.6		1.93	1.69	24.9			9.75		107	22.6	2730			66.8	.m																																																		313
SUB231108	Atopic	CSLRI	1.0	expected	239185	b	193	12.8	857	369	5860			3230			2.87	8.92			2.64	215	229	14.8	100			23.2	12.4	177	290	8040			4490	778	63.3	644	137			50.2			3.51					2.16	86.9	106	2020			133	.m																																																		193	13	953	322	3900			2260			2.97				3.4	215	203	17.6	79.2			13.7	15.6	198	322	9620			5410	670	91.2	530	90.2			71.1			3.34						46.8	107	1980			92.7	.m																																																		315
SUB231109	Atopic	CSLRI	1.0	expected	204346	b	193	27.7	5.39	58.4	279			1030	1.95	3.57		100			10.1	9.04	5.39	1.38	64.8			11.5	32	16.8	196	1560			2640	48.9	7.64	22.5	841			88.3								2.51	78.1	48.4	572			92.9	.m																																																		193	17.1	3.97	51.5	257			885	5.63	3.47		75.6			10.1	18.2	7.48	1.33	63			10.8	39.9	14	172	1410			2600	51.1	10.4	20.4	1000			108								3.59	69.3	42	560			112	.m																																																		299
SUB231110	Atopic	CSLRI	1.0	expected	169766	b	193	6.42	5.29	111	393			868		1.45		37			7.46	92.3	6.56	4.72	79.8			20.2	31.2	17.4	610	1180			1790	351	25	17.8	2240			43.8								1.95	10.1	22.1	514			55.4	.m																																																		193	6.42	5.29	97.4	195			381		2.62		49.3			10.4	105	7.64	4.29	78			20.9	35.8	14.3	558	811			1590	307	6.34	13.6	1280			33.2									8.98	25.1	374			51.9	.m																																																		305
SUB231111	Atopic	CSLRI	1.0	expected	121666	b	192	11	6.02	285				2510		2.84		3.5				244	103		50.2			21.1	16.8	41.1	580				1060	134	18.3	113	838			82.5	2.8							5.3	9.15	8.84	2360			17.2	.m																																																		192	11.6	6.21	258				2240							2.75	357	115	1.11	71.8			31.5	21.7	24.8	497				1060	109	18	135	442			82.1	2.72	2.06						1.16	14.3	8.34	2340			17.2	.m																																																		317
SUB231112	Atopic	CSLRI	1.0	expected	164777	b	193	3.23	10.1	799	905			1160				3.65			3.97	167	22.2	3.62				4.28	11	5.55	232	2830			3120	228	15.1	86.9	967			34.7									10.9	54.6	2060			28.2	.m																																																		193	5.78	9.15	736	1190			1360				6.6				147	31	3.71				3.28	9.04	4.22	242	2820			3080	147	13	87.5	462			34.8									16.3	61.9	2580			48.5	.m																																																		313
SUB231113	Atopic	CSLRI	1.0	expected	208974	b	193	4.33	2.53	118	399			318	2.09	1.54	1.38	51.7			1.93	1.81	2.9	2.26	56.4			10.1	13.1	2.25	238	1700			2250	1.04	2.16	18	52.9			14.8		2.16		26.1			5.78	5.16	12.6	8.49	669			13.7	.m																																																		193	4.55	2.43	101	396			306	2.37		1.07	18.1			6.86	2.87	1.8	1.64	14.6			9.98	11.6	2.81	197	1920			2570	4.48	1.76	19.8	57.6			13.5		3.77		40.5			7.2		3.72	10.7	972			13.2	.m																																																		311
SUB231114	Atopic	CSLRI	1.0	expected	247065	b	193	12.5	43.3	389	544			1680		2.53	4.22	54.6			8.7	265	135	40.1	230			46	23.8	10.6	542	6460			738	4.08		240	80.1			8.83				9.68				9.8	11.8	32.3	2190			45.3	.m																																																		193	17.2	61.9	472	582			1860		2.16	3.85	22.6			11.2	175	119	35.6	145			35.2	20.3	6.5	520	7280			712	13.1		272	113			8.83				13.9					18.6	43.5	2430			49.8	.m																																																		296
SUB231115	Atopic	CSLRI	1.0	expected	130460	b	201	64.1	3.02	118	449			1120		2.14	1.77				2.29	73.9	171	9.47	504			8.21	118	6.44	401	2310			5310	105	18.8	31.7	114			46.6		5.42	2.32						68.7	82.3	199			12	.m																																																		201	63.1	5.16	138	458			1300		4.64	1.87				1.51	77	239	8.32	489			9.41	102	6.69	314	1700			5030	110	15.4	35.8	88.9			25			1.32				2.15		50.6	80	390			9.41	.m																																																		325
SUB231116	Atopic	CSLRI	1.0	expected	254543	b	204	17.9	1.84	108	873			809		1.5		37.6				112	6		62.5			2.58	42.2	1.54	682	4610			6800	331	5.05	183	154			15.2		1.5		27.7					5.68	82.8	2450			34.7	.m																																																		204	16.1		113	1050			866		1.82		29.8				105	7.15		79			2.46	41.6		689	4470			8110	254	6.87	154	115			12.2		2.72		18.7					6.27	75.7	2660			31.5	.m																																																		329
SUB231117	Atopic	CSLRI	1.0	expected	154760	b	201	51.8	44.6	339	1540			793		1.5	4.19				2.24	257	275	10.7	307			6	110	19.7	638	3510			2340	43.8	13.3	64.5	52.3			13.2			3.85				1.24	9.58	41	51.9	2560			82.5	.m																																																		201	44.6	25.9	263	1410			668		5.42	4.4				1.6	226	304	11.8	314			4.59	107	10.4	929	4460			3150	58.3	17.5	75.8	86.3			13.2		2.73	4.61				1.24	5.68	65.9	55.7	2570			60	.m																																																		335
SUB231118	Atopic	CSLRI	1.0	expected	238502	b	201	17.2	309	110	1770			204		1.5	2.49					45.6	585	9.18	511			2.76	107	113	392	6160			2930	15.7	10.9	96.7	48.5			6.09		4.11	2.85				3.4	6.48	211	41.3	1540			77.6	.m																																																		201	16.8	320	91.3	1560			191		2.29	2.42					52.4	515	9.41	536			5.56	100	159	554	8520			2570	24.6	15.2	115	30.6			6.75		1.5	32.3	346			6.23	13.3	427	68.8	1680			129	.m																																																		326
SUB231119	Atopic	CSLRI	1.0	expected	300297	b	204	21.2	3.69	175	4310			1010		3.26		9.02				95.2	344	14.6	377			23.2	42.7	329	1280	8530			2670	838	32.6	596	303			59.6	2.54	1.98		18.3				10.1	67.6	106	4620			93.4	.m																																																		204	27	9.12	222	3940			1160		2.1		22.3				83.5	225	17.2	270			13.7	50.1	125	1100	6100			4000	866	30.4	539	291			54		1.86		23.1				8.53	52.8	88.8	4270			85.6	.m																																																		326
SUB231120	Atopic	CSLRI	1.0	expected	268607	b	214			695	532			1050			1.65	4.7				75	38.1	15	539			20.8			1520	5110			234	108		138	42.1			4.1			1.53	11.3					16.7	331	3020			86	.m																																																		214			1480	682			1100			2.32	4.28				68.7	6.25	11.2	360			7.54		3.32	1240	4780			253	87.9		126	64.4			6.39			1.7	13.2					9.01	336	2740			101	.m																																																		362
SUB231121	Atopic	CSLRI	1.0	expected	150810	b	214		1110	179	4260			285				7.66			2.59	813	1580	20.6	1680			42.1		122	294	5960			975			268	98.8			27.4			3.02	27.7					10.7	57.1	2140			60.9	.m																																																		214		907	333	5480			282		3.81	1.32	18.7			1.19	1120	2250	47.2	1750			55.7		230	398	4500			414			319	113			45.6			1.73	10.5					75.5	82.4	2640			144	.m																																																		357
SUB231122	Atopic	CSLRI	1.0	expected	157632	b	214		12.7	161	3960			1020				3.29				32.9	165	1.93	830			20		118	232	13800			767			64.6	54.2			15									105	23.5	3910			27.3	.m																																																		214		14.3	160	6170			820				5.34				40	164	2	473			16.7		117	145	13100			622	6.57	1.17	92.8	62.6			17.6		1.17		1.25					69.4	25.7	3800			28.8	.m																																																		364
SUB231123	Atopic	CSLRI	1.0	expected	139004	b	214		43.1	472	1670			980		1.04		7.66				62.5	469	1.32	203			5.17		22.4	518	4370			500	1040	74	31.3	88.7			31.6		1.17							5.65	58.1	484			4.79	.m																																																		214		27.3	579	1070			975				2.55				119	464	2.02	284			5.93		15.5	1280	7250			319	861	32.5	25.5	66.2			4.91				6.24					11	101	796			9.47	.m																																																		364
SUB231124	Atopic	CSLRI	1.0	expected	134071	b	201	9.13	148	57.1	1410			109		3.98	2.32				3.19	56.3	94.1	7.47	174			3.19	109	596	424	6080			2440		6.69	56.5	121			5.25			2.64				3.37	2.85	747	17.7	1450			36.8	.m																																																		201	11.9	108	54.8	1480			120		3.3	2.89				2.72	52.2	91.1	7.59	149			2.29	98.9	265	312	4800			1980	3.09	3.3	53	100			3.52		2.14	2.81				2	4.34	1840	21.4	1390			65.3	.m																																																		324
SUB231125	Atopic	CSLRI	1.0	expected	130684	b	193	26.7	172	605	4610			1600	2.8	1.1	1.17	29.5			6.77	163	122	5.2	117			17.9	36.5	48.7	887	4750			2460	546	13.2	156	92			28.6								8.87	45.9	151	4320			204	.m																																																		193	23.4	108	625	4820			1390		2.76	1.57	20.9			11.8	158	98.9	5.25	135			13.4	36.6	108	1000	6330			2630	542	6.88	158	82.8			32.2								3.81	46.9	111	5930			301	.m																																																		282
SUB231126	Atopic	CSLRI	1.0	expected	203749	b	214			192	202			878				2.2				75	2.21	4.49	128			15.8			460	1750			255	8.09		56.9	59			1.16			4.27	25.3					1.46	156	565			27.7	.m																																																		214			407	392			947			1.05					89.5		3.51	170			10.3			693	1310			316		1.46	57	76.5			1.83			1.13	2.37					1.6	191	887			55.2	.m																																																		363
SUB231127	Atopic	CSLRI	1.0	expected	297414	b	214		1090	138	2660			62.3		1.53		5.43				107	692	7.8	225			15.1		1820	633	5000			637	22.5	9.84	77.6	42.7			7.67		3.24		9.01					291	53.6	2200			37.5	.m																																																		214		1320	132	3430			80.2		3.4		10				143	807	8.81	199			16.3		1160	319	5420			623	38.6	9.29	85.9	56.1			9.49		1.53		14.5					362	48	3520			81.5	.m																																																		361
SUB231128	Atopic	CSLRI	1.0	expected	305579	b	214		124	119	6020			576		3.24		9.78				193	396	5.95	208			24.4	3.47	125	404	9170			2020	305	54.3	770	270			115		2.6	1.24	10				2.38	6.08	73.6	1280			43.2	.m																																																		214	5.05	334	101	7690			877				8.5				143	381	10.3	205			27.1		144	622	8550			1930	271	82.5	721	756			788		3.56	1.06	12.8					8.2	67.8	1020			59.1	.m																																																		349
SUB231129	Non-atopic	CSLRI	1.0	expected	295635	b	214			66.7	3800			43.4		3.48		7.04				37.1	37.8	1.33	406			18.6		12.7	666	8310			611	4.11	1.75	29	54.3			20		1.83		15.1					109	32	4380			12.3	.m																																																		214		6.6	82	3790			36.8				8.25				28	33.8	1.98	303			20.8		16	705	7860			755		3.08	18.1	65.5			14.2		3		9.52					97.8	30.3	3080			13.7	.m																																																		349
SUB231130	Atopic	CSLRI	1.0	expected	238614	b	214			536	1980			321	5.96	2.76		4.36			1.05	19.2	4.22	2.3	693			14.3		2.44	1660	7290			559	175	2.13	99.7	33.7			17		2.13		9.78					1.38	35.2	1620			15.1	.m																																																		.m																																																		.m																																																		350
SUB231131	Atopic	CSLRI	1.0	expected	227325	b	214		3.08	163	154			20.3		1.46		10				65.6	3.24	1.15				6.1		7.84	491	2590				76.6	7.66	17	526			16.5		2.29							8.2	5.67	978			148	.m																																																		214		3.89	199	199			4710		4.13		2.8				113	6.95	1.25	19.4			7.38		31.5	433	1760			22.4	40	4.89	16.4	285			14.9		1.68		12.2					4.89	6.47	784			141	.m																																																		361
SUB231132	Atopic	CSLRI	1.0	expected	166136	b	216		34	51.9	1100			147									483	4.19	267			31		360	170	3370			1130	142	23.8	17.6	34.6			7.33									400	5.01	1780			25.7	.m																																																		216		32.3	54.3	1000			188								12.1	541	4.38	356			29.5		166	171	2500			664	167	30.6	21.2	20.9			7.43									480	3.49	2260			23.9	.m																																																		355
SUB231133	Atopic	CSLRI	1.0	expected	250081	b	216		3.11	216	377			323								8.55	10.9	2.67	107					28.8	815	1640			248	143		201	81.5			4.15		3.11	3.23	24.2					32.2	153	749			36	.m																																																		216			230	308			261								14.2	6.05	3.27	123						193	1140			173	112	17.3	149	78.9			4.08		3.57	1.07	4.93					10.9	20.5	325			4.46	.m																																																		347
SUB231134	Atopic	CSLRI	1.0	expected	328953	b	217	7.04	4.31	397	810			764								182	671	48.1	735			38.4	24.4		854	1740			1630	9.53	1.08	297	25.9			57.5				19.7						74.2	476			34.6	.m																																																		217	7.48		345	729			861								179	504	63.7	611			30.6	24	8.02	1030	2170			2070	23.2	10.8	251	32.6			90				1.79						84.9	383			33.8	.m																																																		369
SUB231135	Atopic	CSLRI	1.0	expected	164891	b	216		21.7	264	1770			346				11.2				62.6	65.3	9.39	177					19.6	829	2450			137		5.14	121	69.4			6.59		4.77	1.44					7.04	11.5	64.8	626			3.88	.m																																																		216		12.1	261	1860			313			1.06	31.2				46.6	52.2	6.46	160					30.4	958	2270			256		6.54	102	66.7			5.68		3.11	1.19						42.4	113	814			15.7	.m																																																		349
SUB231136	Atopic	CSLRI	1.0	expected	254097	b	216		34.1	199				809	5.95	2.58	1.22					883	229	224				5.35		73.5	414				3470	58.7	5.5	747				27.4			1.27						7.2	18.4				286	.m																																																		216		45.7	152				754		7.52	1.31					819	199	191				6.02		110	511				4730	32.6		796				30.6		3.78	1.44							93.8				8.39	.m																																																		335
SUB231137	Atopic	CSLRI	1.0	expected	154872	b	216		1620	138	2410			966			1.35	24.2			5.78	67	934	29	552			113		11500	518	9900			8380	495	180	259	195			191			59.9	745			460		143	34.4	2640			633	.m																																																		216		879	124	2050			883		6.37	1.73	23.1			9.55	84.7	1970	45	771			202		11500	490	13300			11200	742	102	227	144			67.5			3.05	18.4			2.45		170	31.7	2830			1000	.m																																																		322
SUB231138	Atopic	CSLRI	1.0	expected	203994	b	216		54.8	55.4	1410			312		23.4	51.6	3370			1050	144	1880	274	343			168		580	676	8480			578	23.7	68.7	1160	1060			668		147	10.4	1070			286		68	9.3	794			201	.m																																																		216		74.3	62.9	1910			369		17.7	45.8	2550			856	153	2650	243	428			218		416	566	7830			464		193	844	1890			1180		117	11.1	1070			270		67.7	14	1000			322	.m																																																		328
SUB231139	Atopic	CSLRI	1.0	expected	235030	b	222		8.25	133				149			2.14					65.6	34.3	170					8.61	14.1	329				932			582				11.2			1.53							26.6				5.83	.m																																																		222	1.46	12.6	152				194			2.57					72.7	37.9	153				1.27	9.72		361				873			610				7.63			1.49							21.3				7.77	.m																																																		349
SUB231140	Atopic	CSLRI	1.0	expected	248162	b	216	4.33		110	1120			413								198	167	4.4	90.7			27.9		9.26	391	1910			630	17.1	8.64	13.5	309			6.89		4.39		8.77				1.81	13	70.1	597			77.2	.m																																																		216		5.5	100	1040			312				4.21				171	188	5.64	81.2			27.4		13.1	245	1480			252	53.5	11.4	12.9	228			5.9								2.75	50.2	62	566			82.4	.m																																																		332
SUB231141	Atopic	CSLRI	1.0	expected	233034	b	234	18.5	15.9	265	7370			1830	3.49	3.98	6.97	1110			9.97	139	59.7	70.5	2140			29.6	18.1	108	1570	6800			2630	163	20.2	333	1420			101	5.64	3.27	5.47	1040			2.96	6.87	5.97	63.8	2120			10.7	.m																																																		234	19.6	53.3	202	7860			1960	4.04	3.57	8.98	1320			11.9	135	53.9	64.2	2170			33.1	22.3	87.6	1230	8640			3090	162	28.3	316	1500			130	3.4	3.16	5.93	989			2.18	5.45	6.48	56	1720			7.67	.m																																																		374
SUB231142	Atopic	CSLRI	1.0	expected	280366	b	222	26.9		170				1320								29.3		4.23					28.5		317				821	1.84		44				3.13										54.5				24	.m																																																		222	22.5		161				1110								30.7		3.37				1.63	36.6		323				1250	6.36		57.7				5.28	2									58.6				21.7	.m																																																		344
SUB231143	Non-atopic	CSLRI	1.0	expected	248050	b	222	25.4	66.7	349				961								86.5		6.59				4.28	21.6	26.8	649				1170	1.72		188				7.97									19.5	57.7				97.8	.m																																																		222	29	110	418				953								108		6.75				4.22	46.7	86.2	606				2170			141				6.75										66.5				15.4	.m																																																		343
SUB231144	Atopic	CSLRI	1.0	expected	305691	b	234	23.6	6.68	222	1260			2890		1.44	1.1	32.7			13.4	184	567	40	708			403	10.9	151	604	3750			7020	3.67	2.2	5.37	334			60.6	6.87		2.04	110				12.7	2.98	10.3	5390			479	.m																																																		234	27.7	7.33	231	1290			3250				46.6			14.9	183	641	37.2	615			479	12.4	144	624	4620			7840	5.12	2.76	6.1	347			69.3	4.04		1.66	88.1				17.8	8.93	13.8	5970			929	.m																																																		367
SUB231145	Non-atopic	CSLRI	1.0	expected	245075	b	235		3.22	13.6	285			80.8		5.89	12.9	311			73.3	7.94	71.1	23.6	184			50.2		1060	27	1540			282	181	54.7	334	412			293			2.05	53.6					3010	53.4	1490			79.6	.m																																																		235		18.1	13.8	234			68.3		10.8	2.29	110			12.6	13.6	122	26.5	201			55.3		788	24.2	1490			281	147	40.4	306	325			265			2.56	94.1					1870	39.7	1190			63.6	.m																																																		367
SUB231146	Atopic	CSLRI	1.0	expected	212094	b	234	8.41	4.77	54.5	114			251	4.51	4.59		54			1.92	24.9	161	2.23	73.1			11	13.7	15.3	180	558			1020	36.1	32.7	85.3	225			37.1	3.3	4.35		44			1.08	3.49	86.6	13.6	283			7.52	.m																																																		234	7.06	7.73	54.5	138			251	3.4	4.47		42			1.69	24.8	68.5	2.12	39.3			6.08	13.5	18.7	200	783			1120	32.9	28.4	75.3	248			15.9	2.11	5.46		31.4			1.53	3.58	63.6	9.24	285			8.17	.m																																																		376
SUB231147	Non-atopic	CSLRI	1.0	expected	342179	b	234	10.9	2.14	185	1350			536	3.21	4.47	1.24	183			14.3	300	1110	16.5	661			33.1	15	5.08	596	5510			1820	47.9	44.9	54.4	551			27.2	3.58	4.1		113			8.75	2.75	2.59	2.8	733			11	.m																																																		234	14.1	3.8	150	1280			472	3.4	4.22	1.35	179			15.1	233	903	14.4	827			30.5	16.6	5.21	704	6440			2160	36	44.2	51.2	930			21.1	3.58	3.51		121			6.92	2.75	4.1	2.02	889			19.7	.m																																																		371
SUB231148	Atopic	CSLRI	1.0	expected	238838	b	235			125	58.6			555								17.3		1.37	3.2						156	572			1010	173	18.2	24.5	240			26.1										9.66	581			17.1	.m																																																		235			302	90			1040				1.89			1.59	29		2.16	18.7			3.71	2.15		140	415			636	262	10.4	36.8	162			49.8				5.86						19.3	669			48.4	.m																																																		366
SUB231149	Atopic	CSLRI	1.0	expected	234806	b	234	15.9	12.2	787	1380			1510	4.51	3.39	4.24	159			3.68	125	18.3	34.3	261			15.3	14.2	7.4	1020	2750			1190	437	29	45.9	333			74.7	3.21	3.16		85.4			2.8	3.86	4.35	22.4	978			5.48	.m																																																		234	16.3	15.6	809	1170			1340	3.81	5.84	4.77	124			4.21	115	12.9	27.2	202			13.5	15.4	11	895	2420			1130	410	28.1	45.6	327			70.8	3.49	5.97	1.17	79.2			4.08	4.98	5.97	18.9	1180			7.78	.m																																																		369
SUB231150	Atopic	CSLRI	1.0	expected	250193	b	235	3.67	17	105	357			589	4.22		1.51	84.1			3.54	91	20.5	4.56	125			19.9		113	622	1830			1770	158	7.99	9.67	66			7.35	1.67		1.81	67.4			3.76	1.59	67.2	1.81	261			43.9	.m																																																		235	2.86	17.4	97.3	349			525		3.22	1.55	76.5			6.02	120	5.12	4.02	135			19.5	4.76	66.3	494	1800			1690	215	6.69	9.51	44.6			7.1	1.23	3.89	1.87	58.9			4.73	1.51	91.4	1.95	297			40.6	.m																																																		363
SUB231151	Non-atopic	CSLRI	1.0	expected	253093	b	235			54.2	118			117							2.88	8.29	14.5	1.82	36.3			3.15			104	359			203	9.5	5.6	8.28	36.3			5.78				17.3							201			3.54	.m																																																		235			46.5	144			103				3.2			1.59	6.39	7.3	1.79	33.4			1.91			104	353			195	14.2	6.82	9.42	62.2			8.76				9.35							198			6.02	.m																																																		364
SUB231152	Atopic	CSLRI	1.0	expected	156292	b	235	6.77	5.89	508	1780			2360	2.93	6.03	3.12	111			11.6	43.6	7.88	9.47	463			11.2	4.9	3.89	342	2130			1830	156	14.2	261	300			20.4	4.35	6.03	1.33	101			5.61	1.67		1.6	69.5			9.76	.m																																																		235	6.77		505	2000			2210	1.42	4.77	2.84	122			12.9	48.3	5.12	9.47	495			16.7	3.54		532	3260			2530	134	20.4	324	346			30.3			1.66	70.2			5.61	2.99		1.35	71.6			8.88	.m																																																		359
SUB231153	Non-atopic	CSLRI	1.0	expected	255384	b	235	6.05		179	242			827			2.22	58.6			3.99	103		14.4	77.6			28.3		16.2	451	436			1130	47.2	28.3	247	326			36.3				2.55			2.66		144	10.1	461			100	.m																																																		235	3.85	10.6	141	267			758			2.52	50			7.16	87.3		12	69.2			23.8		25	415	466			1020	45.8	24.5	203	264			49	4.26		1.39	23.1					142	10.5	435			107	.m																																																		363
SUB231154	Non-atopic	CSLRI	1.0	expected	244844	b	235	1.42		57.6	161			762			1.75	68.8			3.43	240	564	14.4	585			181	10	11.5	204	1290			4900	56.7	16.2	78.2	115			54.1	9.24	10.6	2.1	77.2			3.65	11.2	35.6	16	7140			128	.m																																																		235			88.7	182			1260			1.93	64.6			1.59	270	681	14.3	495			186	13.3	10.3	200	1310			4610	44.9	11.6	73.3	111			69.7	12	7.99	2.52	66			2.55	11.2	25.8	20	5390			170	.m																																																		357
SUB231155	Atopic	CSLRI	1.0	expected	293154	b	235			25.4	121			162				20.9				24.2	11.2	1.94	11.5			3.87		22.9	155	1390			1060	98.6	115	70	849			67.8	1.64			43.6					1190	6.2	691			50.3	.m																																																		.m																																																		.m																																																		362
SUB231156	Non-atopic	CSLRI	1.0	expected	297568	b	235	14.4	40.7	70.6	391			915	1.89		1.92	64.6			4.44	316	104	15	96.4			45.8		344	421	2160			1280	57.8	119	27.5	394			40.3		5.74	1.5	50.3			3.87	5.73	155	22.6	1480			1070	.m																																																		235	9.6	28.6	87	533			1080		7.77	1.64	70.2			8.02	361	157	17.2	115			64	2.79	305	545	3080			1700	57.3	113	29.2	361			62.5	1.33	4.37	1.43	56.8			3.59	2.45	265	15.9	1200			756	.m																																																		360
SUB231157	Non-atopic	CSLRI	1.0	expected	298899	b	253			105	198			198								44.9	47.8	41.8	129						286	473			409	218	7.96	598	154			9.18									52.8	81.2	530			84	.m																																																		253			124	216			226								47.2	122	64.4	111				1.88		282	552			442	169		360	20.5												30.6	64.9	450			102	.m																																																		381
SUB231158	Non-atopic	CSLRI	1.0	expected	264865	b	235	4.35	21.6	78.9	7060			2760	3.81	9.06	2.83	292			28.9	42.9	513	9.62	957			102	6.98	298	1040	33400			12100	16.8	34.3	126	375			166	3.67	10.1	7.32	299			5.78	4.35	58.1	42.6	9660			574	.m																																																		235	6	34.6	71.5	7130			3520	7.68	9.06	3.08	295			31.7	49.9	675	12.5	971			161		407	974	32700			12200	17.5	41.6	133	422			211	5.73	10.3	5.98	295			8.14		107	40.3	8900			466	.m																																																		350
SUB231159	Atopic	CSLRI	1.0	expected	267673	b	235	2.17	111	169	4040			1790		5.44	2.53	106			7.53	374	5560	28.1	500			325	3.74	3890	681	8360			2980	1610	1200	453	402			316	2.38	6.57	2.33	144			7.59	3.33	995	69.6	8710			897	.m																																																		235	2.38	117	174	3860			1680	3.94		2.31	113			12.2	387	4270	28.3	488			209	1.42	1860	917	4780			3480	1560	1770	422	544			538			3.3	125			5.49	4.9	698	76.9	8350			498	.m																																																		345
SUB231160	Atopic	CSLRI	1.0	expected	293280	b	245		15.1	630	4930			1230			18	492			71.4	28.9	57.9	69.7	1460			130		15.8	3260	10300			489	17.9		404	662			174			26.4	469			18		15.5	331	2000			110	.m																																																		245	7.91	13.1	816	5650			910			18	495			70.8	32.7	67.6	66.8	1370			125		9	2260	8360			367	14.7		449	735			154			24.6	497			8.66		21.7	346	1970			118	.m																																																		354
SUB231161	Atopic	CSLRI	1.0	expected	250305	b	237		110	27.2	448			567							4.26	111	21.1		10.9			14.6	2.95	346	69.1	1310			1570	9.95	68.8	36.1	165			38.3									398	7.37	101			34	.m																																																		237	1.65	134	15.2	278			450				9.98			5.46	135	27.7		17.9			20.8	1.12	290	76.6	1270			1660	15.5	37.7	38.8	122			39.6	2.24	1.25		23.2					183	10.6	70.4			31	.m																																																		351
SUB231162	Atopic	CSLRI	1.0	expected	271543	b	237	5.01	41.1	167	10700			2520		2.39		486			3.83	1530	2480	44.4	1620			413		77.1	661	16900			9170	316	416	271	1700			721	2.52	1.47	2.8	722				4.8	5.87	27	4900			143	.m																																																		237	2.66	40.3	178	10000			2500				533			18.5	1340	2000	37.5	1710			347	2.19	67.5	723	18800			13900	246	387	234	1510			838	2.43	1.21		768				1.34	2.62	8.56	4900			92.1	.m																																																		352
SUB231163	Atopic	CSLRI	1.0	expected	276327	b	245			107	384			420				4.89				73.1	20.3		56.8			13.3		8.12	515	1540			367	229	26.8	10.5	103			50.1									26.6	10.7	317			19.8	.m																																																		245			116	435			444								91.1	71.9		64.7			21.6		11.1	536	1810			426	222	29.7	12.6	109			52.6									97.1	9.01	390			26.5	.m																																																		361
SUB231164	Atopic	CSLRI	1.0	expected	314448	b	245	9.11	174	858	4220			733			21.7	975			42.1	874	855	64.8	1320			163	5.36	539	1930	5980			1950	249	95.3	375	872			189			12.2	1010					2.15	202	2970			26.3	.m																																																		245	9.11	271	839	4190			918			19.8	960			40.5	803	256	65.9	1370			118	7.07	773	1910	8370			2640	229	57.1	400	861			138			11.4	1020			4.3			120	4250			34.2	.m																																																		348
SUB231165	Atopic	CSLRI	1.0	expected	288756	b	245		314	84.5	3190			1260		85.6	7.69	2020			79.7	133	443	34.5	3050			314		937	915	6620			2560	286	847	825	584			364		181		3490			3.16		186	5.81	9200			203	.m																																																		245		463	107	3540			1330		91.9	5.16	1710			80.9	153	476	29.9	2970			307		750	888	10300			5260	241	861	901	970			251		250	1.04	3560			6.49		168	5.41	8310			179	.m																																																		351
SUB231166	Atopic	CSLRI	1.0	expected	292812	b	245		90.4	303	9070			1150				1070			45	73.3	264	9.2	1660			132	17	809	1040	20400			6170	1190	4540	429	6620			1290	67.1		1.63	1830				5.84	170	78.6	5800			279	.m																																																		245		89.7	223	13200			2210				1130			35.2	71.3	263	7.4	1660			128	11	523	1590	30400			9390	1720	1090	471	2010			220	10.6		2.42	1850			1.9	5.61	121	96.6	5100			227	.m																																																		339
SUB231167	Atopic	CSLRI	1.0	expected	256367	b	245		35.1	171	456			612			8.07	29			37.4	255	196	81.4	99.2			78.5		72.5	1220	3440			1740	66	147	682	105			124			10.8	40.5			5.77		52	69	122			32.7	.m																																																		245		33.9	211	501			473			8.22	35.5			32.3	276	370	95.2	116			92.3		132	1450	2870			1760	90.1	238	710	123			175			9.89	40.9			1.63		33.3	64.9	120			40.5	.m																																																		342
SUB231168	Atopic	CSLRI	1.0	expected	333655	b	247	4.31	14.4	186	2790			1960			8.69	373			9.32	107	1420	65.6	848			206	2.56	256	1020	10300			4180	1640	292	1080	664			245			10.1	385					34.6	188	2570			221	.m																																																		247	2.65	11.7	264	2600			1110			8.67	352			15.4	104	811	63.1	829			71.2	3.29	260	1260	13000			4880	1440	486	907	789			508			10.5	326					60.9	241	2610			127	.m																																																		318
SUB231169	Non-atopic	CSLRI	1.0	expected	431299	b	247	4.6	33.8	294	3700			999		1.7	1.63	71.9			1.95	591	1510	117	1660			20.5	3.41	359	1640	12200			15900	149	38.1	530	188			27.7	1.39	1.6	8.01	66.6			1.61	1.29	31	161	1310			162	.m																																																		247	4.66	40.8	344	3930			977		2.2	1.74	73.5			2.35	652	1530	127	1730			23.8	3.35	448	1780	15300			14400	152	33.6	553	185			29.6	1.29	2.41	10	111			1.57	2.03	14.2	128	1620			138	.m																																																		301
SUB231170	Non-atopic	CSLRI	1.0	expected	417678	b	247	4.14	175	187	4280			1990	1.64	2.39	1.64	65			9.71	298	4150	27.7	1120			89.2	2.71	5330	1110	16900			5030	91	953	404	195			90.9		1.65	2.46	73.1			2.04		377	29.2	3740			37.8	.m																																																		247	4.4	162	174	3100			1440	2.36	2.72	1.27	73.3			11	296	3660	18.5	951			60.2	3.35	5200	893	23600			5130	103	933	437	196			100	2.53	2.15	2.57	91.8			3.52	2.48	407	35.1	3340			58.4	.m																																																		299
SUB231171	Non-atopic	CSLRI	1.0	expected	438453	b	248	1.35	35.6	402	1780			555			43.4	337			69	136	706	253	639			244	1.3	52.2	499	2160			1110	1.53	10.1	61.2	325			86.3		2.33	22.9	390			1.94		16.8	34.4	1230			15.8	.m																																																		248		15.8	365	1950			781		8.13	43.7	439			184	112	1180	238	700			341	3.74	75.1	637	2750			1480	12.3	13.4	71.9	349			95.7			17.4	243					22.6	38.9	1290			44.5	.m																																																		227
SUB231172	Non-atopic	CSLRI	1.0	expected	446625	b	248	1.25	10.5	508	2890			870				58.7			5.14	7.2	15.1	2.3	533			3.72	3.51	41.8	1900	5230			435	5.68		4.73	112			3.67								1.66	311	101	1810			368	.m																																																		248	3.74	7.91	413	2700			707				54.2			4.85	7.56	15.9	3.1	507			5.98	3.38	42	1690	2950			267	9.39		4.87	94.6			1.27									102	111	1780			267	.m																																																		225
SUB231173	Atopic	CSLRI	1.0	expected	5835	b	69	28.77	4.87	787.16	46.38		414.29	1148.55	33.28		8.32	21.44				140.51	481.27	54.35	230.58	290.75	503.38	8.15	11.08		1014.3	381.7		629.3	745.42	762.23	71.58	972.96	275	4.16	869.38	99.81	26.36					579.81		37.47	5.63	95.66	444.62	7.42			69		10.48	815.08	34.38	11.89	431.89	1158.02	11.08		7.99					132.87	460.99	55.22	206.78	290.75	616.47	8.82		0.13	1069.19	381.31		684.44	759.02	670.5	63.36	976.49	343.6	12.37	1716.74	96.82						550.7			6.76	86.93	444.22	8.44	1171.26		69			863.17	47.84		439.83	1235.66	21.09	0.56	9.55	12.93				166.12	375.02	67.04	250.63	259.15	531.67	23.11	22.47		1148.52	440.65		653.29	1020.05	702.2	47.47	1013.67	281.59		1024.59	147.26	21.09			43.1					2.17	60.18	401.43	17.52	757.48		69	37.47	0.56	791.25	55.53		504.85	1098.65	22.47		7.8	29.33		1114.66		117.04	294.69	56.62	145.1	244.02	573.59	17.42	6.18	11.96	1050.15	429.14	5.29	777.04	957.6	510.48	55.78	932.97	309.99	2.96		133.52	25.1	7.51		26.45	4.16	1038.49		18.14		50.84	396.3	14.27	611.28		153
SUB231174	Atopic	CSLRI	1.0	expected	8187	b	70	44.21	139.11	89.93	128.78	1.27	987.47	1759.08	9.55					438.99		102.61	104.72		52.99	38.4	1198.95	33.42	41.22	9.01	258.4	455.61			1815.61	48.9	64.85		331.07	5.59	565.13	25.55	13.5			13.58		103					3.23		217.94	18.42	70	19.35	146.88	110.86	135.69	1.77	983.24	2014.5	10.36					446.29		141.67	110.84		64.26	48.89		44.28	23.49	24.31	268.45	457.98	7.62		1835.5	65.26	72.04		340.67	3.91	542.27	27.49					1.52	88.87					3.88		195.96	18.95	70	47.74	19.21	123.41	110.33		635.93	1455.16				9.87	1.27			90.3	93.17		50.53	37.03		26.34	61.39	15.87	312.36	465.88			2046.4	91.34	97.81	6.7	376.21		432	25.91	12.73			14.25		106.91						3.36	227.2	31.2	70	31.98		114.34	119.72		739.04	1307.5					7.33	829.04		81.41	80.98		38.66	40.13		24.41	32.61	17.89	280.82	466.67			1799.45	88.74	106	7.21	425.72		403.46	34.34				3.23		100.91					9.87		195.22	26.34	142
SUB231175	Atopic	CSLRI	1.0	expected	15679	b	70	30.07		248.39	152.47		473.5	921.81				10.88	6.74			146.49	103.44		51.24	69.86	880.83	9.12	46.57		529.56	1045.65		767.07	3224.41	1643.28	21.15	16.95	469.44	5.59		30.9		8.62		3.55		419.13		24.17	7.82		125.15		626.38		70	33.24		228.93	150.28		449.06	907.33	6.09			11.22		1589.52		111.69	108.29		65.67	84.02	849.42	10.39	45.39		467.01	1027.66			3050.62	1380.69	23.06	16.33	392.91	1.77		30.65	21.44			5.2		438.28		6.09	18.55		120.45	1.77	547.68		71	6.58		225.03	143.18	8.03	471.68	870.86				17.94				119.33	57.65		72.49	83.48	688.43		56.07		342.32	925.6		1000.75	2666.85	1470.31	47.6	15.03	605.64			30.24				7.71		634.45				7.06	95.24	7.09	459.94		71	42.98		234.38	121.68		472.33	962.58				8.6				97.63	62.16		63.08	67.83	694.89		43.55		363.94	946.33		945	2713.18	1535.44	21.36	16.35	517.74			33.32						671.66				7.12	96.19	7.09	504.84		127
SUB231176	Atopic	CSLRI	1.0	expected	15340	b	71	20.68		78.74	33.85		734.91	352.05				8.9		500.6		45.86	7.35			29.62	808.9	7.94	93.43	48.61	135.75	467.77		584.75	770.53	318.68	42.57	69.13	679.19	5.04	733.87	568.01				13.1	5.71	377.47			673.89	10.94	120.08	7.09	794.78	11.04	71			83.14	33.24	7.09	655.41	333.04						488.62		10.82			24.64	14.56	744.94	8.73	54.39	28.7	126.1	429.92	7.09	538.93	724.91	317.77	28.44	69.34	634.09	7.56	664.14	535.7					5.48	370.5			679.75	11.26	132.25		817.64	12.14	.m																																																		.m																																																		125
SUB231177	Atopic	CSLRI	1.0	expected	11693	b	70			82.32	104.21		474.92	492.55	14.26			11.89				38.2	103.44		41.1	50.31	631.98	7.52	31.98		127.03	186.69		848.55	1125.96	249.2	9.4	37.9	262.55			75.13	20.06					496.3			132.08	8.75	518.34	5.31		11.85	70	3.17		81.5	139.33		446.12	456.16				10.21				14.26	104.72		36.58	58.18	598.76	6.34	54.65	5.72	132.49	177.09		707.77	986.95	217.26		38.09	259.53		851.58	83.42	21.44					530.54			140.37	8.57	532.34	3.63		10.84	70	40.62	4.82	83.51	142.98	10.3	554.03	521.47				5.2	5.03			23.49	56.76		42.84	76.52	586.66	7.31	36.97		228.88	329.53	5.31	715.63	1566.06	284.85		44.28	239.21		891.96	87.87					1.77	549.92			167.34	8.15	579.45	17.77		10.17	70	17.21	2.28	85.37	140.42		557.24	525.67		6.15						30.71	61.9		37.62	92.35	572.23	10.62	54.65		227.89	335.68		892.88	1609.07	279.01	16.55	45.82	253.88	7.33	1433.13	100.67	8.71			1.92	3.63	503.32			169.08	8.81	619.64	15.24		10.9	113
SUB231178	Atopic	CSLRI	1.0	expected	7739	b	72	49.47	35.3	139.82	282.43	16.76	647.08	1165.4	31.41					366.43		133.87	20.98		26.19	12.61	942.22	42.74	64.54	28.5	237.49	569.21	4.29		2327.75	513.71	27.01	12.37	332.12	26		51.47		15.26				298.31	0.11	25.73	1478.21	19.87	558.32			202.72	72	72.01	22.25	140.07	285.5	4.99	662.75	1176.8						349.12		98.85	8.7		40.39	27.02	917.08	31.74	115.11	12.58	250.06	597.23	10.92		2559.68	522.27	45.71	7.93	390.55	86.5		47.55		3.35			0.45	313.63			1316.43	16.12	511.05			173.36	73	107.66	35.58	132.9	256.32		948.05	1384.13						404.07		135.71	17.94		33.79	43.47		40.43	75.3	41.84	303.27	661.25	9.79		3320.71	729.65	109.88	29.84	715.04	12.3		88.38						262.72		85.7	1411.58	21.06	551.96			267.37	73	96.49	42.41	147.29	239.48	11.04	1918.42	1584.08		7.77		9.39		374.14		142.81	24.21		27.46	43.47		41.8	97.9	36.72	301.62	627.27			3274.29	740	117.42	32.39	701.38			85.64		10.48				268.36		54.03	1313.43	19.72	581.76	22.13		267.58	114
SUB231179	Atopic	CSLRI	1.0	expected	7291	b	72			98.38	32.14		618.1	345.46					5.45				14.73		20.82	16.52		23.56	57.62	52.64	168.46	287.74			830.35	87.71		15.67	473.71	2.46	423.56	55.03	58.5					637.91			474.82		3.86			28.67	72		6.98	96.33	66.99		574.53	349.48								54.95	3.35		19.69			21.69	95.19	63.51	161.09	306.09			765.53			12.16	390.55	4.06	418.7	53.63		3.67		21.94		582.68		15.51	430.22		22.48		1062.92	25.8	72	105.32		105.21	73.28	1.78	610.91	356.75				30.21					1.36			19.49	1100.79	18.34	22.11	4.6	167.82	356.41			791.84	3.54		15.39	345.93	5.92	350.19	60.62	43.76			14.85		537.51			689.17				891.47	12.6	72	33.57	1.36	93.98	34.03	0.03	684.66	334.95	14.08							23.34			13.55			19.02	102.46		160.49	342.62			768.23		10.38	13.61	354.75	3.14	334.4	58.2	15.51				5.22	551.27			723.06		30.21		1119.82	15.49	108
SUB231180	Atopic	CSLRI	1.0	expected	13294	b	86	87.62	63.21	283.94	677.22		568.8	4074.13				39.72		244.2		268.25	33.96		65.32	18.11		45.42	92.98	101.77	418.04	1618.6			4503.95	523.44	43.93	16.54	329.54		363.97	14.41				9.87		64.7		32.62	142.8	29.84	684.86			409.73	86	111.39	73.8	340.94	704.3		605.07	4731.54				37.46		258.83		316.51	45.9		61.17	16.58		49.02	86.17	92.99	447.57	1487.51			5001	565.42		16.76	332.72		358.14	17.08						67.09		35.15	125.57	30.72	624.17			379.38	87	0.05	46.61	373.1	572.04		790.75	3974.86	8.22			16.24		293.61		374	41.18		45.4	25.9	867.95	28.25		316.88	648.13	2040.18			4489.25	873.42	11.03	13.96	278.51		346.45	19.55						142.77	15.34	9.36	190	24.49	492.95			294.19	87	2.96	41.44	322.61	527.78		827.67	3539.75	10.11					309.58		318.5	41.44		42.89	26.73	971.13	28.67	7.05	272.47	655.27	2031.7			5001	786.18	9.56	15.66	289.23		356.5	25.29	5.46	2.46		12.36		140.45	7.26		170.36	16.66	474.64			267.14	161
SUB231181	Atopic	CSLRI	1.0	expected	31933	b	97b	31.71		168.58	80.99			527.52				0.43				177.32	104.61	8.29				17.93	55.29	31.35	381.89	1072.52			1920.8	496.09	122.52	186.82	515.36			66.65	25.27	363.34	17.93	314.85			71.44								.m																																																		97b	14.35	6.05	173.39	126.93			549.39								205.06	58.74	5.4	20.8			8.2	54.59	39.96	503.38	1173.79			1773.59	557.15	130.18	177.09	545.18			71.65	9.14	393.51	17.04	263.84			65.9								.m																																																		208
SUB231182	Atopic	CSLRI	1.0	expected	28239	b	97b	52.15		214.05	165.2			1292.98				17.08				46.56	29.75						66.73		649.74	1593.26			2372.3	582.37		87.04	199.63			10.42										9.21	53.63				.m																																																		97b	17.65		201.88	195.36			1165.95								38.81							77.06		1035.16	2423.46			3507.45	537.56		75.49	186.09			7.41										8.55	38.5				.m																																																		195
SUB231183	Atopic	CSLRI	1.0	expected	135717	b	156	10.4	27.7	255	384			498	1.27	3.41					1.13	172	6.59	3.02	94.6			1.99	35.3	19.6	370	1280			266	44.6	6.59	19.3	58			4.88	2.44	26.1		57.2			3.29	4.21	26.9	24.3	946			10.1	.m																																																		156	10.8	1.4	258	324			470		9.01						212	22	3.63	92.9			2.8	39.7	8.2	228	1290			338	32.7	4.99	17.5	36.6			2.52	2.76	24.5		34.2			1.43	3.54	21.2	21	929			9.73	.m																																																		519
SUB231184	Atopic	CSLRI	1.0	expected	27279	b	97b	58.77		298.93	322.25			2026.33	9.14							205.06	203.62	13.91	43.61			64.6	43.04	665.21	670.56	4211.48			5753.2	65.7	74.65	87.93	474.44			103.24								20.2	39.96	83.02	574.81			1372.28	.m																																																		97b	59.12	3	248.59	277.54			2037.36	9.14			15.18				193.85	259.81	12.22	31.57			79.55	58.42	968.33	880.57	4397.48			7711.8	51.11	58.38	80.95	443.48			89.2								31	15.64	77.22	455.76			1045.13	.m																																																		176
SUB231185	Atopic	CSLRI	1.0	expected	135922	b	146	121	80.5	431	756			574	4.49	8.58		42.6			2.59	137	38.8	5.1	52.1			10.8	187	219	315	8140			2770	795	10.5	132	241			32	2.05			27.8			4.59								.m																																																		146	124	96	417	1050			744		10.2	10.3	88.8			9.01	168	53.1	7.31	62.3			10.7	167	247	396	7140			3690	669	10.9	97.9	160			29.4	1.93			28.3			5.42	3.66			32.3				.m																																																		384
SUB231186	Atopic	CSLRI	1.0	expected	26154	b	102		53.5	910.52	845.06			2130.94								780.49	1190.78	9	115.95			17.3		327.82	1075.08	7115.59			10726	365.48	319.7	104.65	555.48			70.81									11.04		29.79			26.97	.m																																																		102		37.65	864.41	936.79			2242.04								905.98	1267.02	10.55	100.4			36.94		274.38	1554.25	7785.14			9634.9	302.1	320.6	115.89	628.83			101.39		20.43							18.88		37.78			10.62	.m																																																		174
SUB231187	Atopic	CSLRI	1.0	expected	26943	b	102		11.04	369.04	624.37			2019.45								175.2	77.85					8.27		14.2	300.47	834.91			2593.77							9.89															.m																																																		102			316.26	613.8			1866.12								120.76	186.3		32.87			10.03																													.m																																																		157
SUB231188	Atopic	CSLRI	1.0	expected	44393	b	114	7.55	168.99	277.52	770.64			1678.19								568.29	2286.45	9.32	223.4			59.97		687.86	548.13	2938.34			2448	469.64	132.82	60.07	349.1			49.88		14.9		16.2				2	24.58	6.24	77.38				.m																																																		114		139.78	276.62	566.26			1609.35								815.14	4147.32	10.84	351.02			160.88	0.74	339.74	556.95	2496.66			3988.15	387.13	105.4	67.4	318.35			42.56								0.74		6.6	38.07				.m																																																		174
SUB231189	Atopic	CSLRI	1.0	expected	47970	b	113	19.37		254.08	439.64			1831.97								146.99	12.14	12.82	133.12			11.33	16.55		679.54	672.24			2287.8	37.64		374.85	94.25			13.89								17.97		31.07	86.42			193.52	.m																																																		113			232.13	452.66			1609.6								118.32		12.55	110.1			9.54			1072.75	866.54			2346.19	42.71		300.59	110.67			11.09										12.31					.m																																																		162
SUB231190	Atopic	CSLRI	1.0	expected	27055	b	130	25.07	374.9	192.34	1508.81			2961.04								369.37	1139.25		194.24			14.98	6.42	1934.97	305.74	8010			7950		9.89	93.86	119.05			38.81											78.96				.m																																																		130	35.85	135.96	161.04	1230.87			3555.46				22.31				405.74	1119.71		215.41			29.89	36.98	494.09	375.91	5080			6060	2.76	16.98	103.6	151.76			52.01											127.6				.m																																																		222
SUB231191	Atopic	CSLRI	1.0	expected	28063	b	114		305.92	285.75	1194.19			4185.23								264.69	338.8	14.12	67.33			39.55		579.01	767.1	4688.95			4848	119.63	109.59	336.79	260.66			109.87		6.25							18	5.59	69.35				.m																																																		114		311.55	301.82	792.32			2149.11								201.27	352.45	14.34	110.49			29.44		746.05	942.28	5750.43			5101	81.23	123.53	343.72	231.11			98.57		6.25	6.87							14.47	391.37			70.23	.m																																																		144
SUB231192	Atopic	CSLRI	1.0	expected	31231	b	114		10.67	131.55	562.39			1671.79				18.36				41.12			142.55			5.96	2.83		292.29	739.83			3104.71	350.72	19.03		34.6			18.91		9.58								8.94	39.45			33.9	.m																																																		114			139.48	588.24			1761.41								43.67	110.05		225.97			27.8	0.74		338.89	778.52			3859.61	304.05	21.06		31.11			21.26											11.07				.m																																																		132
SUB231193	Atopic	CSLRI	1.0	expected	75022	b	114		82.05	111.14	802.19			919.64		20.05						166.45	4662	163.27	1196.93			10.82		232.61	388.3	3899.02			2658.3	413.81	74.07	806.05	72.03			20.04		8.49							12.8		26.2				.m																																																		114		47.52	95.59	762.77			910.13								179.27	4824	141.78	1513.06			13.04		342.09	423.46	4120.87			3074.3	434.19	76.89	661.96	89.36			23.7											14.01				.m																																																		124
SUB231194	Atopic	CSLRI	1.0	expected	79402	b	114		5.09	102.4	254.24			923.55								60.66	1069.71	10.69	140.6					77.83	453.47	2440.09			3669.75	121.55	60.39	189.84	220.82				3.46	6.25						2							.m																																																		114			118.67	338.21			904.68								84.72	1293	15.73	254.24			5.96		84.39	426.63	2631.27			3301.4	173.53	43.19	200.43	328.6					7.38								9.43	12.55				.m																																																		118
SUB231195	Atopic	CSLRI	1.0	expected	79666	b	115	7.09	6.57	104.27	224.93			499.11								161.4	17.47		15.81				9.16	18.95	285.11	612.96			1215.17	79.14	24.58	58.84	66.39			16.55															.m																																																		115			97.59	213.89			447.91								142.85	18.95		4.98				19.43	20.67	330.54	654.41			1284.79	78.14	48.6	80.04	294.86			13.32				11.27							12.41				.m																																																		120
SUB231196	Atopic	CSLRI	1.0	expected	79314	b	115	8.95			39.5			1585.97				56.32											9.16			26.56			435.06											0.94							7.27				.m																																																		115	18.41			12.97			1420.35				154.21														61.92			432.46															8.54		11.48				69.29	.m																																																		119
SUB231197	Atopic	CSLRI	1.0	expected	80370	b	115	26.57	88.39	379.38	1068.73			2179.77				5.56				284.43	2326.99	8.24	292.11			18.95	18.82	62.55	448.1	3209.07			5357.6	491.38	7.32	34.76	49.6														63.03				.m																																																		115	22.09	98.87	359.52	1197.21			2320.51								317.12	1972.05	9.24	286.61			21.81	19.63	63.51	583.6	3272.35			5001.85	552.45	7.07	32.05	52.96														64.15				.m																																																		114
SUB231198	Atopic	CSLRI	1.0	expected	79754	b	130				30.4			33.86								30.54	7.79		2.84							60.22			78.2	12.17			162.4					6.95		26.73							2.84				.m																																																		130				42.82			36.39								22.88	18.23							4.43		55.88			98.72	18.09	21.96		281.53							0.5					20.3		16.39				.m																																																		165
SUB231199	Atopic	CSLRI	1.0	expected	79952	b	130	35.16	10.31	168.78	280.83			1779.02				20.83				472.11	1585.13	11.13	158.86			120.48	28.19	28.59	638.25	848.46			2586.58	107.83	105.78	122.31	199.18			95.19											18.61				.m																																																		130	22.88		149.3	238.66			1374.14								392.55	1165.57	8.78	136.13			85.28	31.01	26.11	500.11	953.45			2950.65	73.12	141.66	133.44	155.31			193.79				2.84							13.41				.m																																																		147
SUB231200	Atopic	CSLRI	1.0	expected	96584	b	134	180.88		102.25	240.11			2393.73				11.49			31.44	105.77	126.76	12.07	328.98			150.41	251.61	6.12	292.08	1198.89			3574.72	627.19	36.26	390.4	58.1			182.5		2.8									7.44				.m																																																		134	188.74		130.58	296.69			2558.78		1.95		28.12			43.85	121.32	505.67	21	467.05			309.37	234.26		318.25	1119.78			3828.48	599.85	24.13	392.86	58.1			163.03											13.53				.m																																																		130
SUB231201	Atopic	CSLRI	1.0	expected	79490	b	142	52.5	18	526	630			2170			2.39	6.84			1.16	414	10300	36.4	533			79.3	55.8	8.12	563	1700			1320	469	135	357	199			25.6		17		26				2.7	23.6		57.5			2.41	.m																																																		142	42.6	21.6	399	489			961		3.67	4.81	15.1			1.4	292	9070	27.7	446			76.3	633	130	268	130			23.4	48.4	13	453	1320			951		1.08		28							42				.m																																																		211
SUB231202	Atopic	CSLRI	1.0	expected	97919	b	142	27.2	8.77	44.3	108			899				16.1			3.69	64.1	51.3		81			20.4	39.4	2.44	119	403			690	71	1.81	53.4	51.5			36.2		1.08		17.2							16.1				.m																																																		142	47.2		36.6	139			1420				3.78			2.33	57.2	8.77		51.5			18.3	48.4		118	380			966	99.8	17.3	56.6	93.5			32.1		6.19									20.9				.m																																																		210
SUB231203	Atopic	CSLRI	1.0	expected	80700	b	142	51.7		144	339			1140				12.9				190	103	5.1	53.5			38.8	79.6		541	1270			2310	95.3	25.6	41.9	59.6			146				16.1			1.24		7.47					2.33	.m																																																		142	43.4		185	336			1110							2.17	185	120	5.78	68.7			55.9	70.8	3.05	282	904			2550	152	32	52.4	70.7			358		3.05		14			5.8		3.05		18.3			2.02	.m																																																		205
SUB231204	Atopic	CSLRI	1.0	expected	80150	b	144	9.74		516	465			1200	6.29	1.69	6.05	41.4			5.34	246	8.29	13.2	136			30.7	8.88		468	691			566	196	1.26	11.4	311			16.2	5.18		5.35	26.6			6.78	3.15		7.11	41.4			6.02	.m																																																		144	10.4		530	424			1220	7.06		5.9	31			9.34	191	6.19	10.1	103			93	8.24		597	1090			987	151	2.12	10.6	257			23.7	4.25		6.2	36.5			7.02	3.53		8.18	67.8			5.83	.m																																																		201
SUB231205	Atopic	CSLRI	1.0	expected	92129	b	144	9.1		207	769			362	6.62		7.11	55.2			17	62.2	2.79	9.73	63.6			39	8.24		573	638			226	12.4		31.3	144			48.2	4.49		7.31	45			7.53	5.63		6.96	40.1			5	.m																																																		144	8.78		172	666			344	4.72		5.3	38.9			23.8	63.4	3.33	13	99			56.7	10.9		475	478			231	10.4		33.5	144			48.1	3.15		7.16	40.1			5.49	9.42		13.1	75			11	.m																																																		201
SUB231206	Atopic	CSLRI	1.0	expected	80260	b	144	6.51		290	284			348	7.71		12.3	42			1.25	71	86.6	35.6	99			4.15	5.06		4.45	26			32.2	12.4		248	70.8			7.3	7.06		7.72	30.3			1.68	13.8	5.53	8.9	90.6			5.64	.m																																																		144	4.01		196	226			385	5.4		8.49	30.3			1.25	89.3	85.9	71.2	127			5.92	4.95		4.55	33.4			30.4	11.8	3.51	110	157			4.86	11.6	3.86	9.52	65.4			4.66	5.63		8.95	60.6			3.22	.m																																																		191
SUB231207	Atopic	CSLRI	1.0	expected	109394	b	144	12.1	2.79	540	660			1180	6.51		7.47	34			4.26	70.5	4.37	28.1	344			8.88	9.1		295	712			431	20.6		336	65.4			30.7	6.95		8.8	52.2			5.59	6.95	1.26	7.67	79.8			5.97	.m																																																		144	8.24	1.8	401	639			981	6.07		8.85	32.8			6.02	191	4.37	19.6	167			6.4	9.52	7.33	391	1120			1000	20.8		271	69			30.1	10.2	1.8	8.28	47.4			5.59	6.84		7.62	58.2			6.02	.m																																																		191
SUB231208	Atopic	CSLRI	1.0	expected	100009	b	144	10.2	88.1	1570	512			2600	7.81		10.9	49.8			7.3	229	25.4	31.7	126			44.1	7.38		5.25	41.4			596	64.1	5.37	428	171			154	13.5		8.75	36.5			3.64	7.17	2.61	9.52	69			4.9	.m																																																		144	11	98.1	1430	563			2620	6.95	1.26	8.08	45			6.07	251	23.4	24.4	129			32.9	8.56		6.65	37.1			1040	42.8	6.92	304	135			228	10.2	2.02	7.06	63			2.37	4.72		10.8	93			5.59	.m																																																		190
SUB231209	Atopic	CSLRI	1.0	expected	109504	b	145	37.9	5.58	146	557			533				24			6.33	52.7		7.21	14.6			5.51	18.6	11.6	193	1070			438											51.8			4.32				47.4			4.88	.m																																																		145	24.8		205	595			492							5.62	55.7		6.06	24			4.65	23.2	11.8	207	1150			407														4.32				18.2			5.88	.m																																																		188
SUB231210	Atopic	CSLRI	1.0	expected	92932	b	156	22.3	17.1	393	180			674	2.82	26.5	1.9	50.6			1.41	60.7	147	36	139			5.2	23.3	32.6	613	765			438	20	67.9	148	248			18.2	3.14	19.6		12.7			1.48	4.9	30.1	2.35	63.8			4.05	.m																																																		156	24.9	26.9	399	155			701	2.25	26.1	1.29	41.5			1.89	45.8	54.7	24.5	110			3.29	31.7	53.1	846	902			380	21	37.4	106	123			13.8	4.28	26.1	15	109			3.47	5.68	30.9	1.29	114			2.73	.m																																																		255
SUB231211	Atopic	CSLRI	1.0	expected	80480	b	156	27.2	98.1	257	1820			1150	2.13	23.6	1.49	63.8			2.48	426	3800	35.1	615			13.1	34.9	47.5	428	3300			1280	101	63.1	171	451			7.54		21.6		70.5			1.86	1.65	24.5	1.33	57.2			2.4	.m																																																		156	30.4	87.8	230	2040			1320	2.69	27.7		32.5			1.48	409	3680	34.9	685			11.4	31.6	43.8	466	3240			947	99	67.9	131	506			19.8	3.4	26.9		50.6			1.48		21.2	1.98	89.6				.m																																																		254
SUB231212	Atopic	CSLRI	1.0	expected	98936	b	156	19.3	56.7	219	1490			1000		15.5	1.96	41.5			1.46	67.6	618	5.21	137			3.06	39	544	651	4230			594	18.8	118	55.7	232			7.54		18.8		53.1				1.05	17.9		127				.m																																																		156	18.6	121	299	1370			911	1.41	19.6	1.15	36.6			2.32	71.6	318	5.21	82.1			3.79	44.4	558	320	4630			1020	12.8	98.1	50.1	211			5.33	4.07	34.2		63.8			1.24	2.5	37.4	1.57	137			3.76	.m																																																		245
SUB231213	Atopic	CSLRI	1.0	expected	90856	b	156	12.3	36.6	167	280			280	2.88	26.1		78.8				104	299	5.26	72.2			5.05	14.4	43.8	261	388			464	9.98	67.9	40.1	211			6.85	2.76	13.9		39.1			1.53	1.65	27.7		44			1.08	.m																																																		156	13.4	63.9	174	256			302	3.01	26.9		52.3				127	233	3.53	59.7			4.14	10.8	35.8	290	258			268	10.3	63.1	38.3	250			6.18	1.65	17.1		15			2.13	1.77	28.5		63.8			1.31	.m																																																		234
SUB231214	Atopic	CSLRI	1.0	expected	125200	b	156	16.2	33.8	153	498			534	2.63	14.7		70.5				711	3130	69.2	174			46.8	34.1	76.6	515	2570			374	77.5	35.8	486	165			10.4	2.63	20.4	2.33	63			2.9	5.25	25.3	2.11	105			2.05	.m																																																		156	15.7	40.6	144	496			616		16.3		62.2			1.31	812	3030	75.1	291			34.3	33.4	60.3	447	2830			345	88.8	33.4	370	115			7.04		21.2		72.2			1.81	2.82	21.2	1.98	92.1			1.51	.m																																																		230
SUB231215	Atopic	CSLRI	1.0	expected	123957	b	156	36	13.9	198	526			944	2.13	15.5	2.22	47.3			18.8	21.4	35.4	3.8	232			18.4	33.8	40.6	620	610			587	65.1	55.9	14.2	501			26.4	4.21	33.8		79.6			4.41	4.76	41.4		80.5			4.8	.m																																																		156	39	20.4	205	520			1120	4.55	28.5	1.09	19.7			8.87	19.1	35.8	2.95	222			10.5	27.8	39	274	474			717	73.7	43	14.3	541			45.6	1.65	17.9		53.1			3.09	2.76	39		57.2			8.1	.m																																																		227
SUB231216	Atopic	CSLRI	1.0	expected	133118	b	167	8.88	34.3	58.7	135			126		17.9					6.93		31.2	2.23	18.9				48.9	43.6	55	781			749	102	120	7.46	90.6			18		14.3		12.1					274	1.51	2.36				.m																																																		167															7.3	27.3	58.6	208			146	6.95	22.6																											.m																																																		276
SUB231217	Atopic	CSLRI	1.0	expected	131617	b	167	19	10.6	273	278			257	11.8	23.8		32.1			4.39	20	113	8.83	312			9.13	80.8	40.9	276	1490			1650	15.5	23.8	173	44.3			13	5.85	22.2	1.59	31.3			1.43	7.61	16.7	17.5	329			57.1	.m																																																		167	20.3	11	240	240			189	4.51	21.4		23.2			2.6	12.9	65.1	7.52	314			6.25	60.1	25.4	471	1570			1050	9.35	24.6	176	33.6			10.4	5.11	14.3	2.03	15.5				9.78	19	4.82	49			12.8	.m																																																		273
SUB231218	Atopic	CSLRI	1.0	expected	105290	b	167	58	137	302	565			1110	7.18	25	1.73	30.6			6.38	40.5	86.4	57.8	72.8			3.36	85.4	72	216	3990			1660	19.7	21.4	719	77.6			30.1	7.61	26.1	2.32	27.6			5.71	4.21	15.9	1.48	38.2			7.89	.m																																																		167	48.3	92.9	256	474			814	9.49	23.4	1.12	53.7			5.58	55.8	30.8	30.9	37.4			31.3	82.7	102	194	3120			1880	13.8	35.5	637	63.2			42.7	7.76	14.3	2.47	39.7			4.13	9.64	27.3	10.7	113			28.8	.m																																																		273
SUB231219	Atopic	CSLRI	1.0	expected	110091	b	167	49.6	37.1	190	476			960	11.2	15.1		27.6			1.57	23.5	241	37.8	216			14.1	53.5	263	177	1390			1210	9.49	11.5	232	72			21.5	5.56	22.2	1.52	24			3.23	11.6	177	15.4	1030			121	.m																																																		167	45.4	46.7	195	490			919		11.5		22.5			1.57	29	241	45	142			25.7	56.8	261	170	1350			1300	7.9	13.1	204	70.4			18.4	2.36	11	1.52	18.9			2.85	5.56	18.2		42.8				.m																																																		273
SUB231220	Atopic	CSLRI	1.0	expected	125999	b	167	117		263	725			755								304	8.62	9.38	32.1			12.7	106	15.5	611	1140			2510	58.8	7.4	69.2	79.2			1.84									2.44	23.4	482				.m																																																		167	105	7.4	321	370			675		4.53		18.9																																							.m																																																		268
SUB231221	Atopic	CSLRI	1.0	expected	135221	b	167	25.5	22.2	10	95.5			331	5.71	21		21.1			5.44	11.8	24.2		18.2			2.47	53.6	16.7	8	252			1040	24.3	32.4		17.5				5.56	23.4	1.32	29.8			2.34	9.21	18.2	3.02	66.4			14.2	.m																																																		167	43.3	17.9	38	157			939	7.18	33.9		55.3			3.36	6.88	22.2		35.9				53.8	27.7	8.79	304			1030	19.4	23.8		32.1			5.05	6.3	22.2		35.9			3.36	4.96	21		26.1			4.65	.m																																																		269
SUB231222	Atopic	CSLRI	1.0	expected	109284	b	167	19.6		245	107			332		5.77	2.87												86.5		193	754			2420	8.88		38.8	2.36				10.1	29.3		33.6			5.71	13.2	507	7.26	150			165	.m																																																		167	10.1		280	55.3			253								25.2							61.8		199	479			1880	10.4		27.2	32.1				8.34	19.4	1.08	40.5			4.39	21.1	858	11.8	186			200	.m																																																		261
SUB231223	Atopic	CSLRI	1.0	expected	116421	b	167	75	22.6	188	602			201	13.8	27.7		36.6			5.44	36.3	23.8	6.89	56.1			9.27	137	40.2	334	1410			1270	259	26.1	45.2	155			2.09	10.5	23	1.52	23.2			2.34	7.47	196	29.4	1690			32	.m																																																		167	58.8	10.2	175	632			99.1	12.5	64.7	4.72	140			39	2.98	11.9		3.5			1.43	141	12.7	213	1100			720	252	31.2	52.9	213			2.85		25		23.2			4.39	7.76	70.1	44.3	2460			79.6	.m																																																		255
SUB231224	Atopic	CSLRI	1.0	expected	126492	b	180	42.4	14.3	644	478			1940		5.32	4.45	31.8			11.6	257	27.4	17.6	59.6			53.8	47.6	5.84	395	2440			3470	195	6.9	120	39.4			1.2	1.19	7.97	7.46	21.3				1.48	11.3	93.6	2360			17.4	.m																																																		180	44.1	19.8	747	572			1740		6.64	3.73	20.3			2.87	210	194	25.1	72.4			60.4	52.5	22.1	524	2520			3270	204	12.9	125	41.6			20.6	5.04	9.06	4.64	31.3			6.53	5.53	6.9	97	2760			16.2	.m																																																		327
SUB231225	Atopic	CSLRI	1.0	expected	124655	b	181		56.2	83.3	115			1220		18.7		57.2			13.8	86.4	31.2		36.2			25.4		81.6	124	769			3230	4.46	26		315			12.2		22.2		47			11.6		26.3		73			59.6	.m																																																		181		47	86.2	124			1300																																											.m																																																		326
SUB231226	Atopic	CSLRI	1.0	expected	106989	b	180	76	182	408	2460			5800	3.37	12.4		20.8			3.76	3.37	8.52	1.09	31.8			5.59	64.5	69.6	872	6020			6080	41.9	14.1	299	80.6			16.6	4.56	9.61	3.31	30.8			7.48	1.48	16.9	4.76	103			9.44	.m																																																		180	81.8	166	437	2400			7300	1.19	15.8		42.7			7.87	2.67	8.52	1.24	37.2			2.7	86.3	34	645	6500			7090	46	7.71	414	148			21.4	2.91		2.53	30.8			1.63		9.61	5.3	56.2			11	.m																																																		319
SUB231227	Atopic	CSLRI	1.0	expected	137525	b	180	32	74.6	139	688			2290	5.28	10.2		16.2			6.72	228	176	74.6	75.3			25.5	52.5	254	255	3000			4050	504	25.6	314	84.2			35.4	5.89	13.5	1.23	26.5			5.96	5.65	17.2	2.28	35.1			12.9	.m																																																		180	35.9	65.2	129	685			2220	1.19	12.7	1.17	34.5			6.34	196	85.9	54.7	44.9			20.6	49.7	262	298	3880			4320	568	33.4	326	101			46.8	2.91	14.1		22.3			11.4	8.52	911	7.3	818			255	.m																																																		319
SUB231228	Atopic	CSLRI	1.0	expected	106651	b	180	20	7.97	175	324			932	4.56	9.06	1.11	38.9				170	14.6	1.89	42.7			22.5	32	14.1	136	579			1480	50.8	21.5	30.4	122			34.1	5.28	10.7		40.5			5.4	2.44	31.9	19	981			2.35	.m																																																		180	31	15.2	143	350			1300	1.97	14.6		24.4			2.87	187	11.8	1.81	43.8			9.83	29.8	21.5	148	578			1550	32.6	23.9	35.1	146			32.6		18.4		49.4			8.65	3.61	111	18.9	1210			11.6	.m																																																		318
SUB231229	Atopic	CSLRI	1.0	expected	106424	b	180	30.1	16.3	106	123			1650	3.49	16.3		41.1			8.65	3.14	14.3		37.2			6.91	46.3	14.3	171	575			4970							32.6				825				1.73	485	1.99	124			42.4	.m																																																		180	20	8.79	76.7	126			1170	3.61	18.6		19.3			6.53	4.56	12.4		28.1				53.7	12.4	141	786			5060	8.65	27.4	11.1	70			25	3.61	13.8		21.3			5.4	7.01	685	2.6	131			38	.m																																																		317
SUB231230	Atopic	CSLRI	1.0	expected	105849	b	181			102	30.5			1150		6.27					3.71									50.1	177	337			1200				184										9.37		538		106			63.7	.m																																																		181		20.9	118	75.2			1300				4.12			2.12									39.1	362	559			1840		7.11		179			32.1		6.55		24.8			14.1		441	3.7	280			83.8	.m																																																		317
SUB231231	Atopic	CSLRI	1.0	expected	117900	b	181			490	66.1			1850		7.67					4.89		3.21		6.88						1100	2230			1670	111	54.6	254	288			35.1		11.9		33.5			2.12	7.19	21.5	61.6	1340			21.8	.m																																																		181		4.31	859	86.2			1790								107	138	63.9	62.3			42.7		2.66	689	2010			1300	99.6	43.9	283	328			20.4		18.6							16.5	58.7	2310			15.6	.m																																																		316
SUB231232	Atopic	CSLRI	1.0	expected	102627	b	181			441	213			4740				8.15			6.44									2.94	359	1290			5690	29	7.11	16.8	37			12.4									1.04	133	820			92	.m																																																		181		12.8	319	218			4040		1.04						21.1			6.22			38			424	1320			6940	18.6	9.37	15.5	127			11									30.2	110	1010			117	.m																																																		315
SUB231233	Atopic	CSLRI	1.0	expected	137979	b	181		15.2	200	318			1280		18.4		37.7			1.29	802	22.5		9.02			11.3		79.5	374	3830			1830	76.7	32.4	42.3	132			15.5		20.7		28.6			7.38		254	28.3	905			87.3	.m																																																		181		23.9	204	354			1320		17.2		21.4			7.8	734	35.1		27.6			29.5		58	377	3190			1860	57.9	30.4	41.8	103			1.63		14.1		23.5			5.66		225	29.8	869			74.2	.m																																																		312
SUB231234	Atopic	CSLRI	1.0	expected	144216	b	181			231	294			2670		18.6		24.3			9.98	162	338	27.3	99			15.3	7.19	143	339	2320			6430	59.1	38.8	129	443			35.1		10.5		12.4			24.8		30.5	14.2	285			74.6	.m																																																		181			217	210			2750		18.9							3.49		17.4					28.2	447	3460			3050	40.5	6.55	113	176			32.7		13.4		9.39			18.7		17.1	18	208			47	.m																																																		312
SUB231235	Atopic	CSLRI	1.0	expected	137193	b	202	26.1	24.2	45.9	254			158								92.4	4.29		65.5				41	94.7	117	8520			260	40.7	1.32	139	127											4.31	488	2.46	769			40.2	.m																																																		202	18.4	14.9	44.3	187			106		3.24							2.16		17.4				53.8	113	170	9840			337	26.3	3.72	124	31											8.62	427	6.32	1120			53.2	.m																																																		413
SUB231236	Atopic	CSLRI	1.0	expected	138089	b	181		40.9	53.2	138			899	15.3	6.55		44.9			21.1		1.85					6.66		195	160	1180			4840		6.55	13	162			22.6							1.82		1880	11	183			78.7	.m																																																		181		81.8	81.7	200			1150								30.6	1.04		10			28.5		49.8	155	1030			4400			13.3	9.39			14.9				9.39			3.95		1520	12.6	253			84.7	.m																																																		314
SUB231237	Atopic	CSLRI	1.0	expected	102407	b	202	86.3		284	278			874		3.58		25.8				59.7	35.8		214			11.5	101		468	3090			1490	52	9.25	29.7	30.1			20.8							4.58	9.75	15.1	8.32	419			68.4	.m																																																		202	98.5		315	287			1040				21.2				46.8	4.29		21.2			3.3	131	3.17	496	2530			3200	66.9	7.92	13.2	483					1.82						19.5	28.5	7.26	324			98.8	.m																																																		401
SUB231238	Atopic	CSLRI	1.0	expected	140727	b	202	162	7.69	1150	323			4240								908	2.29	7.68	99.2			13.9	165	1.96	571	5690			5550	69.1		115	71										5.72	2.33	6.33	8.92	2010				.m																																																		202	146	3.72	1200	275			3860								750	2.36	4.85	101				152	3.31	492	5200			3980	59.8		132	206										3.37		6.55	8.86	706				.m																																																		390
SUB231239	Atopic	CSLRI	1.0	expected	131984	b	202	145	6.18	239	1180			762								316	242	4.9	199			33.4	183	17.9	726	4820			1240	14.8	7.39	65.5	174			22								5.75	75.2	54	5760			41.4	.m																																																		202	147	2.22	243	1120			558								126	191	3.53	213			18.4	176	5.29	654	3310			569	9.91	9.56	66.5	166			21.8								8.22	77.3	66.8	5460			65.3	.m																																																		385
SUB231240	Atopic	CSLRI	1.0	expected	137303	b	202	97.3	8.31	584	141			902								147	14.6	17	137			43.1	153	71	542	2290			4640	20.8	2.9	16.6	65.9			16.3								14.5	710	37.3	5030			82.3	.m																																																		202	87	6.18	642	154			952															120	20.8	876	1520			1990	21	2.76	18.6	81.1			15.1								23.3	1530	32.7	3920			137	.m																																																		384
SUB231241	Atopic	CSLRI	1.0	expected	157404	b	202	31.7	5.29	398	268			1690	3.26														86.2	39	519	2130			3960	89.6	6.93	69.7	242											610	257	21.4	199			226	.m																																																		202	24.8	22.8	313	687			1650								70	8.16	2.39	499				59	18.2	395	2350			3340	80.3	5.29	97.9	281				6.62							29.5	31.8	10.4	22.2			123	.m																																																		380
SUB231242	Atopic	CSLRI	1.0	expected	221461	b	191	4.75	4.57	228	58.7			1690	1.14			16.4				177	57.3	13.9	19.1			8.54	9.72	46.9	418	1560			1460	121	4.84	123	120			15.2	1.81			1.09				2.35	11.1	19.4	824			8.27	.m																																																		191	5.62	4.2	256	37.2			1650								186	44.2	11.2	27.2				10.1	18.8	300	1460			1960	111	4.52	114	160			12.3	1.46							1.85	9.05	19.5	663			11.1	.m																																																		330
SUB231243	Atopic	CSLRI	1.0	expected	144555	b	191	7.5	24	154	683			1620	1.22							573	17		24.6			5.16	7.79	18.5	363	2080			2330	28.7	11.5	15.7	463			16.8	1.06			7.96				3.21	1280	26.3	4860			146	.m																																																		191	7.73	28.7	158	799			1780	1.3	2.09		7.66				560	14.9		26			6.48	8.86	31.1	450	2570			2810	43.2	12.7	26.7	254			21.7				10.1				3.97	1620	23.6	4450			172	.m																																																		329
SUB231244	Atopic	CSLRI	1.0	expected	132323	b	191	7.5	4.78	182	465			719		1.35		6.78				58.2	12.7	5.53	82.6			18.4	8.21	34.2	990	3180			2960	29	17.6	389	521			67.5	1.38	2.92						2.82	65.2	23.3	1360			180	.m																																																		191	9.78	3.27	215	809			1050		1.72						57.7	26	9.55	110			18	9.53	16.6	843	2650			2340	35.1	15.4	364	722			65.3	1.81	2.09		11.7				3.26	132	33.4	2200			239	.m																																																		330
SUB231245	Atopic	CSLRI	1.0	expected	85926	b	122	70.05		188.24	137.28			1331.85								41.94	59.74	6.78					176.37	11.04	284.13	490.6			4853.58	442.5		68.55	64.36			7.71										88.69	392.53			6.11	.m																																																		122	83.25		180.11	139.42			1306.15				6.9				33.07	20.39		25.58				146.29	12.91	221.58	398.07			3181.14	417.75	0.62	55.41	155.07			8.26				17.91						58.75	434.01			14.88	.m																																																		135
SUB231246	Atopic	CSLRI	1.0	expected	96235	b	191	9.23	5.32	406	142			656	1.9	1.81		2				334	113	7.73	24.9			11.8	8.74	8.7	574	877			3600	16.6	12	31.7	151			34.4	1.1	1.11		3.47				3.81	139	25.6	905			455	.m																																																		191	7.38	7.49	397	92.7			834	1.46	4.09		11.7				321	108	6.07	42.8			12	7.09	5.1	458	857			2780	13	8.53	36	21.6			45.3	1.94	3.53		28.7				6.52	124	25.5	770			1320	.m																																																		315
SUB231247	Atopic	CSLRI	1.0	expected	114238	b	191	8.15	181	215	12100			6420	2.92	3.17		22				203	579		51.1			14	4.97	1520	619	13200			3390	183	82.1	25.1	11.1			20.2	1.38	1.35		15				4.65	3690	19.8	7900			745	.m																																																		191	7.91	115	177	2030			3690	2.97	1.76		21.3				251	557		48.1			15.5	5.73	1320	605	11700			5760	112	79.4	20.5	52.7			20.2	1.63	2.43		32.5				4.75	2550	20.6	7280			507	.m																																																		315
SUB231248	Atopic	CSLRI	1.0	expected	108489	b	201	9.45	34.5	255	203			119	9.26	68.6	38.6	294			93.6	304	630	144	239			137	28.8	43.8	301	1320			354	21.3	66.6	169	153			103	1.06	1160	29.2	465			28.6		53.1	2.69	182			3.01	.m																																																		201	6.6	27.9	224	244			118	9.32	50.3	43.2	363			93.7	255	342	154	269			131	31	290	322	1370			355	20.8	85.6	164	168			166		496	8.85	659			14.6		46.5	2.77	180			2.7	.m																																																		345
SUB231249	Atopic	CSLRI	1.0	expected	116311	b	191	6.57	5.59	307	398			1440	1.9	1.58		6.78				149	36.1		77.6				10.8	5.59	666	3690			1430	78.7	3.63	17.1	52.3				2.17	2.28		27.2				3.81	18.8	18.8	1290			7.32	.m																																																		191	7.21	2.53	341	502			1770	1.55							150	39.2		112				7.67	10.1	546	2600			1660	94.8	8.3	21.3	819				1.94	1.86		15.3				2.54	21.5	19.8	1150			8.94	.m																																																		306
SUB231250	Atopic	CSLRI	1.0	expected	162757	b	201	5.43	2.73	86.8	223			81.2		4.11	3.46				2.37	10.2	26.3	10.3	71.4			4.2	56.9	12.8	277	1760			809	14	12.5	165				4.56		4.64	2.93				2.41		630	27.3	2200			10.2	.m																																																		201	9.51		139	282			87.5		3.3	2.89				3.12	7.04	15.2	9.03	65.6			2.1	50	8.55	327	1880			809	10.4	10.6	141				6.02		6.19	1.77				2.86		486	26.8	2550			10.6	.m																																																		345
SUB231251	Atopic	CSLRI	1.0	expected	146752	b	201	2.3	22	98.2	86.5			46.8		6.94	3.15				4.03	57.6	309	46.8	133			6.03		221	135	4170			25.4	80.8	14.4	317				4.8		8.55	2.97				3.23		1870	10	820			9.73	.m																																																		201	2.79	19.9	132	68			45.7		6.31	3.39				3.78	62.7	465	54.7	163			5.09	1.92	22.7	138	4190			32.9	82.8	12.9	337	117			4.87		4.25	2.35				2.7		1020	16.2	873			8.51	.m																																																		340
SUB231252	Atopic	CSLRI	1.0	expected	264755	b	201	41.7	143	47.8	991			587		8.92	3.22				3.04	81.5	32.2	6.17				4.77	89.7	447	102	2740			1820		14.9	12.4	84.8			4.29		6.19	2.64				2.84		2570	6.85	2140			13.7	.m																																																		201	41.3	165	36.1	818			573		7.69	2.77				3.47	143	66.6	7.32				3.14	72.9	192	103	1970			1390		15	12.8	97.7			3.67		2.73	2.42				2.7		2950	9.09	3050			14.6	.m																																																		333
SUB231253	Atopic	CSLRI	1.0	expected	224192	b	201	51.4	23.5	213	751			826		8.18	4.02	35			5.45	510	80.8	12.9	46.8			4.45	94.2	38.9	333	3480			2200	502	35	40.2	156			5.14	3.39	17.3	3.52	51.1			3.98		87.8	13.8	642			7.69	.m																																																		201	50.5	17.3	173	621			719		10.4	2.89				4.95	418	44.1	7.91	24.1			5.02	86	42.2	429	3820			2420	602	35.8	40.1	111			5.66		13.7	2.73				4.8		91.8	19.4	473			6.24	.m																																																		333
SUB231254	Atopic	CSLRI	1.0	expected	157184	b	201	23.4	10.1	55.8	236			314		10.6	3.07				4.57	63.1	20.4	6.47	25.3			6.31	126	26.6	184	943			2870	3.87	9.77	41.5	183			30.8		6.69	2.51				4.08		298	9.09	1800			12.1	.m																																																		201	23.5	12.3	51.9	183			305		4.64	2.62				3.67	38.9	14.9	5.54				6.67	95.3	29.1	111	758			2140	2.55	8.92	34.4	163			30.8		4.64	2.97				3.04		140	8.4	1290			10.9	.m																																																		332
SUB231255	Atopic	CSLRI	1.0	expected	136032	b	201	86.3	11.7	736	549			1940		1.83	2.77				3.76	5.8	22	5.83	11.5			1.45	123	7.69	518	2630			3110	71	6.44	19.1				3.62		6.56	3.01				3.84		48.9	19.8	1950			5.33	.m																																																		201	86.4	12.4	780	606			1790		6.94	2.56				2.21	10.9	29	5.96	36			3.26	114	16.3	515	2320			2810	83.1	12.3	19.5	256			4.47		8.8	2.77				2.8		68.6	19.1	1600			4.8	.m																																																		333
SUB231256	Atopic	CSLRI	1.0	expected	136142	b	202	53	3.45	86.5	54.8			357								22.2	1.75	7.4				14.1	94.1	59.8	174	687			1410			17	75.9			13.7									165	3.24	664			14.4	.m																																																		202	52.8	14	118	37.5			377								12.2	1.82	6.89				13.3	86.7	11.1	240	692			1250		6.11	16.2	101			20.3									411		821			19.7	.m																																																		331
SUB231257	Atopic	CSLRI	1.0	expected	132552	b	202				34.6			11.3								10.8	4						19.3	72.8	9.93	426			144			19.3	38.7												260		89.8				.m																																																		202		9.56		51.6			8.75								7.39							15	604	8.08	407			146			30	35.8												156		22.9				.m																																																		324
SUB231258	Atopic	CSLRI	1.0	expected	128787	b	214	7.48	3.89	147	197			1290		2.29		7.76					2.68		5.65			1.13		3.32	136	1330			84.8		12.5	1.52	845			9.3									1260		339			15.4	.m																																																		214			96.4	235			1270		2.29		15.7					3.08		11.1			1.49		2.92	94.6	1060			66.7		11.2	1.24	744			7.55		3.08		10.3					540	1.57	282			15.4	.m																																																		371
SUB231259	Atopic	CSLRI	1.0	expected	137759	b	215		2.2	652	271			507				6.15				349	26.8		408			17.7		3.86	658	567			4610	166	4.42	15.5	67.1			13.2									1.34	109	568				.m																																																		215		2.85	524	286			472								410	28.9		390			20.4		4.19	635	564			3590	175		18.2	61.3			11.5										125	547			6.75	.m																																																		362
SUB231260	Atopic	CSLRI	1.0	expected	310825	b	215		22	525	292			1440		2.31		4.92				361	13.3	8.51	10.6				23.5	10.7	373	2080			492	156	17.9	216	32.2			19.2				4.92				4.14	209	21.5	1620			84.1	.m																																																		215	9.29	9.51	492	259			2330		4.65		13.6				342	21.3	7.83	21.7				14.3	19.3	599	2150			839	171	19.6	212	27.8			18				4.43					166	11	2450			101	.m																																																		357
SUB231261	Atopic	CSLRI	1.0	expected	207491	b	215		7.29	633	268			1980		4.19		22.3				216	485	8.74	171			72.9		11.6	899	1920			2180	52.4	15.2	40.8	130			45	6.25			4.19					214	56.4	2460			575	.m																																																		215		13.1	603	368			3260		1.77		17				165	515	7.01	182			109		40	949	2370			4200	48.4	10.5	44.8	105			54.2				6.91					129	47.3	2140			222	.m																																																		351
SUB231262	Atopic	CSLRI	1.0	expected	142804	b	215	6.25	10.2	327	625			551		2.63		3.72				342	615	96.9	210			16.2	6.25	9.27	194	4380			1690	33.8	4.87	338	82.6			9.46		1.77		4.67					49.1	11.1	4610			159	.m																																																		215		4.42	254	556			540								393	751	98.4	198			17.8		28.9	291	4090			1500	38.9	5.9	370	80.3			8.66								64	59.4	9.2	3600			97.8	.m																																																		350
SUB231263	Atopic	CSLRI	1.0	expected	157751	b	215			502	145			791		4.19		11.4				92.8	5.33	8.81	40.3						530	770			2210	24		27.2	116												1.66	118	2100				.m																																																		215			628	247			1100				14.7				79.4	4.42	6.13	48.7						600	799			2870	29	2.42	36.2	18.1												5.67	81.6	2610			16.3	.m																																																		347
SUB231264	Atopic	CSLRI	1.0	expected	143031	b	222	23.2		124				1270	3.5						224	24.5		3.05				596	29.9		149				1050	16.5	12.1	12.9				466									138	7.92				26.6	.m																																																		222	21.5		94.4				1210	5.15						221	26.7		4.66				181	32.1		372				1030	21.3	35.7	21.7				138									139	10.1				25	.m																																																		371
SUB231265	Atopic	CSLRI	1.0	expected	132094	b	222	22.4		171				1620								298						11.1	40.8	56	203				3260	116		3.46				7.83									3.35	17.5				25.2	.m																																																		222	24.6		170				1520								268						14.3	47.9	34.7	297				2980	201	14.1	4.61				20									25	32.1				210	.m																																																		359
SUB231266	Atopic	CSLRI	1.0	expected	346725	b	222	7.86		368				222								16.2		8.91				7.01	17.7		214				1390	28.9		6.86				9.63									35.9	1.07				5.65	.m																																																		222	9.14		372				287								21.9		7.02				9.46	27.3		270				1760	27.8		6.28				7.92									34.3	1.19				2.53	.m																																																		357
SUB231267	Atopic	CSLRI	1.0	expected	133237	b	231	8.43	8.41	155	642			564		1.45					11.6	37.2	187	18.1	401			51.5	9.19	15	168	5000			1560	99.2	29.3	390	150			61.2				5.1			3.4	1.84	13.4	10.6	675			16.1	.m																																																		231	6.98	7.08	166	551			570	1.06	2.37					17.3	41.2	357	23.1	528			103	9.32	69.9	177	6110			1760	134	32.9	325	166			81.6	4.62	4.23		5.91			6.25	1.75	3.93	7.01	675			18.4	.m																																																		377
SUB231268	Atopic	CSLRI	1.0	expected	283726	b	231	1.25		30.2				7.33	2.51	1.39		5.91			70.7	2.04	8.24		21.7			1.55	1.8		28.9	13			85.4										5.72	19.7				2.04		1.66	2.76			2	.m																																																		231			41.9	5.91			17.5							20.4	4.17	11.8		34.6			4.44	4.12	3.19	38.2	34			91	1.25	2.43		1.03					2.04	4.7	11.2			2.18	2.32		4.11	18.8			4.29	.m																																																		375
SUB231269	Atopic	CSLRI	1.0	expected	157861	b	231	8.79	5.55	341	311			233	2.04			4.3			7.33	113	77.5	6.26	64.1			144	10.4		388	1120			294	140	15.7	25.2	664			38.3	1.02	2.81		7.6			3.89	1.55	6.32	12.4	905			34.3	.m																																																		231	9.85	6.03	355	306			303	1.15	1.18		5.1			5.85	117	136	4.79	86.7			118	10.4	1.52	356	1040			232	150	17	25.3	606			41.3	1.45	1.78		5.5			7.55	2.42	7.72	14.2	910			33.6	.m																																																		368
SUB231270	Atopic	CSLRI	1.0	expected	276067	b	235			186	88			323			2.38	17.3			1.64	61.6		9.88	22.4			12.2	2.07		669	784			669	122	19.8	133	205			21.2			2.32	36.3						7.83	197			10.1	.m																																																		235			156	82.4			273			2.2	14.4																																							.m																																																		378
SUB231271	Atopic	CSLRI	1.0	expected	276808	b	238		390	52.3	276			534	4.9	2.73		64			20.3	193	1610	9.97	48.9			63.1	4.43	149	306	3640			2200	49.6	330	74.3	120			57.2		2.53					1.45								.m																																																		.m																																																		.m																																																		382
SUB231272	Atopic	CSLRI	1.0	expected	363920	b	238		5.08	199	1400			1190			3.04	179			15.2	438	4120	228	884			827	7.25	166	1190	9660			1880	557	145	172	1310			363			1.56	328					187	15.3	867			74.4	.m																																																		238		3.98	181	1380			1440			2.31	177			15.7	261	1420	52.2	443			69.5		5.31	1260	3740			1170	497	162	155	1580			399				306					634	57.3	4860			1270	.m																																																		377
SUB231273	Atopic	CSLRI	1.0	expected	366212	b	243	9.85		235	581			806			2.73	45.6			5.83	392	142	22.5	75.6			24.3		49.4	578	4510			6440	906	30.1	37.8	45.3			35.1			2.21	66.9					4.84	13.7	1330			23.6	.m																																																		243	12.6		239	610			678			2.43	46.6				369	110	22.5	91.9			24.3		46.8	676	5160			5510	734	19	38.5	24.8			31.9			1.55	54.9				9.37	8.86	11.2	1500			15.9	.m																																																		381
SUB231274	Atopic	CSLRI	1.0	expected	244106	b	243	12.6	28.2	193	3930			3110	4.09	4.02	4.82	1200			329	123	2010	29.6	1660			2020	11.1	334	445	27300			5580	133	967	126	2080			1540	5.01	5.63	1.62	1520			7.54		36	14.1	2850			77.6	.m																																																		243	9.88	67.9	166	4030			3320		3.8	4.08	1060			352	115	2230	35.8	1730			1940	9	266	329	19600			6070	159	824	130	2540			1180		2.53	1.18	1400			8.86		134	14.1	3480			105	.m																																																		379
SUB231275	Atopic	CSLRI	1.0	expected	300187	b	243			428	427			4380								124	559	9.78	1420			145	7.57		634	1090			4490	44.6	3.11	163	195			114			2.77							339	1660			25.8	.m																																																		243	9.21		471	293			4700								134	526	11.3	1940			174	11.3		681	1340			4410	46.3		113	180			50.7			2.46	1.23						231	1250			15.5	.m																																																		378
SUB231276	Atopic	CSLRI	1.0	expected	338504	b	243			183	656			782			2.06	132			52.3	263	38.6	13.9	392			253	7.06	2.7	501	3090			3980	60.7	68.8	30.7	990			140			4.51	286						7.15	580			25.6	.m																																																		243			228	719			614			1.81	130			48.8	242	57.3	14.9	412			268	3.94	2.85	541	3160			3750	72.5	78.1	33.5	971			134	2.71	2.29	4.22	1210						8.89	655			14.2	.m																																																		374
SUB231277	Non-atopic	CSLRI	1.0	expected	311545	b	243	12.1	3.48	129	794			2470				7.13			7.74	53.5	83.5	20.9	102			141		18.5	358	2710			4700	52.9	39.2	96.3	205			168			2.09	8.68					72.6	13.9	594			59	.m																																																		243	16.2	1.22	134	765			2030			1.01	9.37			10.5	43.6	143	29.6	98.6			323		13.6	458	2830			4650	57.4	19.5	80.1	108			135			2.31	4.24					118	15.4	648			55.1	.m																																																		373
SUB231278	Non-atopic	CSLRI	1.0	expected	316479	b	243		4.31	46.4	1360			1040				117			15	20.9	45.5	3.75	332			50.8	1.77	1.12	144	5730			3340	138	51.2	51.4	677			49.4				61.8							101				.m																																																		243	2.85	1.92	45.6	1570			1400				87			14.2	4.77	33.7	3.44	255			45.7	4.87	3.26	168	6480			3800	155	40.9	47.3	596			50.5				52.7							136			3.16	.m																																																		373
SUB231279	Atopic	CSLRI	1.0	expected	356231	b	243		4.78	127	949			660		1.79	1.3	65.6				225	178	10.8	171			33	8.43	8.6	726	1420			282	347	36.2	92.1	481			47.1			1.55	52.1				8.35	14.7	42.5	441			37	.m																																																		243	2.77	3.12	153	1110			520		1.32	1.23	64			2.04	220	169	12.4	189			32.3	10	12.5	732	2250			487	210	66.4	83.1	580			96.5		1.75	1.92	70.4				13.1	22.2	40.8	407			45.4	.m																																																		366
SUB231280	Non-atopic	CSLRI	1.0	expected	281102	b	245			119	753			908				53.9				83.7	52.9		54.7			24.4			351	5480			345	78.7	76.7	8.04	613			61.6				50.3					171		536			63.7	.m																																																		245			110	845			1050				46.6			3.16	89.2	30.1	1.39	61.2			28.8			356	4470			242	65.3	93.3	8.98	694			71.7				37.8			2.13		256		527			87.6	.m																																																		365
SUB231281	Atopic	CSLRI	1.0	expected	268019	b	245		4.53	51	189			1600							18.7	83.4	9.24	2.06				76.9			266	2720			800	6.63	19.9	2.34	167			130							3.55		132		122			196	.m																																																		245			59.4	216			1290							21.5	76.2	18.9	3.55	10.7			132		16.4	299	2780			1020		12.7	7.49	203			214							2.77		388		134			172	.m																																																		361
SUB231282	Atopic	CSLRI	1.0	expected	292695	b	245			38.5	615			1170								55						5.04			211	1870			694	7.15		68.3	62.6			31.3										2.05	248			14.4	.m																																																		245	4.54		46.4	646			1180								69.4			37						153	1760			1730	24.3		80.5	80.2			57										2.97	371			35.3	.m																																																		351
SUB231283	Atopic	CSLRI	1.0	expected	286903	b	245			145	1210			750				87.2			30	442	44	14.4	174			24.2	13.7	47.5	609	2600			1140	37.5	33.7	28.3	437			59				95.4						11	856			51.7	.m																																																		245		7.98	142	1090			1070				82.3			34.7	355	35.7	13	173			15	9.68	15.7	466	3090			2340	27.1	33.4	30.6	440			35.3				103						11.7	727			59.2	.m																																																		344
SUB231284	Atopic	CSLRI	1.0	expected	363178	b	246	3.16	32.6	83	2030			1650				11.9			10.7	184	1270	4.01	117			69.4	4.18	94.7	415	5080			4010	43.3	32.7	49.9	193			65.3			3.6	24.1			2.7	4.45	61.3	11.9	1910			34.4	.m																																																		246	2.49	28.6	75.3	1930			1720				15.1			8.27	207	310	3.67	109			46.9	4.91	133	573	5910			4540	41.4	39.9	45.6	224			86.6	1.07		3.63	37.7			4.79	2.4	237	6.43	1700			68.7	.m																																																		344
SUB231285	Non-atopic	CSLRI	1.0	expected	356682	b	245		452	250	4000			6600				74.3			106	680	4580	69.4	373			1800		246	1010	13600			16700	26.2	183	290	446			1060			3.98	113			57.7		131	93.2	2870			1790	.m																																																		245		240	269	3040			4990				65.1			133	669	4320	59	333			993		352	789	9620			11200	65.1	177	316	264			857			3.64	69.7			35.2		37.7	82	2750			383	.m																																																		340
SUB231286	Atopic	CSLRI	1.0	expected	301261	b	246	4.32	348	119	3500			3100	5.27			68			16	617	1830	19.5	729			341	4.64	188	493	12100			4590	867	121	238	396			105			4.36	163			2.46	4.73	294	20.5	2080			124	.m																																																		246	1.75	762	122	3170			3370				133			28	532	1940	19	579			285		485	643	10600			3800	598	260	199	241			176			4.22	161			4.22	2.2	105	6.17	1860			85.9	.m																																																		341
SUB231287	Non-atopic	CSLRI	1.0	expected	347716	b	246	5.81		243	1950			3180			1.3	91.3			4.14	377	24.4	17.2	575			41.9	2.64		997	4940			4840	12.3	18.4	58.2	641			32.6	3.58		9	99.4						34.3	818			4.38	.m																																																		246	5.09		260	1900			2850	3.16		1.11	96.5			11.1	288	30	26.6	662			314	6.08		761	3450			3360	5.45	18.7	46.1	767			2520			8.69	151			1.05			38.2	516			2.18	.m																																																		341
SUB231288	Atopic	CSLRI	1.0	expected	397739	b	246	3.16	2190	152	438			1020		6.37					14.2	34	7400	19.6	164			165	4.41	3100	705	2350			688	307	3360	547	926			389	10.3	17.9	8.7	71.5			34.8	7.6	3900	11.1	405			110	.m																																																		.m																																																		.m																																																		330
SUB231289	Atopic	CSLRI	1.0	expected	311435	b	246	3.53	4.02	79.2	134			665	5						2.67	3.72	22.9					10.7	5.13	7.24	145	530			2020	14.2	86	4.97	191			50.4							2.24								.m																																																		.m																																																		.m																																																		330
SUB231290	Atopic	CSLRI	1.0	expected	375316	b	246	3.9	41.8	51	673			1930							1.38	26.7	39.1	3.32	12.3			22.4	6.17	3.55	146	1540			2350	66.3	14	33.3	56.5			13.4								2.35	585	10.9	1290			164	.m																																																		246	3.86	23.3	66.9	629			1990							1.65	22.7	201	4.16	49.3			37.5	3.9	7.53	128	1330			2300	83.7	13	35.4	89.6			24.2							1.32		406	6.3	1160			34.7	.m																																																		326
SUB231291	Atopic	CSLRI	1.0	expected	341398	b	246	5.81	3.05	569	152			1040	3.49	2.67	1.53	16.3			14.8	257	17.5	5.62	44.5			64	8.72	4.42	455	1450			813	92.5	11.4	22.2	32.7			83.5		1.55	6.02	59.3			3.73	4.73	24.2	16.5	1780			19.8	.m																																																		246	5.22	1.92	515	175			1270	1.95	3.05	4.19	27.3			37.8	284	20.6	6.52	51			84	6.53	14.5	837	2330			1910	181	19.7	24.7	333			112	1.59	1.48	7.34	47.6			4.38	1.49	9.82	16.6	1140			13.1	.m																																																		322
SUB231292	Atopic	CSLRI	1.0	expected	418356	b	250	1.11	42.1	41.5	372			816				20			20.2	167	241	5.69	56.3			65.4	2.8	67.8	117	1610			905	86.8	41.8	86.8	106			112									85.3	13.4	1200			38.5	.m																																																		250	1.14	43.2	48.8	495			761		1.9		24.8			20.8	184	503	4.87	93			282	1.98	127	158	2050			868	94.9	31.8	91.8	173			110									263	15.8	1990			98.4	.m																																																		329
SUB231293	Atopic	CSLRI	1.0	expected	8075	b	59	132.53	9.75	232.08	33.01		288.09	4919.42				5.5	4.25	717.86		285.92		8.76	51.96	24.32	416.79	30.82	141.34	25.89	389.21	484.64	6.14	348.89	2841.98	224.87	93.31	33.8	736.76			22.52						196.88			41.77	20.95	375.14		184.09	25.04	59	128.08		194.78	70.42	15.25	275.2	3755.95					1.69	595.27		224.87	14.88	8.59	29.49	35.76	437.74	30.7	161.72	7.95	351.24	481.74		415.96	2968.03	150.66	54.02	23.89	840.94			19.93				20.55		165.78			9.75	17.92	288.9		150.26	21.39	59	117.16		209.53	73.73		244.67	3614.18					2.05	583.05		271.6	56.67	8.59	60.4	49.18	384.82	31.95	111.3		390.02	512.08		330.95	3061.48	189.35	36.14	30.94	752.2	2.05		18.26				8.44		188.16			17.33	18.92	285.14	4.25	187.94	7.6	59	188.76		189.75	65.42	7.3	270.08	3575.25		11.5		7.47	6.53	583.2		194.67	30.35	7.31	26.83	34.47	445.08	28.11	117.16	6.07	382.65	450.54	5	399.25	2989.13	197.61	17.33	30.69	669.09	16.07		14.03				31.25		156.73		17.8		17.77	251.93		169.54	8.44	139
SUB231294	Atopic	CSLRI	1.0	expected	77	b	57	37.38	13.3	256.75	41.52		177.93	1224.11	20.37				5.86	790.55		172.6	128.47	14.76	160.89	218.2	287.57	55.12	58.99	15.98	446.18	325.45		236.71	1685.31																						57	44.68	16.65	262.31	56.5		183.26	1379.84	36.53	5.57				715.93		157.89	127.93	16.49	166.74	232.32	280.53	55.89	68.68	9.17	460.5	311.95	6.49	225.82	1782.69																						.m																																																		.m																																																		167
SUB231295	Atopic	CSLRI	1.0	expected	7875	b	59	100.07	25.89	352.62	144.64	7.3	221.69	4756.58				11.3		514.64		502.06	73.47	13.38	50.26	52.69	861.74	14.67	159.88		535.06	526.48	1.34	308.68	2773.02	691.7	36.85	45.44	725.51		376.69	16.51						284.67		11.07	45.23	14.82	2014		143.75	8.04	59	156.21		366.76	119.23		250.03	5001					2.05	549.31		446.23	83.49	12.91	23.25	29.37	1011.91	12.55	209.87		528.83	526.48		367.7	2728.51	657.65	15.71	48.21	562.36	3.5	400.66	20.04	6.87			18.73		324.25			40.37	16.93	2065.85	1.34	151.79	6.77	59	154.98	41.77	345.96	94.24		220.68	4807.56	11.07					532.27		578.43	60.62	18.38	45.14	71.34		14.99	125.53		649.94	571.67	6.53	367.26	2918.34	367.73		57.22	523.6		480.41	15.32					2.05	349.22			14.05	19.47	1946.83	3.5	220.54	6.29	59	138.83	23.61	366.63	99.11	8.08	225.61	5001				29.49	3.87	503.41		474.3	111.28	16.63	51.11	74.48		10.93	146.33		592.2	555.2		409.29	2505.06	306.07		48.43	563.8	3.5	383.34	15.15						292.1		19.63	22.07	17.01	1790.39	3.5	186.9		141
SUB231296	Atopic	CSLRI	1.0	expected	10223	b	60	151.89	86.48	251.64	89.6	12.65	367.52	4167.8	8.71	8.11				652.24	5.59	47.11	30.91		18.5	17.02	644.18	18.89	208.32	27.23	294.8	492.32	4.49		3186.4	47.7		13.09	596.24	9.14	753.96	28.64	16.08				5.13	82.38		8.71	992.77	10.51	414.95	6.77	798.31	103.87	60	175.66	93.29	243.83	59.58	10.53	421.3	5001		22.01		8.68	23.04	732.08		54.74	48.93		32.67	5.46	613.9	19.82	169.44	13.63	271.86	483.16			5001	48.87		12.11	453.6	9.83	788.79	26.5		26.49		29.23	6.44	90.85	5.99	28.73	1036.59	10.23	453.6	12.65	883.25	102.44	60	174.53	91.25	281.01	82.02	10.18	397.16	2914.75		7.3		14.71	14.82	669.5		45.34	43.94		6.51		592.5	21.25	192.57	27.23	465.39	810.32	16.28		4070.55	14.25	18.24	12.69	532.53	12.65	677.98	26.1	15.47				14.09	44.79		54.74	258.93	9.43	418.46	15.55	675.27	72.34	60	188.63	95.33	247.79	78.97	7.78	439.21	5001	27.54	31.64		47.6	11.94	575.77		20.92	27.97		20.34	7.78	667.41	20.2	131.42	22.76	455.28	776.39	18.5		5001	35.88		11.79	627.5		680.02	23.94	8.71	12.85				45.19		13.63	250.05	9.09	412.84	7.11	704.09	70.45	129
SUB231297	Atopic	CSLRI	1.0	expected	10786	b	60	162.09		273.3	85.06		459.18	2569.85						432.4		125.15	1713.51	20.83	317.37	629.72	826.93	92.22	246.96	50.35	370.99	363.7	11.23		4047.19	257.01	176.85	39.75	737.55	22.28	1021.81	37.99	17.29	15.18			16.65	203.7			48.93	10.13	155.79	3.25	170.56	27.37	60	162.65	30.91	231.97	85.06		526.74	2286.48		10.5		63.51	12.65	338.74		99.38	1579.66	20.05	355.98	582.91		80.46	123.44		363.32	353.88	7.44		3790.1	192.01	124.23	34.27	847.26	3.86		37.2	12.41	0.46		6.51	9.83	226.78		5.58	16.71	11.04	112	14.09	189.56	25.81	61	252.53		250.04	42.38		734.46	2131.05				0.64	8.69	521.72		107.31	561.84	16.23	204.96	508.24		69.77	312.12	4.28	412.44	310.87			3628.93	358.86	32.94	29.05	905.12	9.88		30.21	39					367.34		24.3	2.89	6.22	96.42	7.23	310.15	12.23	61	222.81		273	26.47			2122.73					9.28	544.65		170.75	575.76	16.78	241.57	480.55		75.61	222.21		410.61	302.95			3587.69	359.97	49.32	25.25	1017.64			42.54				8.88		445.42			3.35	6.7	90.45		346.64	16.2	126
SUB231298	Atopic	CSLRI	1.0	expected	16015	b	61	127.89		182.81	11.86	9.28		881.96						189.21		29.33			6.94		569.18		238.34	5.9	338.39	160.75			2198.97	30.97	2.66	16.12	209.43		503.28	25.77	23.45				11.08	110.47		27.67	166.07	8.27	217.11	13.52	849.43	73.21	61	135.71		190.99	32.98			943		0.6				183.96		58.83			14.9	17.9	624.18		246.63		320.23	163.25			2012.03	25.99		16.04	204.32		544.42	32.6					6.94	105.89		42.14	138.62	6.82	230.6	16.01		72.08	61	125.26		164.97	31.88	14.76	935.75	756.17		2.89				175.52		45.25	1.06		2.32	18.86	592.2		204.68		302.44	132.85			1921.83	12.73		13.14	197.32		510.85	26.8		0.6		0.64		114.34		40.58	267.58	6.94	242.86			66.43	61	151.8	0.15	170.58	21.67		905.39	819.76						204.8		13.67	0.15		16.96	8.1	542.53		258.99	2.43	273	163.25		970.8	1871.55	26.83	3.58	12.86	151.4		479.12	27.71				1.46		107.11		30.15	238.28	5.64	200.5			55.84	112
SUB231299	Atopic	CSLRI	1.0	expected	16602	b	61	188.76		338.97	5.04		519.96	1585.54						657.23		128.54	17.37	5.64	20.62	27.65		10.85	245.45	2.89	694.61	185.27		782.58	3252.26	107.31	13.14	20.65	731.12	6.94		13.57				6.94		426.71			1.97	13.04	215.83	11.69	446.75	12.46	61	228.2		330.51	37.38		525.66	1551.16				13.88		644.84		107.98	17.13	5.1	24.33	27.65		8.72	267.18	3.82	618.78	194.14		683.56	3276.7	77.64	23.96	19.18	734.67			10.85		2.43				396.76		19.98	8.93	12.76	219.67	6.94	408.15	9.55	61	165.73		371.49	49.13		512.9	1238.44				21.14	11.69	711.06		168.87	26.32	6.64	31.88	15.38		13.51	240.12	3.82	609.07	163.25			3471.9	106.63	38.4	22.96	785.92	11.69		14.7				5.04	13.83	462.69		4.7	8	12.03	322.77	10.48			61	144.75	2.2	354.18	32.98		454.65	1179.69		4.28		9.37		630.9		125.26	23.96	6.28	30.25	25.01		8.83	306.99	1.97	521.28	166.39	17.9	792.18	2901.13	116.67	20.19	15.75	811.65	7.81		9.49		0.38		7.91	7.52	404.36		11.79	5.21	11.11	317.48			3.89	112
SUB231300	Atopic	CSLRI	1.0	expected	23987	b	73	61.33		89	78.57	12.51	1779.48	1286.84	26.1				14.83	131.54		136.36	20.98		30.31	30.11	358.63		107.66		273.26	420.6	7.93		3866.3	159.27	143.05	29.17	736.87	13.56	193.2	25.14					10.63	115.29			26.67	13.26	431.71	10.63	397.85	56.74	73	58.93		97.23	73.07			1418.65		7.77		7.52		136.84		118.54	31.98		49.14	17.81	357.72		119.21	15.46	289.71	435.51	9.59		4563.01	110.4	154.96	27.9	761.94	8.13	171.36	26.25		11.82				128.77		58.93	28.57	14.02	451.06	21.26	430.9	58.17	73	90.78		88.88	68.13		1415.21	1406.29	14.11				16.52	130.54		116.52	29.9		15.77	16.52	369.52	6.52	91.49	23.07	336.83	453.11	19.53		5023.46	133.1	146.75	30.82	829.07		188.08	39.05						122.14			20.79	15.62	348.94		162.88	49.17	73	54.03	7.96	78.16	66.58		1061.34	1261.51				6.54		128.91		127.19	27.24		38.57	14.19	378.6	4.68	132.45		262.18	410.39			4224.66	106.28	130.99	31.25	888.81		191.58	41.43					8.55	126.88		29.08	15.08	12.83	333.38		159.84	46.98	108
SUB231301	Atopic	CSLRI	1.0	expected	20677	b	87			358.33	62.21		756.88	4473.75				25.85		591.74		268.15	228.54	6.1	97.31	94.57		89.98		12.77	552.76	320.14			4020.15	81.54	29.6	63.41	708.42		518.98	33.48				1.05		205.47		9.36	34.11	22.06	943.21			29.74	87	2.96		329.88	60.35		709.95	5001				17.53		542.74		242.05	223.62	3.47	129.61	92.35		90.55		7.78	529.73	355.74			5001	65.04	34.11	59.15	664.12		480.51	25.71						195.91			31.73	21.35	927.74			27.61	87			327.73	60.97		752.33	5101.25						492.52		231.57	201.33		88.11	71.38		85.63	0.05	15.05	468.85	250.49			3633.6	33.78	32	63.7	724.38		600.36	27.19				2.43		190.75			61.58	23.92	1058.45			74.94	87			328.39	78.28		737.01	5001	8.22			1.74		472.74		222.84	203.14	1.96	80.12	70.63		92.73			467.1	258.24			5001	41.13	32.79	62.97	809.59		538.73	35.73	4.23					181.85			66.08	19.07	1078.82			66.82	152
SUB231302	Atopic	CSLRI	1.0	expected	26378	b	73	97.19	13.55	633.36	65.02		717.03	2449.23				52.37		644.75		42.07	26.86		55.25	27.87	765.62		113.81		896.51	614.18			5001	154.88	35.58	30.12	535.19	20.83	468.45					12.88		234.13				173.34	122.59		81.72		73	84.97	10.09	667.11	86.75		751.06	2601.51				26.02	8.55	630.54		79.06	16.22		40.58	11.25	867.76		114.49		841.46	579.64			5001	123.22	15.84	23.83	570		443.12					24.56		209.76			7.77	154.48	129.3		74.01		73	73.03		513.75	62.52		614.9	1260.92						389.42		157.39	36.72		15.36	22.13	1402.15		173.5	12.78	997.13	552.56			3335.65	106.97	19.65	24.6	609.62	11.46	589.08							314.92				91.48	96.04		67.79		73	47.3		499.94	42.58		670.78	1107.97						340.26		145.37	46.96		55.57	43	844.21		140.24	8.54	848.31	499.76			5100.05	173.5	22.31	35.02	607.49		883.24	5.07				13.72		336.48				77.9	69.37	9.17	71.62		98
SUB231303	Atopic	CSLRI	1.0	expected	26490	b	74	95.21	22.46	63.48	21.45	6.8	420.92	1196.93		12.67		8.7	6.14	310.34		37.83	33.26		31.66	12.23	1113.51	56.02	120.43	15.31	119.31	131.59	5.7	834.9	2934.49	61.15	49.67		490.85	4.43		59.95					8.86	109.31		32.96	60.25		130.94	4.02	707.83	69.62	74	94.51		62.18	41.36		455.8	1217.44	20.43			9.83		343.88		39.72	48.58		13.15	16.31		55.98	118.47	12.33	105.18	114.45	6.8		2636.18	51.69	62.68		570.77		835.12	61.46	21.03			0.85	7.93	109.84			64.29		153.29	4.43		72.72	74	88.52		59.38	51.96		522.87	1206.14	13.93	22.16		9.08		263.24			65.63		25.7	22.22		49.37	125.31	24.56	160.53	182.81	9.33		4788.55	95.55	46.66	7.55	690.56	13.74		62.89	21.63	9.54		4.5	4.85	128.79		41.57	65.63		196.91	10.04		80.36	74	102.44	9.9	57.58	39.98	4.85	486.75	1161.16	11.73	20.33		33.75		243.77		10.16	70.72		32.36	20.03		46.47	141.55	15.95	138.23	135.87	4.85		3437	72.42	54.3		696.25	4.02		49.16						100.43		39.72	56.74		165.76	3.62		65.77	101
SUB231304	Atopic	CSLRI	1.0	expected	27682	b	74	87.46	11.3	196.88	103.2		558.53	886.16	23.37	15.95		27.46		282.32		166.25	71.26		48.56	21.12	769.49	40.55	113.53	19.1	302.55	723.34			4362.95	184.3	37.22	58.03	427.26	8.86		47.34	8.48	14.33				121.54		48.69	67.78	12.97	342.11			30.99	74	88.52		177.17	95.91		463.31	701.17				15.34	6.8	274.7		177.42	72.59		45.14	27.86		41.55	115.18	12.33	258.26	703.72			3628.72	181.62	31.55	48.19	513.7			37.64						104.81		37.83	62.95	15.05	351.4	15.79		29.52	74	101.75	19.1	164.14	115.11	8.86	455.47	752.71				10.94		303.58		145.63	80.06		38.6	25.57	695.88	40.33	117.16	46.66	274.94	583.58	4.02		3483.86	212.89	40.02	48.56	486.09	8.86		35.24				18.95	3.42	62.24		24.51	26.33	71.35	1225.03	6.14		61.03	74	68.98		194.44	114.12	4.02	510.07	858.6				18.95	6.58	277.82		151.22	82.73		76.24	21.12	619.33	41.6	89.94	60.79	248.53	539.75			3290.59	189.66	34.97	40.63	508.92			29.57		9.9				53.62		40.65		58.76	1124.53			55.38	97
SUB231305	Atopic	CSLRI	1.0	expected	29550	b	82			153.44	33.08			1831.24		1	4.17			467.34		16.25	60.27		79.34	15.48	747.2	9.1	16.25	10.89	419.93	689.4			2249.85	160.82	23.97	20.21	1040.28		298.13	10.67						109.43			4.22	8.74	200.88		253.38	24.74	82		1	136.5	28.03			1671.29	0.62	3.56				423.54		18.7	58.18	4.53	58.18	11.13	710.27	8.16		2.26	360.37	597.75			3893.78	174.26	14.22	13.6	1213.31		333.45	7.9						103.3			6.71	7.25	181.37		215.49	11.91	83	7.54		105.53	63.67		782.96	1336.19	3.03			22.84		464.81		9.75	10.76		53.2		534.44	7.86	18.77		324.45	608.45		927.38	2024.25	144.13	8.59	10.44	1057.24		270.14	10.6				5.67		114.09				7.86	204.63		58.59	17.83	83	4.01		98.72	50.88		967.41	1421.86				14.44		479.97		6.26	7.34		50.3		547.09	7.1	23.06	3.99	288.76	585.58		985.16	3744.43	127.76	10.94	12.12	1116.48		271.01	10.34				17.78		111.47			0.94		143.65		51.03	15.27	109
SUB231306	Atopic	CSLRI	1.0	expected	29638	b	83			95.29	67.17		930.37	1376.21				11.67		292.42		39.1	6.09		20.02	10.83		10.94	13.2	20.75	241.72	723.43			3435.64	5.62		26.75	891.3		654.24	22.84				12.22		215.54			345.95	8.02	289.02			99.05	83	5.94		86.51	50.88		950.81	1403.97				10.02		292.86		25.51	9.67		23.4	10.56		12.03	11.64	17.39	250.54	713.16			3502.38		7.87	27.95	880.91		627.9	26.3				1.43		210.74			358.14	11.95	296.41			117.57	83	5.62		114.51	62.5		918.6	1472.72				1.43		225.07		43.29	16.64		37.05	8.82		8.24	15.68		194.5	552.62			3196.48	4.33		22.65	524.81		628.12	23.15				6.75		123.39			185.86	16.68	264.45		1003.41	143.43	83			116.74	74.19		908.04	1524.25						257.8		35.79	7.69		10.57	7.14		12.1	18.77	3.3	202.67	541.24			3176.53			19.53	514.72		619.47	20.23						144.13			180.47	15.52	254.64			137.31	107
SUB231307	Atopic	CSLRI	1.0	expected	32474	b	83	27.94		47.82	293.95		934.58	1935.72		5.39				344.77		22.15	9.67		6.75	11.75	519.84		7.54		134.1	838.78			1963.4	108.72		11.78	479.46		266.59					14.99		168.8				52.06	1203.79		244.52	35.25	83	26.72		47.82	311.21		873.99	1822.27				2.47		355.49		9.12	15.16		23.4	10.99	528.18		21.23		129.92	866.64			3111.21	109.01		13.32	519.77		240.27							172.22				51.84	1255.61		248.12	34.24	83	10.7		45.39	208.27		927.81	1628.13						286		27.63	7.52		16.67	15.21	502.19		14.44	1.93	196.1	1465.97			3999.55	81.38		11.44	415.54		259.26					10.02		151.05				77.17	1571.51		214.02	32.49	83			45.5	209.49		944.98	1744.68				16.67		288.06		11.64	1.27		35.91	16.24	541.31		35.19	2.61	209.28	1517.3			5001	89.55		10.6	510.31		250.43					6.75		193.85				74.62	1585.09		230.35	31.66	101
SUB231308	Atopic	CSLRI	1.0	expected	27858	b	84	7.54		69.3	134.53		637.4	1389.18				2.1		755.18		1.66	2.69		17.01				18.5		218.6	311.01			3333.34	21.45	0.54		530.16		676.09					17.59		273.32			26.08		263.43		567.37	23.28	84	21.45		57.91	119.62		683.08	1250.85						670.68		7.54			18.74				27.55	1.29	198.54	336.77			3290.15	7.96			575.5		644.41							269.29			20.48	8.81	297.59		553.91	20.97	84	9.19		62.27	114.27		690.57	1310.19				3.35		742.99		10.41			17.01				23.99	8.16	295.68	368.63			4032.18	18.13	5.24		652.86		689.17							299.76			16.27		193.08		585.22	6.64	84	18.5		62.98	112.13		826.58	1331.09						771.54		10.01			27.88		915.97		25.78	3.64	268.97	386.59			3570.77	4.51	6.37		668.63		693.38							288.38			20.14		200.94		584.34	4.63	101
SUB231309	Atopic	CSLRI	1.0	expected	34559	b	84	34.85		69.9	27.88		713.15	4844.15						87.99		64.29	5.56		12.93		334.95	23.69	12.4		225.96	303.78		819.06	6578	107.44	20.65	16.76	858.07		83.17	12.65				30.14		98.69					196.75		535.58	140.27	84	25.06		73.04	23.9		736.34	5008.81						81.46		57.3	11.11		2.1		351.94	26.12	25.42	5.24	227.38	299.65		725.69	5001	100.34	25.23	13.65	701.7		88.64	10.08				0.14		106.08					207.74		618.23	143.02	.m																																																		.m																																																		93
SUB231310	Atopic	CSLRI	1.0	expected	33851	b	95a	9.34		135.35	107.55			2275.38	9.61						5.07	45.9	48.55		97.27			7.57	12.58	14.13	242.59	479			3280.6	68.14	17.9	36.06	359.45			14.69	14.76			5.92						16.07	223.15				.m																																																		95a			124.99	139.15			2187.7	12.58			10.4				33.54	32.56		129.77			8.89	11.49		311.51	439.77			4075.15	75.54		46.4	471.49			16.86				8.61						12.1	220.61			5.15	.m																																																		172
SUB231311	Atopic	CSLRI	1.0	expected	38583	b	95a			153.47	21.03			702.74	12.58			13.07				49.38		7.58	31.56			10.52			541.78	561.44			3778.44	84.77		102.39	128.92			54.75		4.34								13.63	229.91			3.89	.m																																																		95a			172.41				592.02	10.41			29.81				47.06	31.65		28.94			11.26		4.34	760.13	679.34			4049.32	113.65		102.39	238.35			51.3									52.06	10.16	240.04			4.35	.m																																																		168
SUB231312	Atopic	CSLRI	1.0	expected	42301	b	95b		22.54	174.28	233.28			3477.49				9.51				103.98	231.71		31.56			25.5	14.21	65.94	161.22	564.77			3962.2	118.5	46.79	14.17	720.76			8.8	20							16.96		10.92	250.17			35.18	.m																																																		95b	16.41	19.76	160.4	295.65			3592.82	61.66	444.63		199.46				108.81	486.47		81.81			27.35		136.43	226.08	747.25			5601.6	109.41	1.17	9.96	678.51			5.39	29.84			36.8			4.67		2.25	12.94	491.51			19.91	.m																																																		161
SUB231313	Atopic	CSLRI	1.0	expected	36312	b	95a			353.45	66.29			1877.58	10.41			4.11				80	42.38		24.55			4.35			1006.26	524.83			4551.52	417.41	136.43	53.76	351.07			7.31								13.12	70.23	7.44	334.29			27.78	.m																																																		95a	10.41		425.6	62.84			2244.13								93.15	10.29		6.82			8.62	21.12		544.7	514.84			3105.18	414.83	124.88	49.74	495.67			12.95				14.85				13.94	14.13	7.67	486.5			14.49	.m																																																		170
SUB231314	Atopic	CSLRI	1.0	expected	35377	b	95b	12.3	37.93	108.44	260.28			2602.96								209.72	491.78	6.79	42.9			12.19	14.21	75.37	199.95	1901.41			3739.95	429.04	37.93	99.76	466.49			22.41									564.23	18.59	521.5			21.15	.m																																																		95b	16.41	8.34	107.69	236.66			2712.02				6.82			4.2	252.37	577.75		59.38			15.87	14.49	39.72	339.61	2414.87			4509.4	490.69	93.18	129.32	629.57			21.99							4.75	15.86	333.04	20.36	441.44			18.27	.m																																																		159
SUB231315	Atopic	CSLRI	1.0	expected	44169	b	97a			16.02				246.7	10.27								18.22		9.31			9.89	12.87		47.56	20.8			638.7	43.04		33.04	76.25													12.87	672.58			18.98	.m																																																		97a	24.55		13.29				241.89									5.56						22.02		56.64	77.84			602.04	41.99		31.42	85.7				11.76									10.1	510.5			11.05	.m																																																		161
SUB231316	Atopic	CSLRI	1.0	expected	44989	b	97a	57.03		125.18	129.17			1992.38				16.13				65.35	5.56		7.26			42.37	32.78		386.03	799.06			3356.5	98.23		13.81	370.22			13.16									68.92	151.93	535.69			20.22	.m																																																		97a	51.11		137.9	71.48			1846.41								66.04			2.92			20.22	68.11		370.34	748.64			3328.95	59.12		8.77	380.78			12.97									72.51	170.99	508.36			20.03	.m																																																		160
SUB231317	Atopic	CSLRI	1.0	expected	44281	b	97a	25.99		200.13	223.6			1595.16								33.14	6.54	7.2	51.15			14.17	57.73		345.37	1326.7			3090.35	480.53		53.47	341.67			32.66								9.14		17.68	1128.52				.m																																																		97a	61.89		283.6	453.83			2193.77								51.11		7.76	74.67			19.36	56.34		594.69	1579.83			3635.1	517		69.47	399.19			45.69				0.43				7.63		21.99	645.97				.m																																																		159
SUB231318	Atopic	CSLRI	1.0	expected	34895	b	97a	52.5	18.22	285.63	441.54			2427.07								275.73	8.91		34.19			24.2	74.66		584.83	1370.58			3014.5	462.73	52.46	63.19	814.77			76.14							6.72			15.25	458.99			11.33	.m																																																		97a	61.89		269.52	379.47			2391.28								249.98			14.23			13.06	57.38	83.14	618.54	1601.08			2938.9	465.6	11.21	50.67	601.14			70.35										23.93	403.12			11.6	.m																																																		149
SUB231319	Atopic	CSLRI	1.0	expected	32021	b	97a	54.25		368.7	208.83			2238.12								57.03						23.42	51.81		1047.39	1547.34			7843.55			31.2	376.83			37.02								20.2			240.34			231.08	.m																																																		97a	75.69		391.35	255.57			2837.52								64.66			5.15			24.11	61.89		1182.29	1572			6890.3			34.78	299.99			48.31										7.72	248.66			208.51	.m																																																		146
SUB231320	Atopic	CSLRI	1.0	expected	46446	b	97b	59.81		170.7	346.33			2537.17								79.81	34.9	5.93	61			9.89	74.31	36.86	298.3	1327.84			4691.4	438.85		172.54	378.15			165.19								28.86	71.79	35.16	712.57			767.32	.m																																																		97b	66.73		172.4	446.07			2626.28	23.82							88.36	65.67	8.42	49.48			12.24	68.8		490.35	863.52			4198.45	521.12		195.85	462.86			161.05				9.31				27.06	32.54	28.48	721.14			328.24	.m																																																		142
SUB231321	Atopic	CSLRI	1.0	expected	31567	b	103			183.66	481.69			1127.36								41.17	2173.41	14.01	90.01						542.57	3639.4			2995.61	63.05		298.17	278.36			71.84										23.75	889.33				.m																																																		103			109.38	263.89			686.25								67.88	2060.22	19.62	110.3					2.99	693	4315.09			4054.29	74.35		319.54	257.7			68.73									0.19	32.93	869.86				.m																																																		167
SUB231322	Atopic	CSLRI	1.0	expected	53722	b	106	8.14		913.92	2.31			1614.33								77.42		7.15	80.58						525.65	138.41			178.12	24.72		86.9	129.74													19.46	225.94				.m																																																		106	5.31		737.54	9.66			2118.59								68.71		7.88	63.04				14.63		1036.38	447.26			1900.57																						.m																																																		165
SUB231323	Atopic	CSLRI	1.0	expected	25137	b	106	5.49		226.98	1370.97			7094.35								132.37	170.87		55.78			14.99	5.49		188.09	2397.92			10817.85	9.02		13.5	264.11												12.59	17.06	428.74				.m																																																		106	12.18		181.34	1187.61			5755.4								142.04	185.25		68.21			22.35	3.88		300.27	3585.55			8686.95	5.84		15.59	265.12													22.42	430.8				.m																																																		145
SUB231324	Atopic	CSLRI	1.0	expected	61632	b	106	5.84		141.09	428.74			804.66								10.25	118.13	9.2	72.34				2.99	5.69	235.87	1515.43			3916.24	552.71	13.19	148.66	19.99			8.75									209.93	9.67	873.44				.m																																																		106	9.02		147.51	476.12			720.36															13.23	37.27	265.9	1687.26			4356.07	507.44	16.79	126.38	319.67			7.06									102.12	9.54	1076.93			6.49	.m																																																		144
SUB231325	Atopic	CSLRI	1.0	expected	33054	b	107	2.45		99.21	345.71			252.13								83.56	19.14	7.75	17.3					51.25	447	2698.63			3322.25	77.76	27.91	188.27	166.97												387.29	22.57	1152.53			15.3	.m																																																		107	4.95		80.76	359.01			179.9								75.54	29.47	8	14.59					94.21	403.86	3419.39			4107.25	34.55	17.21	194.81	91.35												547.43	18.04	1195.66			11.05	.m																																																		-220
SUB231326	Atopic	CSLRI	1.0	expected	66355	b	107		36.86	86.55	420.7			315.52								97.03	222.49							328.24	384.04	4137.83			3307.35	38.97	29.7	67.57	238.21					3.11							2131.2		935.27			6.91	.m																																																		107		29.7	89.52	444.26			375.95								95.8	249.11		33.53					131.95	213.45	2058.73			2440.95	44.52	50.8	63.02	254.59					12.78							1887.06		1307.31				.m																																																		-232
SUB231327	Atopic	CSLRI	1.0	expected	54754	b	115			463.68	56.32			350.77								137.65	83.14	10.97	141.47				13.69	0.98	824.17	987.33			2357.29	93.41	2.01	63.8	174.13							4.98						13.02	495.52			5.53	.m																																																		115			482.66	64.15			363.48				3.83				128.66	60.63	10.39	145.34				17.59		952.03	1040.52			2303.46	49.71		60.73	151.99													13.77	510.28				.m																																																		153
SUB231328	Atopic	CSLRI	1.0	expected	67927	b	114		6.25	655.25	147.11			1110.86	7.34							75.42	95.61	9.32	40.83			8.3		52.78	663.31	1879.77			2881.1	27.73	15.94	130.97	306.18			8.45		12.8						2.42	124.46	81.79	918.03			20.12	.m																																																		114		47.04	636.22	182.13			1089.03		5.67						131.93	56.11	8.01	49.05			10.19			877.02	2156.74			2760.05	23.97	21.06	131.98	204.72			14.16		7.93						2	97.48	81.79	1064.22			153.66	.m																																																		143
SUB231329	Atopic	CSLRI	1.0	expected	57365	b	107			106.61	841.8			6824.9		10.57						40.14	18.55		80.34			15.93		24.34	172.12	3657.93			7160.45		15.44	9.67	260.44					4.85							8.36		726.08			18.9	.m																																																		107			113.77	850.17			7115.5		17.21						36.18	2.24		69.33			14.76		6.16	150.62	3237.02			7738.15			8.37	230.02					15.44							26.57		1089.52			22.55	.m																																																		-229
SUB231330	Atopic	CSLRI	1.0	expected	65372	b	112		105.44	46.9	104.05			739.86		55.66		32.51					27.85		15.11			6.66		48.4	12.7	102.74			970.69	13.91	21.43		80.02			11.42		3.95													.m																																																		112		51.16	55.02	105.36			841.16		28.53		39.44				3.82	19.42					6.59		25.14	8.83	33.29			795.27	34.12	19.75		33.29			4.82		5.55													.m																																																		129
SUB231331	Atopic	CSLRI	1.0	expected	64738	b	112		0.22	55.21	33.29			1165.27		10.44						54.41	25.14		23.68			11.74		0.82	76.99	122.89			1381.92		9.78		69.03					6.2							473.82	10.42	1048.67				.m																																																		112			47.57	16.88			940.92								70.32	60.87		76.61			10.47		8.47	109.51	114.49			1659.01		10.11		104.05												1426.58	9.46	1049.91			5.35	.m																																																		124
SUB231332	Atopic	CSLRI	1.0	expected	67547	b	112			435.31	88.8			2580.25								176	11.43	9.03	67.64			24.32		8.8	431.62	221.73			984.96	194.36	15.07	67.36	113.84			16.27										62.03	676.89				.m																																																		112	172.54	4.59	8.65	82.73			18.3			599.64	324.71			1699.79	155.2		62.63	177.03			8.18										72.97	594.98				2.9		419.34	86.11			1779.05								.m																																																		120
SUB231333	Atopic	CSLRI	1.0	expected	81418	b	112			533.52	298.57			5068.1								377.51	227.72	10.17	11.44			5.76		22.44	916.08	2164.77			8487.3	26.8	9.13	87.25	295.59										5.89		69.23	119.38	376.77			19.38	.m																																																		112		21.77	509.87	280.08			4046.85								381.48	216.86	10.63	26.95				6.55	26.83	814.64	2092.13			9061.05	36.09	0.52	73.53	239.87					11.1							56.35	145.56	385.03			7.52	.m																																																		115
SUB231334	Atopic	CSLRI	1.0	expected	81821	b	112		12.42	501.47	159			2500.05								246.37	157.79	10.06	145.18			23.75	4.43	5.87	521.04	538.84			2453.85	54.68	15.74	28.41	277.09												18.41	158.22	354.32				.m																																																		112			524.54	113.19			2015.55								392.63	96.61	10.06	121.6			24.99	5.64	4.91	735.87	805.12			2219.4	82.58	10.11	25.98	197.35					3.31							6.2	29.63	720.45				.m																																																		113
SUB231335	Atopic	CSLRI	1.0	expected	82789	b	112			711.73	168.97			912.61								117.17	127.08	9.46	86.78			5.09		8.47	1598.01	1566.65			1488.86	29.34	18.74	181.41	476.95			13.29									8.47	189.05	354.32				.m																																																		112			735.87	157.13			645.44				8.54				128.72	130.64	8.76	97.46			10.78		15.74	1376.89	1446.63			1405.15	28.21	13.08	147.73	356.68			13.29		7.17							7.82	17.29	673.92				.m																																																		113
SUB231336	Atopic	CSLRI	1.0	expected	88876	b	112			416.14	120.31			1579.06		2.68						81.77	4.59	49.28	83.41			8.25	6.55		1118.32	563.64			2158.98	125.5	54.62	8.33	101.42																		.m																																																		.m																																																		.m																																																		116
SUB231337	Atopic	CSLRI	1.0	expected	82085	b	122	40.2		282.61	116.54			489.03								24.64			10.09				114.43	7.75	562.08	1211.1			2626.8	15.92		86.83	292.65			9.6				11.67					171.88	26.95	714.11			13.41	.m																																																		122		199.19	27.66	954.79			13.96		1.58						40.4	1.58	6.2	13.24				126.02	3.49	467.28	1304.86			3215.35	20.27	5.39	93.33	329.49			13.96									68.95	46.58	523.02			6.74	.m																																																		136
SUB231338	Atopic	CSLRI	1.0	expected	83757	b	125			140.72	288.79			842.56								125.35	69.25					8.18		102.55	543.19	1619.85			2812.56	226.09	61.87	339.12	275.99			68.48		5.59								123.09	1159.61			25.19	.m																																																		125			124.02	166.57			714.97								124.6	88.62		8.5			1.49		193.43	533.24	1586.17			3100.74	229.29	52.83	311.77	263.07			48.97									3.93	124.66	1125.58			25.19	.m																																																		149
SUB231339	Atopic	CSLRI	1.0	expected	81733	b	122	101.48		356.24	923.44			1654.28		1.58						90.57	7.27		65.83			9.49	146.69		654.2	1826.25			3577.23	379.01		96.5	220.68			14.7				5.29					73.09	236.35	564.39				.m																																																		122	75.16		340.16	852.55			1407.22								81.47	16.65		45.89			9.77	136.85		729.02	1917.64			3002.71	439.75		110.82	179.15			20.82				6.9					118.94	159.93	672.68				.m																																																		130
SUB231340	Atopic	CSLRI	1.0	expected	81997	b	125			585.87	41.68			366.84				73.87						997.39	277.6			214.97	309.11	384.8	63.65	444.79				122.84		685.24	164.78			1.24									267.48	172.58	449.97			8.72	.m																																																		125			578.11	32.7			372.71			4.74	17						780.15	275.99			167.15	274.04	397.34	66.98	439.6				141.44	6.12	732.36	131.81			8.72									286.56	168.62	467.64				.m																																																		150
SUB231341	Atopic	CSLRI	1.0	expected	81909	b	125			222.37	558.3			1441.37								486.54	2067.05	51.22	443.31			124.37	4.62	17.26	658.94	4608.38			4271.48	304.66	34.75	208.33	435.15			60.17				4.43					41.17	12.87	1372.03			3.93	.m																																																		125			264.46	687.85			1639.96								503.84	1399.45	43.97	394			114.12	21.15	13.09	609.81	5198.8			4746.79	266.63	70.71	210.73	429.95			43.45									29.81	13	988.59			16.4	.m																																																		146
SUB231342	Atopic	CSLRI	1.0	expected	96695	b	125			210.84	102.82			2503.59								385.97	55.11		53.71			56.83			427.2	443.31			4078.2	33.66		5.47	421.01							36.61						6.4	182.46			137.19	.m																																																		125			246.98	97.81			2657.86								383.1	36.37		82.38			53.33			480.06	488.88			4004.9	40.2		6.4	403.03													7.06	199.78			98.29	.m																																																		144
SUB231343	Atopic	CSLRI	1.0	expected	101829	b	125		33.93	144.75	1791.86			2731.36				67.32				436.99	173.84	14.18	191.16			49.8		58.13	821.66	5597.62			3216.05		27.72	87.87	606.8			85.71			9.36	71.7				27.45	128.62	34.75	2589.78			102.27	.m																																																		125		52.83	150.42	1739.89			3026.64				60.61			7.99	455.11	171.29	12.15	211.72			44.84	11.66	41.17	632.23	5187.52			3329.65		12.62	91.19	586.89			85.08			6.27	13.77				44.81	223.52	36.91	3039.72			111.17	.m																																																		136
SUB231344	Atopic	CSLRI	1.0	expected	101484	b	125			166.59	103.81			522.19								34.37			23.02						749.44	1468.99			4128.24			133.93	161.19			54.14										293.53	2122.1			39.23	.m																																																		125	7.25		173.52	113.65			491.69								22.38			46.58				5.32	0.81	670.65	1199.07			4043.81			107.64	325.04			67.17									11.18	288.16	1824.51			83.93	.m																																																		136
SUB231345	Atopic	CSLRI	1.0	expected	83405	b	125			232.37	288.79			1751.99								249.27			35.32			0.98	10.62		311.89	788.75			3062.3	27.45		61.05	299.91			23.51									326.55	30.04	299.91			31.16	.m																																																		125		5.04	211.49	332.82			1487.79								245.65									331.52	965.36			3751.54	51.79		61.83	395.51			20.87									160.38	33.17	390.98			24.27	.m																																																		132
SUB231346	Atopic	CSLRI	1.0	expected	104576	b	125			112.33	323.48			720.75				39.17				302.65	64.46	10.76	53.71			13.09	7.25	16.8	533.02	3400.63			2755.7	58.81	10.2	153.88	472.78			56.3									274.66	58.54	1078.6			73.03	.m																																																		125			117.16	321.92			852.85								294.18	81.53	8.77	104.81			9.26	7.25	32.29	585.72	4192.26			3613.3	76.73		198.58	211.72			67.95									95.63	81.65	710.93			8.9	.m																																																		134
SUB231347	Atopic	CSLRI	1.0	expected	106879	b	129	27.22	14.06	95.53	236.19			546.2								70.05	351.42		31.71			8.15	43.09	219.28	256.71	1334.95			1321.72	38.45	45.08	16.81	274.74			11.02		12.36		36.46					763.36		1320.15			15.17	.m																																																		129	28.57	20.44	109.27	174.64			543.5		9.58						86.73	183.99		20.75			13.04	44.64	792.7	266.55	1686.99			1845.55	35.37	38.76	16.44	193.61					11.24		15.99					989		1516.14			18.93	.m																																																		134
SUB231348	Atopic	CSLRI	1.0	expected	106314	b	129	40.85	25.52	201.4	561.54			1537.83								179.32	86.6	23.86	29.84			14.98	52.27	49.23	554.24	3065.73			2460		24.61	125.71	306.18			13.53			8.95					19.16	71.48	118.12	1470.1			38.74	.m																																																		129	35.37	27.03	147.62	559.37			1255.67		11.8		21.64				178.34	98.19	25.02	51.77			20.94	50.18	51.49	509.91	2718.47			2719	15.66	15.78	149.88	306.18			12.85			9.56					20.16	89.65	122.19	1216.42			41	.m																																																		130
SUB231349	Atopic	CSLRI	1.0	expected	96917	b	129	24.86		89.52	109.97			662.5								69.16	13.49	17.8	42.78			31.43	39.48	46.35	276.2	1199.39			2305.59		21.03	50.24	261.79			25.53		24.01						12.5	622.47	34.18	926.66			47.39	.m																																																		129	19.49		84.88	113.38			591.1				22.53				96.18	545.86	15.48	41.31			22.84	37.76	57.32	312.85	1353.08			2574.14	19.16	27.63	61.4	274.74			24.76		14.06							273.22	51.68	544.22			9.31	.m																																																		133
SUB231350	Atopic	CSLRI	1.0	expected	105047	b	129	42.92		79.46	308.16			3029.36		10.41		17.7				104.06	22.22		91.53			87.62	50.36	9.04	94.01	822.37			4551	29.25	18.1	10.63	273.44			16.9								15.49	35.32		255.35			13.04	.m																																																		129	40.16	16.36	82.12	283.2			3026.55	12.17	12.93		22.53				77.01	27.63		53.29			71.24	56.12	18.1	205.82	1722.85			2369	34.35	22.22	11	65.69			12.24		8.49	9.56	22.53					28.24	8.22	292.36			8.21	.m																																																		126
SUB231351	Atopic	CSLRI	1.0	expected	104018	b	129	29.59	20.44	192.93	123.12			831.51	14.49			16.41				29.42	42.54		31.24			14.54	38.62	70.48	544.61	1090.8			2576.52	34	19.85	139.4	290.4			52.83		9.04		23.42					77.83	52.25	390.98			17.56	.m																																																		129	26.88	33.15	211.91	150.62			982.27	12.5			21.64				34.86	42.22		31.71			11.63	39.13	59.6	456.66	990.1			2074.52	26.88	22.22	109.27	247.66			53.78				27.98				13.83	176.72	69.32	384.14			28.35	.m																																																		134
SUB231352	Atopic	CSLRI	1.0	expected	83053	b	129	31.62		645.59	188.08			1117.31								137.87	20.44	28.59	137.06			12.18		12.93	53.97	37.42			28.92			323.17	60.47			26.86		12.93		15.56						100.58	790.31			7.81	.m																																																		129	32.47	14.63	853.43	248.3			1626.81								173.26	19.85	31.53	155.98			17.03	22.34		284.39	74.16			180.73	12.17		312.18	49.25			23.94			8.62	23.42						91.01	584.75				.m																																																		120
SUB231353	Atopic	CSLRI	1.0	expected	83229	b	129	13.66	397.46	24.15	204.76			123.84		101.97		65.69			16.97	15.82	283.08	11.21	55.84			52.03	15.49	568.17	22.44	198.55			146.78	173.45	381.01	23.7	443.53			78.11		557.21		51.26			9.31		613.45		123.12			10.43	.m																																																		129	17.99	697.53	26.15	209.74			128.35		143.65		87.13			25.67	14.49	1029.02	14.44	83.32			90.25	19.49	330.54	16.86	175.25			115.85	121.49	419.5	25.83	619.82			66.32															.m																																																		120
SUB231354	Atopic	CSLRI	1.0	expected	103106	b	129	27.56	19.27	210.22	1119.61			1022.57	17.15	21.03						65.09	120.71		65.69			8.04	27.05		61.83	352.24			450.67	25.53	15.2	21.35	152.4			10.49		18.68		27.06					17.51	40.82	434.48				.m																																																		129	32.98	12.08	229.66	1207.49			1165.98		8.76						73.97	109.22		58.41			11.87	26.54	17.51	78.74	444.93			839.45	27.9	12.08	19.71	145.29			9.31	14.33	15.2		31.71					28.55	51.59	792.6			10.01	.m																																																		120
SUB231355	Atopic	CSLRI	1.0	expected	83669	b	130			265.01	249.91			609.33								195.9	1775.82	39.64	74.65			43.03	22.38	25.28	267.74	977.29			1163.14	27.48	29.83	184.96	475.95			60.25									1023.54	17.78	892.52			22.92	.m																																																		130			263.59	284.34			584.67								179.23	2417.25	33.09	114.05			38.4	18.6	79.6	415.97	1461.49			1398.54	40.81	40.98	193.36	521.29			68.45															.m																																																		121
SUB231356	Atopic	CSLRI	1.0	expected	97479	b	129	24.86	20.44	45.62	122.54			411.42		13.49		15.99				89.45	353.36	19.66	52.78			19.47	22.67	22.22	23.96	95.4			279.9	20.33	15.78	100.89	352.91			45.45		12.36		28.91					1575.98	19.28	484.29			27.85	.m																																																		129	16.82		39.84	72.03			340.87		16.36						77.55	280.04	18.5	60.47			16	20.83	28.24	43.88	270.2			493.06		31.92	93.34	331.43			42.53															.m																																																		120
SUB231357	Atopic	CSLRI	1.0	expected	92586	b	129	72.19	26.72	147	80.07			1425.87																																											.m																																																		.m																																																		.m																																																		114
SUB231358	Atopic	CSLRI	1.0	expected	82525	b	144	1.22		85.3	44.7			416			4.3	17.3				126	30.4	19.6	96.4			14.1	5.06		117	244			265	16.4		33.3	158				1.01		1.75	14.6			6.59			13.7	528			9.2	.m																																																		144	4.13		58.7	59.2			425			1.75				1.62	151	18.6	15.1	66.3			12.2	2.63		212	347			342	12.2		33.9	339			2.66			1.64				6.68			10.9	426			6.59	.m																																																		202
SUB231359	Atopic	CSLRI	1.0	expected	94437	b	144	2.9	9.29	1060	837			2440	2.9		2.8				1.48	2710	153	100	420			661	5.74		365	2380			3580	12.6	2.48	472	224			24.2			12.1	3.2						36.2	929			5.1	.m																																																		144	2.35	4.08	947	938			2410			3.55					2610	129	129	323			523	6.62	2.38	260	2570			3640	18.1		449	216			20			11.3							30.3	916			5.59	.m																																																		200
SUB231360	Atopic	CSLRI	1.0	expected	82173	b	129	34	61.9	196.38	365.08			1072.25	18.99	27.33		49.25			7.93	52.1	235.64		49.25			9.77	46.02	483.88	258.94	1378.68			2234.98	34	100.94	51.87	274.74			17.03		27.63						12.5	112.69	74.43	470.17			38.81	.m																																																		129	29.93	55.04	181.14	382.09			865.74		17.51		35.03			8.61	45.5	295.26		38.39			7.76	54.02	594.65	356.48	2008.41			3284.79	29.25	92.03	39.22	209.74			16															.m																																																		119
SUB231361	Atopic	CSLRI	1.0	expected	82965	b	144	3.15		411	388			2840			2.85				1.68	550	10.2	37.8	215			17			91.7	206			724	35		141	44.7			6.31	5.29	1.64	8.18	29.5			1.55	8.56	3.03	217	665			3.9	.m																																																		144	1.41		445	330			2490			4.05					536	3.82	30.5	169			17.2	5.06		196	409			1510	48.9		121	58.6			6.02															.m																																																		197
SUB231362	Atopic	CSLRI	1.0	expected	98042	b	144	5.18		247	260			500			2.39					160	68.9	25.9	248			11.3	6.18		1120	2560			2380	11.6	2.28	217	109			14.3			5					3.89		48.9	1100			8.88	.m																																																		144	3.41		212	277			527			3					175	111	32.7	280			15.4	3.28		1150	2870			2020	18.7		221	105			13.8			4.75	5.28						82.8	816			3.74	.m																																																		194
SUB231363	Atopic	CSLRI	1.0	expected	102884	b	144	5.29		133	113			414			4.15	16.6				6.18		8.44	11.7			5.44																													.m																																																		.m																																																		.m																																																		196
SUB231364	Atopic	CSLRI	1.0	expected	119576	b	144			301	340			570	2.35		3.1	9.47			3.48	868	210	52.2	89.1			67.4	7.92	39.4	802	3290			9220	35.9	61.5	207	288			144			7.92					3.15		28.1	989			20	.m																																																		144	4.83		282	315			569			2.49					621	133	35.4	48.4			66.3	2.63	49.3	1080	3740			11200	14.2		153	314			68.4			7.92	6.2						28.6	1170			21	.m																																																		186
SUB231365	Atopic	CSLRI	1.0	expected	113573	b	144			398	210			207			2.59				3.22	174	177	56.6	149			51	9.1		356	977			1040	42.8	4.87	208	292			72.8	2.21		6.76	4.71			2.55	6.07	46.4	25.7	850			28.7	.m																																																		144			439	214			206			1.58				2.01	154	249	53.2	176			39	7.92		358	1010			1310	37.6	7.16	238	340			105	3.53		6.96	21.5			4.21	7.49	66.4	23.7	868			31.5	.m																																																		178
SUB231366	Atopic	CSLRI	1.0	expected	102738	b	146	150	13.4	301	305			1800				16				87.8	12.6	17.8	79.3			28.1	138		226	967			1290	38.7		186	228			12.8			8.43	13				25.6	67.3	62	2990			478	.m																																																		146	139	12.4	245	346			2680				14				121	29	16.6	103			26.8	133	4.77	262	807			1460	29.5	4.23	173	231			12.3			12.5	25.9				18.1	15.7	74.7	1880			175	.m																																																		188
SUB231367	Atopic	CSLRI	1.0	expected	100909	b	145	102		109	374			641			3.77	88.9			26	155	42.3	43	196			128	132	40.6	543	3110			1510	5.88	1.16	173	141			89.9			11.9	100			7		61.8		5900			4.88	.m																																																		145	93.1	4.93	164	342			691		2.28	7.37	103			26.8	176	67.8	51.3	219			140	126	43.8	502	2870			1720		2.68	149	141			90.7	38.8	5.77	15.3	4720			759		58.9	2.74	12100			2.64	.m																																																		184
SUB231368	Atopic	CSLRI	1.0	expected	105960	b	144	8.24		274	133			943	4.01		5.4	45				68.3	3.68	36.8	86.4			44.6	10.8	1.26	86.5	215			1240	32.6	5.37	173	58.2			70	7.6	2.79	8.18	53.4			5.39	7.49	45.2	15.4	636			16.2	.m																																																		144	6.29		198	138			899	5.85		5.75	24.1			3.64	63.4	6.44	40.2	64.2			45.9	10.4	2.61	419	720			3030	33.8	1.8	208	169			108	3.03		5.35	37.7			4	4.01	16.9	14.2	700			12.3	.m																																																		176
SUB231369	Atopic	CSLRI	1.0	expected	97368	b	146	42.4		63.9	114			619				13				28.8	679	66.3	205			55.4	93.7	83.1	92.6	732			1830	14.1	13	145	233			48.9				7.78											.m																																																		146	39.2		47	119			516				9.38				35.3	1070	88.5	161			65.9	106	134	96	776			2300	12.6	10.3	172	217			50.3									98.5	59.4	644			10	.m																																																		183
SUB231370	Atopic	CSLRI	1.0	expected	123586	b	146	102		258	106			1960	1.93			19.5				20.6		4.92	36.2			10.5	63.7		212	180			1130	149		229	193			27.5			6.45												.m																																																		146	86.4		229	63.8			1660				24.9				18.1		9.53	38.7			10.9	35.5		81.3	101			451	123		187	167			22.3										55.6	281			5.39	.m																																																		177
SUB231371	Atopic	CSLRI	1.0	expected	124068	b	146	85.7	10.1	395	653			2010				15				236	184	30.4	190			45.7	162	11.1	300	3150			1060	12.9	2.49	175	153			35.2															.m																																																		146	86.8	11.1	257	659			1660				24.9				203	205	29	196			37	155	15	1340	2920			1240	13.3	3.36	313	163			39.7				5.54						58.7	881			13.6	.m																																																		176
SUB231372	Atopic	CSLRI	1.0	expected	113013	b	156	36.2	18.8	275	386			1470								152	827	7.68	168			43.9	51.9	16.7	305	1310			5250	3.38		93.2	49.8			59.9				28.5				5.58	168	19.3	1960			144	.m																																																		156	45.2	45.5	255	369			1410							1.83	141	786	7.65	188			33.3	39.6	55.1	608	1920			3210	14.1	56.7	86.4	206			66.3								3.64	45.5	19.3	2450			59.3	.m																																																		237
SUB231373	Atopic	CSLRI	1.0	expected	127278	b	146	92.4		290	317			1900				12				44.1	74.3	28.7	119			78	140	48.8	462	1620			1030	14.2		48.5	193			87.5				4.95											.m																																																		146	83.3		300	345			1710				5.54				58	48.7	21.9	102			79.1	132	22.1	421	1410			1280	12.2		53.2	258			94.3									321	5.78	1780			39.1	.m																																																		172
SUB231374	Atopic	CSLRI	1.0	expected	107455	b	156	32.3		83.4	131			307								8.02			11.2			8.35	28		69.2	97.9			1760	27.2	72.7	105	209			68.8		1.45						1.15	161	4.91	525			24	.m																																																		156	30.8		79.4	76.3			266				12.7				17.1						13	26.9		67.2	76.3			1330	4.6		81.8	518			99.9								2.35	108	3.21	531			31.2	.m																																																		232
SUB231375	Atopic	CSLRI	1.0	expected	109636	b	157	66.5	37.3	39.1	538			749	4.29	11.7		34.2				14.8	186		58.4			11.6	54.6	12.9	7.92	196			657	29.5	12.1	32.4	79			53.7		12.9		28.9				8.92	593	6.37	2160			42.1	.m																																																		157	64.2	29	41	555			615		8.87		29.4				24.9	71.5		64.8			11.1	42.9	25.2	11	160			512	24.3	27.9	25.3	423			48.3	5.31	26		50.8			1.31	9.29	773	7.89	1960			38.6	.m																																																		236
SUB231376	Atopic	CSLRI	1.0	expected	127542	b	165	1.32		191	42			1140		18.3						39.1	39.4	13.5	108			6.35	1.57	9.27	202	104			433	23.6	8.01	45.9	63			2.86		7.41		10.6			2.94		6.22	82.2	202				.m																																																		165	2.89	3.02	194	34.6			1080		9.27						30.9	17.6	10	120			1.47		4.03	52.5	15.7			95.4	31.7	3.51	58.5	96.3			1.13		5.1								99.7	173				.m																																																		273
SUB231377	Atopic	CSLRI	1.0	expected	122244	b	165	6.73	22.1	100	453			1510		6.81						92.3	69.8	1.59	51.4			1.72	6.73	77.6	251	3910			2310	26.9	22.1	37.5	218			42.9		5.1		4.75					25.2	6.52	705			16.6	.m																																																		165	2.46	50.1	110	522			1490		6.22		17.1				110	112		39.7			5.32	7.2	160	265	4380			2530	44	34.3	32.1	209			32.9		7.41							34.3	6.81	949			22.4	.m																																																		268
SUB231378	Atopic	CSLRI	1.0	expected	135111	b	165		8.01	147	127			513		1.63		3.26				20.8			1.36				2.02	16.1	92.7	236			674		7.11	20.8	13.3			10.2		5.1							92.4	31.8	1790			29.3	.m																																																		165		8.01	145	125			452		2.54						15.4	4.29						3.11	17.6	108	418			833	3.11	13.6	14.8	23.7			8.48		2.08						1.68	164	29.3	1510			37.3	.m																																																		267
SUB231379	Atopic	CSLRI	1.0	expected	141940	b	165	6.96	75.6	388	880			476		7.11						601	3550	46.2	225			106	9.93	6.81	64.5	716			1130	78.6	15.7	146	136			38		1.85		7.97					10.6	18.3	864			9.98	.m																																																		165		35.1	507	908			504								486	4040	45.8	218			88.7	11	9.91	69	781			809	90.4	13.6	166	100			54.4		9.27							21.3	21.4	790			8.38	.m																																																		260
SUB231380	Atopic	CSLRI	1.0	expected	83933	b	157	78.2	53.8	310	669			377	1.89	18.3		14.5				218	185	12.9	86.8			15.8	57.5	19.1	345	819			796	19.8	25.2	298	186			31.6		11.3		53.3				5.82	45.4	35.9	814			10.2	.m																																																		157	69.3	35	363	548			395	1.59	8.87		44.6				190	147	8.97	77			13.9	102	29	305	1820			428	12.5	38.4	226	227			34.4	1.19	12.9		21.2				1.43	31.3	43.5	797			4.38	.m																																																		213
SUB231381	Atopic	CSLRI	1.0	expected	148430	b	165									3.51						94.4	414	11.3	327			13.3	12.2	5.37	153	246			492	164	17.6	134	234			101		6.51	1.41	14				2.28	29.7	12.4	1770			39.1	.m																																																		165											7.14				103	359	8.98	262			18.7	10.3	8.01	209	350			1160	117	18.3	114	156			79.3	4.6	11.2		15.4			2.44	3.38	93.4	13.4	2620			45.4	.m																																																		258
SUB231382	Atopic	CSLRI	1.0	expected	132891	b	165	8.14	2.54	300	206			1330		4.03						113	15.4	1.04	7.97			42.3	8.73	4.55	293	500			638		6.22	64.1	131			10.4		5.1	7.7						8.01	43.3	198			1.56	.m																																																		165	9.57		321	245			1390		3.77						112	14		22.7			21.6	7.9	11.9	470	762			1150	1.8	8.01	72	138			14.3		13.6	6.34						8.63	35.1	330			1.72	.m																																																		254
SUB231383	Atopic	CSLRI	1.0	expected	107566	b	167	25	24.2	15.9	219			343		24.6		10.8				47.9	1510	11.5	334			18.6	51.8	30.1	40.5	416			1070	205	87.2	183	155			101	9.49	25.7		30.6				9.78	110	4.8	359			15.8	.m																																																		167	20.3	31.6	18.4	222			312	5.71	26.9		9.5			6.38	36.6	1320	5.09	257			15.5	49	50.2	34.8	402			886	217	122	184	196			130		11		33.6			3.36	2.36	116	7.13	461			25.3	.m																																																		253
SUB231384	Atopic	CSLRI	1.0	expected	118604	b	166	23.2	19.2	298	142			1360		19.7		19.3					44.2		73.7			1.79	12.9	15.6	139	149			881	42.8	26.3	138	81.7			7.31		11.7		19.8					14.3	45.3	145			2.61	.m																																																		166	18.3	12.6	210	156			1210		17		22.7				1.65	22.5		73.2				21.3	13.5	112	163			1180	59.4	28.2	125	87.5			13.4		14.3		23.2					17.9	39.8	187			3.37	.m																																																		252
SUB231385	Atopic	CSLRI	1.0	expected	146641	b	166	27		525	89.5			460								262	98.6	2.81	69.6			1.87	40.9	11.3	389	1180			486	58.6	25.8	26.7	16.4			8.49									2.32	5.18	692			4.15	.m																																																		166	28.9		554	122			438								253	98	2.21	110			1.12	34.3		478	1420			577	43.1	26.3	23.2	39.4			12.3		6.9								5.75	610			1.87	.m																																																		249
SUB231386	Atopic	CSLRI	1.0	expected	138892	b	166	12		173	90.7			847		1.41						55.3	19.2	26.5	19.9				24.3	2.01	73.7	719			348		5.03	199	109			16.8		2.32							79	1.6	567				.m																																																		166	8.32		165	106			753		5.77						46.7	41.7	25.3	4.85			2.39	28		100	857			350		1.09	130	95.8			12.6		10.1		1.1					45.8	1.28	377				.m																																																		247
SUB231387	Atopic	CSLRI	1.0	expected	139339	b	166	32.4	1.71	177	85.1			468		13		1.1				24.3	12.6	7.6	31.7				62.3	13.9	160	525			1700		6.52	31.3	4.45					8.07								4.65	461			7.31	.m																																																		166	31.6	4.32	228	117			654		20.6		1.83				27.1	3.63	8.24	33.9			1.32	50.4	5.4	122	321			1220		10.5	54.5	29.6												8.86	5.09	485				.m																																																		245
SUB231388	Atopic	CSLRI	1.0	expected	82701	b	166	22.8	41.7	260	848			1550		4.68		6.48				112	850	6.63	54.1				56.7	54.2	293	2260			1410	29.6	150	237	214			3.21		12.6		4.45					1080	2.07	1420			16.1	.m																																																		166	17.5	13.9	204	808			1160		21.1						104	329	4.45	39.4				58.3	26.8	262	3250			1400	32	180	227	209			1.94		23.4		17.4					534	2.32	1030			30.5	.m																																																		242
SUB231389	Atopic	CSLRI	1.0	expected	125311	b	166	6.93	2.97	101	169			552		1.09		4.85				15.2	12.6		15.5				44.5	18.3	135	744			587	31.6	11.7	44.2	33.3					11.3		13.6					985	3.54	373			7.31	.m																																																		166	5.08	5.03	94.2	186			537								12.3	13	1.22	25.4				46.3	6.52	156	670			490	25.1	29.7	38.9	48.4					4.68		9.05					1280	2.69	562			12.3	.m																																																		240
SUB231390	Atopic	CSLRI	1.0	expected	109864	b	168	19.1	2.3	178	242			456				44.8				38.5	696	35	115			29.4	57		83.1	450			1300	4		137	275			44.4		2.3		10.8					82.6	3.47	727			9.18	.m																																																		168	13		181	177			444								39.9	929	34.2	134			29.5	58.3		60.9	460			1180	7.66		174	198			45				7.06					70.7	5.97	1000			9.7	.m																																																		245
SUB231391	Atopic	CSLRI	1.0	expected	123729	b	168	115		78.5	98			1330								130	2.67	3.63	8.3			18.5	22.1		9.65	3.44			598			33.4	342													22.4	409			6.12	.m																																																		168	146		90.6	116			1590								108		2.82				5.34	19.1		7.38	15.3			494			26.7	181							1.15						14.8	249				.m																																																		244
SUB231392	Atopic	CSLRI	1.0	expected	127389	b	182			176	427			1340		7.75		16				260	1560	37.3	20.4			9.5	4.3	16.4	226	1230			3430	12.3	51.3	154	776			18.8		2.02		26.2					153	7.75	1310			27.7	.m																																																		182		18.7	156	389			1250								256	1290	34.9	49.9			29.3	1.3	23.9	245	1270			4000	25.2	55.1	152	665			8.06		7.75		56.1					71.4	9.77	1230			25.6	.m																																																		311
SUB231393	Atopic	CSLRI	1.0	expected	82877	b	168	83.1	49.1	172	193			1570				7.06				316	272	2.82				30.6	22.3		32.7	50.5			508	12.3	30.6	71.3	280			26.7		2.3		14.7					452	38.1	127			9.52	.m																																																		168	48.6	23.3	135	137			1330				11.5				190	210	1.99	2.27			22	58.6		101	115			1410	10.1	34.2	63	285			29.6		5.99		5.23					662	28.2	175			21.1	.m																																																		244
SUB231394	Atopic	CSLRI	1.0	expected	157514	b	182	3.05	31.4	660	1700			1300		4.6		40.2				186	678	15.2	240				1.74	104	778	5860				16.8	29.6	176	507			21.6		7.16		16					134	42.3	2160			69.8	.m																																																		182	1.74	21.1	596	1700			1400		19.1		49.9				213	574	18.1	301				8.07	433	784	5890				7.97	52.8	164	803			48.4		5.15		32.5					158	121	1920			139	.m																																																		307
SUB231395	Atopic	CSLRI	1.0	expected	213759	b	182	4.21	11.5	356	389			2730	1.74			24.7				88.4	59	18.8	114			10.5	2.82		155	564			1530	13.3	26.8	487	411			77.1		6.86	2.33						12.1	11.4	1830			6.4	.m																																																		182	1.13	6.86	313	355			2350		4.06		20.4				105	181	33.1	140			9.5	3.5	6	278	1340			2710	8.54	28.9	525	336			101		1.54	2.02	30.4					10.5	12.4	1540			22.2	.m																																																		303
SUB231396	Atopic	CSLRI	1.0	expected	162984	b	182		3.01	187	250			974								71.3	415	183	127			44.4	3.12	17	68.6	341			1220	134	97.7	376	946			252		21.8		30.4					38.4		538			6.4	.m																																																		182		30.7	145	217			815		2.51		36.8			9.26	61.3	401	181	93			37.8		17.7	107	547			1500	178	110	435	798			260		32.5		33.9					39.5	1.35	528				.m																																																		304
SUB231397	Atopic	CSLRI	1.0	expected	154003	b	182	7.05	13.4	264	468			1120		6.28		31.1				50	39.9	25	131			13.4		5.15	146	968			2760	5.29	19.1	432	231			1090		15.7		24.7					66	8.85	3550			76	.m																																																		182			277	432			981		5.15		42.3				77.3	143	33.5	141			36.4	1.88	4.87	184	782			1040		31.8	453	269			160		7.45		29					120	7.56	4070			80.9	.m																																																		300
SUB231398	Atopic	CSLRI	1.0	expected	226351	b	182	1.45	6.86	388	416			1600		4.6		11.5				325	856	30.8	142			102	5.12	13.1	673	1050			2690	19	90.9	360	412			324		3.79		27.6					171	18.6	1530			340	.m																																																		182	3.5	26	360	376			2120		14		21.8				266	763	26.7	146			87.9	2.02	9.88	596	1310			2490	23.7	119	381	323			325		11.8							168	12.1	1520			274	.m																																																		300
SUB231399	Atopic	CSLRI	1.0	expected	210882	b	188	6.77		556	177			2790								31.4	10.9					10.6	7.89	1.32	716	1300			5420	1.79		46.3	210			5.9							1.5		2.31	55.9	1160			33.2	.m																																																		188	7.11		532	186			2820		1.56					2.71	36.3	2.53					3.31	10.9		912	1720			5410			40.6	165			4.89										40.7	768			10	.m																																																		342
SUB231400	Atopic	CSLRI	1.0	expected	210757	b	188	1.79	13.5	43	506			685								21.5	245	6.29	64			11.5	5.34	30.7	140	1430			2220	20.8	1.45	71	294			18.6									59.8	5.66	480			31.5	.m																																																		188		16.7	40.3	430			618								23.8	370	8.29	60.1			19.1	5.84	28.1	113	1270			2010	18.4	5.15	70.9	397			19.8									169	7.01	383			20.7	.m																																																		336
SUB231401	Atopic	CSLRI	1.0	expected	227564	b	192	9.06	2.69	187	126			824	5.6	4.76		13.7			7.69	50.2	10.7	5.17	56.1			17.8	18.9	7.16	294	295			1870	10.5	13.6	46.3	1180			30.4	5.78	5.41		11			5.35	4.56	12.9	3.79	382			12.6	.m																																																		192	7.57	6.24	171	126			758	3.73	7.16		17.7			4.95	48.6	28	7.63	68.8			32.8	20.8	7.72	358	325			2580	9.06	13.3	46.9	1290			26.5	1.19	10.8					2.07	2.13	12.5	4.53	320			4.56	.m																																																		346
SUB231402	Atopic	CSLRI	1.0	expected	169181	b	192	9.81	5.51	375	124			615	3.56	9		28.6			3.92	315	68	21.7	108			40.6	13.2	7.35	227	387			1220	22.7	8.18	227	821			99.6	2.91	5.87		32.9			1.43	2.28	9.37	11.8	883			4.17	.m																																																		192	9.34	6.61	366	130			612	3.56	7.81		35.7			2.19	319	94.4	20.5	128			41.6	16	4.3	528	869			1630	18.1	10.5	217	827			97.5	1.28	7.53		19			4.17	1.19	9	10.2	761			6.85	.m																																																		343
SUB231403	Atopic	CSLRI	1.0	expected	172621	b	192	23	2000	142				5230	3.81	7.99		37.1			9.42	320	686	26.3	128			68.2	21.9	2600	341	12600				17.1	36.1	126	1060			43.4	3.07	7.07		7.08			3.16	5.6	1330	3.43				176	.m																																																		192	18	2360	140				4890	2.59	244		74.1			44.4	320	620	22.9	68.8			49.2	27.2	2510	237	11300				20.8	37.6	118	1130			37.3	5.69	10.5		45.8			4.56	5.6	1600	3.39				160	.m																																																		340
SUB231404	Atopic	CSLRI	1.0	expected	135574	b	192	4.74	7.53	378	111			620	2.52	7.9		20.4			6.99	341	100	22.5	127			39.9	13.9	5.32	491	878			1560	17.1	7.9	203	898			93	3.15	7.53		21.1			1.43	3.97	6.8	11.3	808			4.69	.m																																																		192	15.6	134	1140	713			2580	3.89	8.64		30				416	694	140	392			80.6	17.2	10.3	274	1170			2180	11.4	17	694	1040			91.5	2.05	5.69	3.23	28.6				4.56	8.82	52.6	1510			4.95	.m																																																		341
SUB231405	Atopic	CSLRI	1.0	expected	248417	b	192	9.9	9.37	151	147			326	4.23	9.92		16.3				60.6	158	8.86	116			11.8	12.3	8.36	127	679			897	71.8	19.3	88.4	1210			11	5.08	9.74		46.5			5.89	4.56	8.08		20.4			11.4	.m																																																		192	5.34	7.9	139	127			361	5.43	7.53		17.7			5.89	45.6	157	7.15	91.7			5.62	9.43	9	44.6	232			263	71.3	17.4	91.3	1410			16	6.49	6.89		15			2.31	3.56	9.74	29.6	689			12.4	.m																																																		329
SUB231406	Atopic	CSLRI	1.0	expected	240545	b	191	3.46	3.02	194	784			1440				1.09				378	112	18.8	47.7			6.48	3.41	1.16	134	1220			1520	6.4	1.9	117	624							1.54					134	20.5	2980			14	.m																																																		191	2.92	2.48	186	853			1350								320	28.4	12.5	48.1				4.97	7.1	355	2530			2380	7.21	3.07	109	484												112	14.6	3470			14.8	.m																																																		322
SUB231407	Atopic	CSLRI	1.0	expected	220834	b	192	11	12.8	255	1020			1960	4.39	5.87		38.6			2.67	261	15.7	2.96	71.1			11.7	21	20.6	207				543	9.81	14.9	73.5	1010			19.5	2.2	16.1	60.3	767			17	3.23	303	10	2530			38	.m																																																		192	13.5	11	233	965			1910	2.75	7.35		25.9			10.5	163	14.4	1.99	24.5			6.71	18	8.64	169				445	11.3	19.8	71	1110			22.6	2.75	9.1		33.6			5.35	2.13	342	12.2	2160			53.2	.m																																																		323
SUB231408	Atopic	CSLRI	1.0	expected	239074	b	191			518	195			197								397	630	19.8	151				4.23		684	1870			1980	12.6	1.81	76.9	130													22.2	463				.m																																																		191	1.1	1.58	432	158			168				1.09				433	522	21.1	124				5.51		624	1790			2000	9.84	3.17	70.3	185			3.13	1.85	1.53		4.53				2.44	2.87	28.6	513			2.45	.m																																																		313
SUB231409	Atopic	CSLRI	1.0	expected	240418	b	202	101		182	698			1790								168	74.8	1.64	64.2				148	12.4	302	3080			6530			38.5	96.7												3.86	12.4	1700			14.5	.m																																																		202	117	1.89	201	826			2170								182	82	4.98	72				148	27.6	259	2820			6070	2.2		42.5	163												6.63	12.4	1720			47.7	.m																																																		355
SUB231410	Atopic	CSLRI	1.0	expected	227453	b	202	36.9		116	64.6			247								91.2	329	9.15	78.2			11.2	118		235	1090			3070	136	2.22	142	245			11.3															.m																																																		202	32.6		97.9	48.8			259								93.2	441	8.74	71.2			9.31	145		244	1080			3100	126	6.63	131	240			14.5															.m																																																		339
SUB231411	Atopic	CSLRI	1.0	expected	280823	b	203	18.7		366	363			1370			1.58	20.9				37.9	389	12.5	415			8.07	38.3		1020	3230			2060	48.8	13.4	180	280													105	542				.m																																																		203	19.4		354	355			1220								27.4	469	11.4	362			2.53	36.1	17.3	862	3110			1460	55.7	11.2	136	243			1.53										109	583				.m																																																		341
SUB231412	Atopic	CSLRI	1.0	expected	268733	b	202	102		173	586			1360								39	34.8		109				150	4.72	419	2610			714	9.47		24.9																			.m																																																		202	77.8		119	363			728								31.2	20.1		91.7				156	2.22	504	2890			816	17.1		27.5	261																		.m																																																		338
SUB231413	Atopic	CSLRI	1.0	expected	270919	b	204	5.3		143	162			181				6.68				156	61	14.4	63.7			5.16	23.2	9.61	415	1410			2860	91.2	18.6	89.4	176			8.94		4.12	3.03	26.2					36.1	35.3	3330			2.59	.m																																																		203	6.32		166	234			273				20.3				168	53.5	14.8	95.4			4.54	19	11.7	465	1780			2750	97.5	16.7	89.9	217			8.15			2.92					2.48	55.6	26.7	2070			94.4	.m																																																		337
SUB231414	Atopic	CSLRI	1.0	expected	154649	b	203	3.42		220	92.9			369			2.1					91	60.1	20.4	153			3.95	23.1		928	773			2350	2.15	14.1	172	211			11.9		6.48	1.89						109	4.55	1410			9.53	.m																																																		203	15.4	3.29	264	191			743			1.28					120	44.1	17.9	114			6.75	22.1	14	543	981			2670	6.08	20	178	411			20.9			1.89	25					35	7.66	1610			7.57	.m																																																		322
SUB231415	Non-atopic	CSLRI	1.0	expected	280255	b	203	11.9		229	380			973			1.56	6.68				51	46.1	13.8	825			5.83	30	10.2	457	2200			4150	30.3	16.9	179	225			18.4			2.07	7.78						26.1	1040			13.1	.m																																																		203	13		188	434			897			1.36					71	129	21.1	596			5.37	23.8	2.62	676	2640			4270	24.8	14.7	147	371			19			2.75	19.1				4.13	7.81	27.6	1100			15.1	.m																																																		325
SUB231416	Atopic	CSLRI	1.0	expected	133824	b	203	9.31	116	65.6	580			973		8.4	1.57					37.3	76.4	15.7	16.8				18.7	184	97.1	2560			1640	17.8	19.9	50.8	156						1.39	2.14					131	3.19	1020			3.17	.m																																																		203	7.1	105	52.4	369			671			1.43	5.58				41.7	58.2	15.3	25				14.9	242	101	2950			1690	12.4	21.5	50.8	213			2.67			1.63	11.1					197	3.98	1010			3.78	.m																																																		317
SUB231417	Atopic	CSLRI	1.0	expected	255273	b	204	17	9.12	278	892			985		2.1		17.5				97.4	253	4.76	257			7.53	37.8	2.35	680	3980			6260	104	7.52	33.4	661			4.09		2.51		49.3			1.68		108	7.58	2900			18.3	.m																																																		204	21	8.74	238	913			991		4.04		16				105	367	4.87	242			6.3	40.2	3.91	651	3500			6590	72.6	9.69	35.2	493			3.94		14		21.5			1.59		208	5.84	2260			39.7	.m																																																		315
SUB231418	Atopic	CSLRI	1.0	expected	304846	b	204	28.2		245	357			466								381	44.8	30.3	312			17	32.7		703	1590			6400	48.4	2.25	196	135			14.1									1.72	156	857			6.64	.m																																																		204	26	1.05	214	303			331				5.38				423	44.8	26.2	237			22.4	36.2		711	1840			4550	37.6	2.91	218	144			14.9										203	885			6.17	.m																																																		316
SUB231419	Atopic	CSLRI	1.0	expected	301385	b	204	49.7	3.56	238	242			5320				16.8				228	289	13.3	374			29.9	41.6	6.96	937	3020			3770	104	10.2	40.5	142			13.4		1.5		19.1					4	6.79	2600			7.8	.m																																																		204	48.8	2.55	227	253			6710		1.66		19.1				297	290	12.5	361			39.3	47.2	4.79	999	3380			3870	84.6	9.74	38.7	144			15.3		1.5		9.37					4.7	8.19	3460			7.89	.m																																																		311
SUB231420	Atopic	CSLRI	1.0	expected	240656	b	204	11.9	6.96	79.1	293			543		1.82		20.3				138	619		87			11.7	22.5	32.3	88.5	892			3000	20.6	7.33	3.05	425			6.35		1.98		28.1					33.2	4.33	2430			15.9	.m																																																		204	16.3	5.59	89.5	275			584		3.1		28.1				147	198		46.6			7.53	25.8	10.1	113	703			2040	26.8	6.96	5.47	311			4.31		3.31		30.6					29.2	4.42	2050			13.6	.m																																																		313
SUB231421	Atopic	CSLRI	1.0	expected	258019	b	204	19	11	135	289			547		1.03		21.5				69.2	103	13.2	61.5			5.05	29.1	31.8	409	2580			3110	35.1	19.2	208	277			26.4		1.19		25.6					398	55.8	1220			12.9	.m																																																		204	16	8.93	127	276			463		3.82		42.5				67.1	68.3	14	72.1			5.29	33.6	157	382	3110			4740	51.4	19	226	329			30.3		3.39		17.1					267	23.7	1720			10.2	.m																																																		310
SUB231422	Atopic	CSLRI	1.0	expected	288868	b	217			180	334			273								72.9	128	4.02	136			3.34	4.67		277	1150			881	790	18.6	23.2	239			12.8		1.23		12.7					6.46	3.46	803			1.23	.m																																																		217			177	238			222								53.4	192	7.76	186			5.49	6.93		394	1830			919	839	18.7	31.1	268			18										2.82	847				.m																																																		384
SUB231423	Atopic	CSLRI	1.0	expected	299371	b	217	16.8		288	308			1310								82.4	3.44	4.28	66			8.06	22.5		515	1060			1270	12.1		156	167			17.7										74.2	562			2.92	.m																																																		217	15.1		285	289			1580				2.62				99.8		3.26	44.8			7.82	21.6	2.33	427	1050			1510	27.8	2.24	122	149			13.1										105	430			2.42	.m																																																		383
SUB231424	Atopic	CSLRI	1.0	expected	129369	b	215	21.9	6.29	223				3280	6.25	3.34						85.9	42.4	9.81				51.6		1.27	632				4900	61.5	11.9	197				60.3	6.25		4.55						17.7	17.1				20.3	.m																																																		215	4.14	8.15	221				3190								77.4	22.1	12.6				66	13.1	6.52	560				3100	57.2	17.7	202				63.9		4.01							21.8	15.3				16	.m																																																		339
SUB231425	Non-atopic	CSLRI	1.0	expected	334873	b	215	6.25	62.5	331	2100			4210		3.79		13.1				14.3	29		36.8			14.3		71.4	509	4450			3320	408	18.9	286	80.1			60.5	15.4	3.79		10.9					10.5	8.04	3170			28.3	.m																																																		215	7.86	77.5	336	2300			5050		2.02		6.5				23.5	45.8		46.8			12.1	7.86	155	442	6160			4000	393	24.1	268	342			27.8		1.81		6					3.9	9.33	1660			18.9	.m																																																		340
SUB231426	Atopic	CSLRI	1.0	expected	300891	b	217	29.1	352	201	854			1720								500	147	9.54	191			34.9	29.2	27.4	266	2810			3200	354	16.7	119	188			53.4				3.45					1.54	33.7	686			30.2	.m																																																		217	22.4	206	166	665			1850								437	124	11	138			33.1	27.9	31.9	216	2430			3010	294	14.2	112	197			58.1									13.8	29.6	827			44.9	.m																																																		366
SUB231427	Atopic	CSLRI	1.0	expected	301115	b	217	22.8		198	139			1520								397	183	10.5	143			54	35.7		357	1190			2630	10.8		46.8	156			3.52									3.1	198	961				.m																																																		217	24.9		236	134			1640								379	259	15.4	138			51	33	8.49	407	1020			3610	3.74		49.6	113			2.16				4.31						245	1150			1.79	.m																																																		360
SUB231428	Atopic	CSLRI	1.0	expected	326610	b	217	12		219	292			746				45.3				15.2	19.3	11.1	149			11.2	13.7		534	1800			1960	17	13.5	76.2	360			60.8				5.18					396	6.58	2030			32.3	.m																																																		217	13.4		221	227			727				21.2				28.4	45.8	11.4	128			10.1	9.2		435	1490			1670	10.2	4.87	65.3	314			48.1				17.2					376	8.08	1260			12.6	.m																																																		359
SUB231429	Non-atopic	CSLRI	1.0	expected	347230	b	217	19.2	11	256	1190			678				11.7				207	141	9.84	468			30.7	18.9	2.88	398	3640			1200	149	13.3	46.1	238			3.55				19.2						54.6	1200			7.58	.m																																																		217	23.8	11.4	235	1030			718				22.8				183	155	7.29	461			16	28.2	4.52	508	3710			980	158	12.9	44.1	248			5.42				7.91						49.2	1100			13.7	.m																																																		355
SUB231430	Non-atopic	CSLRI	1.0	expected	293043	b	231	10.2	45.6	393	257			1140		1.45					1.43	96.1	52.5	11.8	136			5.42	9.89	31.9	291	2680			1990	98.5	8.3	50.7	112			6.76								1.06	13.7	154	1410			4.61	.m																																																		231	11.5	43.2	370	261			501		2.37		9.35				107	37.8	10.9	116			8.4	12.2	49.1	287	3170			1590																						.m																																																		370
SUB231431	Non-atopic	CSLRI	1.0	expected	293719	b	217	12.1	16.6	498	434			1010				16.7				221	629	29.2	439			24.9	29.7	28.4	979	3140			1850	346	69.1	189	159			10.9									10.5	26.7	1020			13.8	.m																																																		217	11.2	18.2	541	343			718				12.7				293	612	24.3	413			19	29.1	5.32	658	2390			1070	367	65.4	174	121			12.6				17.7					1.76	32.1	793			5.06	.m																																																		351
SUB231432	Non-atopic	CSLRI	1.0	expected	337244	b	231	10.2	1.25	71.4	307			341	1.84	2.68		7.6				208	27.9	22.1	136			20.1	11.6	2.94	224	1430			1240	32.8	4.41	135	96.1			29.8				2.76					2.87	78.8	463			2.63	.m																																																		231	11.3		71.7	322			290	1.25							186	37	17.5	125			14.7	10.7	2.81	194	1150			1090	43.4	3.06	134	130			18.4	1.06	1.25						1.15	1.18	66.7	442			1.55	.m																																																		369
SUB231433	Atopic	CSLRI	1.0	expected	326499	b	231	9.81	4.32	216	955			552	3.03	3.27		19.9				298	193	44.6	260			8.43	13	7.86	691	6610			3010	13.4	8.72	175	185			13	4.12	5.1		23.4			1.26	3.4	6.29	145	798			6.76	.m																																																		231	10.3	4.62	240	1080			494	3.17	3.02		22.4			1.9	295	204	45.9	272			6.35	14.4	9.8	781	5770			2520	11	9.12	202	196			16.7	2.65	4.26		12.3			1.04	3.67	3.89	138	672			4.82	.m																																																		365
SUB231434	Non-atopic	CSLRI	1.0	expected	283476	b	231	10.6	9.75	289	245			1170	4.71	4.5		22.4			1.17	300	1030	20.4	444			29.6	14.2	20.6	1530	2250			826	29.9	11.3	37.4	172			5.06	3.4	2.14	6.6	32.7			1.13	4.57	63.5	277	697			7.2	.m																																																		231	10.7	12.6	358	287			1350	4.75	4.8		19.9			1.04	229	492	19.7	340			19.9	16.6	20.5	1240	1800			1120	17	9.18	33.3	115			6.57	3.26	2.84	5.61	21.4			1.92	3.12	23.6	177	820			7.3	.m																																																		364
SUB231435	Atopic	CSLRI	1.0	expected	316610	b	231	11.4	4.5	358	427			571	3.4	3.89		23.4			1.8	137	125	43.6	241			19.6	10.2	4.38	1000	2100			1550	587	16.3	423	164			63.7	7.33	2.9		15.6				7.15	43.9	226	3500			19.7	.m																																																		231	9.54	4.2	379	407			558	4.12	2.96		28.5			2.39	130	138	55.3	259			16.1	8.7	5.4	1180	2300			1420	555	14.2	347	169			57.1	14.4	3.4		16.5			1.77	4.26	114	190	2090			35.2	.m																																																		362
SUB231436	Atopic	CSLRI	1.0	expected	237128	b	217	24.9		120	296			2000		1.67		13.2				72	10	3.62	38.4			4.33	29.7	6.49	258	1670			2190	228	7.97	64.2	99.1			4.61				2.21					31.8	55	1150			22	.m																																																		217	21	1.15	103	280			1860				18.7				67.9	5.95	3.77	36.3			2.98	34.8	3.39	484	1950			3230	205		50.4	38.4												96.6	44.3	1320			53.6	.m																																																		356
SUB231437	Atopic	CSLRI	1.0	expected	336376	b	234	14.4	19.1	647	127			113	3.95	3.27		30.1			1.47	123	1780	133	953			107	14	7.4	672	1300			162	61.3	13	277	176			17.7	6.39	2.25	1.19	25.6				8.32	7.53	11.2	1530			3.91	.m																																																		234	14.6	19.8	561	124			134	2.94	3.16		35.3			1.28	164	1730	160	1110			112	13.1	7.4	778	1530			169	51.9	14.6	287	158			20.9	4.88	4.53	1.41	49.3			2.24	4.23	38.3	28.2	1050			8.2	.m																																																		366
SUB231438	Non-atopic	CSLRI	1.0	expected	371667	b	237		1.47	208	201			1140								241	18.6	11.2	77.7			21.7	4.29	3.43	527	1410			1350	83.9	5.3	40.3	106			1.94				25.9					3.39	120	871			4.36	.m																																																		237			220	170			1130		2.32		52.9				213	14.5	7.47	67.6			13.1		4.09	548	1060			1040	60.6	4.01	39.6	80			1.25									2.81	109	1100			9.45	.m																																																		368
SUB231439	Non-atopic	CSLRI	1.0	expected	347098	b	238		3.47	224	185			548				15				101	5.12	1.71	49.5			2.85	4.93	10.4	468	1300			3670	20.4	16.5	90	262			10.7		2.42							96.8	20.7	1320			44	.m																																																		238	3.89	3.4	239	200			628		1.16		16.2				143	5.52	3.28	48.2			3.49	4.79	11.1	623	1390			2890	7.03	12.3	68.3	199			11.1				14.4					64	28.5	1370			56.5	.m																																																		362
SUB231440	Atopic	CSLRI	1.0	expected	326777	b	238	5.65	9.18	44.6	522			1740				27.4				74.5	17.3		62.1			22.7	1.34	14.6	158	2810			8380		32.9	24	777			11.9		1.46		6.96					112	5.23	2570			26.7	.m																																																		238	3.21	7.48	46.1	580			1800		1.96		24.3				72.2	54.1		67.2			14.8	6.47	44.3	195	3000			5710		34.9	23.1	751			10.1		3.67		14.4					105	3.98	2590			30.3	.m																																																		361
SUB231441	Atopic	CSLRI	1.0	expected	244223	b	234	23.2	142	268	677			5010	3.67	3.74		22.4			1.61	350	1490	34.4	479			99.3	13.3	246	674	6370			11100	134	57.5	262	255			69.3	2.39	4.22	1.47	40			1.17	6.3	9.54	44.7	1500			136	.m																																																		234	20.1	114	257	646			4690	3.03	3.27		27.5			2.09	309	1580	34.3	470			89.5	11.5	380	737	7940			12300	107	49.6	240	248			51.6	2.71	2.59	1.31	34			1.58	8.9	12.6	14.1	2460			348	.m																																																		365
SUB231442	Atopic	CSLRI	1.0	expected	252982	b	231	12.4	95.6	201	517			1100	3.26	3.09		16.5			1.6	91.2	75	3.58	79.2			9.8	14.3	30.1	639	1760			1870	77.2	34.9	64.9	727			12.6	3.12	1.61		22.4			1.77	3.81	55.6	162	740			5.61	.m																																																		231	12.6	85.3	209	476			1100	3.03	2.84		12.7			1.33	79.6	59.1	3.33	54			9.66	12.7	24.7	553	1650			1300	92.8	44.3	77.9	957			11.8	3.4	3.15		17			2.23	3.99	14.7	146	985			6.35	.m																																																		362
SUB231443	Atopic	CSLRI	1.0	expected	316832	b	238		3.2	137	1040			842		1.96		26.8				138	197	15.8	358			38.5	4.32	8.15	223	1640			3490	122	14.4	74.9	197			29.9				5.69					49.5	24.6	1790			19.5	.m																																																		238		4.26	149	1010			900				41.9				122	158	16.2	393			27	3.67	2.71	620	1590			2310	71.4	10.4	72.6	142			27.6		1.23		24.9					37.6	19.2	2890			20.7	.m																																																		358
SUB231444	Atopic	CSLRI	1.0	expected	258139	b	238	4.59	4.46	267	150			880		2.65		18.7				222	141	2.11	91.1			11.9	4.45	6.05	938	903			2890	117	8.05	6.23	82.3			4.59		1.86		16.8					86.7	52.3	1200			31.6	.m																																																		238	8.97	1.76	370	197			1410		2.61		23.7				285	56.3	1.77	102			16.6	8.43	9.64	1140	1190			2680	195	9.11	10.1	104			6.74		1.46		18.7					15.2	77.4	1220			26.9	.m																																																		355
SUB231445	Atopic	CSLRI	1.0	expected	349889	b	238	3.29	14.5	352	1210			1540		2.22		36.9				120	57.4	5.27	83.5			5.37	8.85	14.8	676	5350			3550	506	25.1	104	321			11.5		2.15		10					17.5	18.7	1340			32.5	.m																																																		238	4.03	13.7	344	1030			1680		2.02		24.3				94.4	74.1	5.25	83.5			6.58	6.29	22.9	1130	7080			5370	676	23.7	101	241			15		2.38		15.6					6.42	14.8	1340			20.7	.m																																																		346
SUB231446	Non-atopic	CSLRI	1.0	expected	342924	b	238		4.99	231	494			545		1.83		43.2				48.2	2040	19.8	176			13.2	5.78	16.4	580	4640			2730	93.9	22.5	80.9	294			59.6		3.44		21.8					310	25	2890			26.2	.m																																																		238	3.52	5.72	245	386			403		2.32		2.93				75.9	3290	25.1	217			20.2	7.52	10.5	487	4900			2740	90.8	17.1	106	253			74.9		3.4		25.6					187	36.4	2230			27.6	.m																																																		347
SUB231447	Non-atopic	CSLRI	1.0	expected	404562	b	238		2.34	453	71.6			206								303	3500	44.7	212			67.2		20.6	1790	1500			391	113	48.9	458	170			108									61.9	97.1	443			46.3	.m																																																		238		2.67	394	69.7			202								252	3530	37.5	215			77.3		6.57	976	1140			373	102	44.7	430	169			106									165	77.8	790			120	.m																																																		335
SUB231448	Atopic	CSLRI	1.0	expected	330343	b	246	9.3	5.52	274	1710			3660	1.7	3.47		10.8			4.51	829	34.9	14.6	160			63	6.71	5.18	440	5350			3530	118	11.8	64.6	178			34.3	4.73	2.44	3.51	14.5			2.64	2.88	6	41.7	1850			27.4	.m																																																		246	8.54	4.34	285	1300			3160	4.55	3.01		13.1			4.9	854	41.8	14.2	155			73.4	6.75	6.4	408	5370			3620	92.1	8.29	76	122			44.3	2.78	3.79	2.47	7.2			2.46	3.44	3.38	55.8	3060			45.8	.m																																																		348
SUB231449	Atopic	CSLRI	1.0	expected	331917	b	246	6.26	2.75	153	222			1450	2.3	4.06	2.1	14.9			3.39	32.2	8.72	9.22	54.5			9.18	8.9	4.06	1580	1060			4440	266	7.93	45.1	109			10.4	2.64	3.26	10.7	29.8			2.24	3.9	4.1	94.3	1320			73.9	.m																																																		246	8.67	3.51	159	233			1590	1.38	2.62	2.77	20.1			5	39.7	9.43	8.87	73.5			7.9	6.48	5.29	2590	1240			4890	381	7.93	50.3	122			10.1	3.9	2.31	12.5	25.8			2.35	4.04	3.34	97.6	1420			93	.m																																																		334
SUB231450	Atopic	CSLRI	1.0	expected	414750	b	247	4.46	5.78	120	2700			1440	1.15	1.65	4	393			119	106	342	53.9	1020			485	5.28	45	1070	10400			5060	190	44.8	319	1010			319	3.99	2.39	4.91	389			15	4.11	61.3	9.79	2650			101	.m																																																		247	5.25	6.66	128	2510			1510	1.61	1.9	3.48	314			92	140	577	44	1180			520	3.29	61.1	1070	6800			4960	224	47.7	320	972			329	5.72	3.59	5.95	397			20.2	5.31	164	9.66	2460			81.1	.m																																																		321
SUB231451	Non-atopic	CSLRI	1.0	expected	406503	b	246	7.47	8	34.8	4400			3020	3.49	2.75		443			109	42.5	336	11.1	1380			348	3.35	38.6	286	12100			5580	96.4	10.2	90.3	1010			365	6.71	5.25	2.44	725			11.8	4	142	7.75	6110			58.4	.m																																																		246	7.87	8.57	37.7	5740			3680	4.64	3.59		428			114	49.8	397	12.3	1610			372	5.72	37.6	352	16200			6530	80.8	10.7	87.1	1230			421	3.16	3.09	3.93	680			14.6	5.18	154	6.95	7710			70.2	.m																																																		324
SUB231452	Non-atopic	CSLRI	1.0	expected	402897	b	247	3.29	4.71	183	2110			1430		1.13		20.3			2.61	211	356	7.12	102			19.2	3.44	58.2	1150	10800			4430	142	101	50.3	527			75.8	1.36			14.5					16.7	14.6	1380			5.62	.m																																																		247	5.34	5.32	161	1800			1450		1.13		16			2.21	212	385	6.61	123			23.9	2.71	41.7	774	10500			3960	156	112	45.8	522			75.2			2.39	28.2					6.02	11.8	1380			2.55	.m																																																		312
SUB231453	Atopic	CSLRI	1.0	expected	407151	b	247	2.48	9.72	179	7140			4100	1.82	1.52	2.66	921			247	394	2030	21.3	1320			1610		200	779	22700			35300	4.31	12.7	48.1	925			1080	1.22	1.8	2.3	1860			97.2	3.47	7.68	7.3	5590			1560	.m																																																		247	2.03	11.4	198	7980			4700	1.58	2.03	2.56	882			373	436	2070	20.1	1200			1690		186	600	29600			36000	5.07	10.8	50.6	929			885	2.03	1.85	2.36	1850			88.4	3.26	4.05	5.93	4890			1490	.m																																																		298
SUB231454	Atopic	CSLRI	1.0	expected	434179	b	247	2.53		53.5	386			578	1.82	1.5	2.44	8.89			11.1	56.9	4.82	8.95	32.3			67.7	4.46	1.73	75.4	357			2950	253	7.59	33.4	174			38.9		1.36		14.5			2.08		1.55	2.05	248			17.6	.m																																																		247	2		55.1	372			546			2.07	7.15			12.2	66.1	4.61	9.03	41			59.1	4.96		91.2	383			3150	321	5.46	36.9	162			38.2		1.19		16.5			2.57	1.19	3.07	3.38	238			15.6	.m																																																		299
SUB231455	Non-atopic	CSLRI	1.0	expected	401000	b	247	5.04	22.7	53.3	3980			2240	1.02	3		71			73.6	158	865	9.39	204			966	3.44	1030	295	12500			4980	113	191	394	638			1120	4.9	93.4	4.29	1260			455	7.53	80.2	35.1	2280			638	.m																																																		247	6.65	18.6	61	4900			2580	1.88	2.05		74.3			86.4	173	738	9.85	255			979	3.47	1570	324	17700			5400	95.5	198	418	539			1060	2.3	2.65	7.57	194			13.1	3.87	76.2	30.8	2430			606	.m																																																		289
SUB231456	Non-atopic	CSLRI	1.0	expected	443257	b	250	3.67	3.33	25	748			1060	1.52	4.6		33.3			5.54	155	1680	4.29	921			206	2.05	5.96	272	4720			12500	513	10.5		205			8.31	2.54	2.98		44			3.75	1.92	4.07	31.6	1670			983	.m																																																		250	1.79	2.12	23.8	627			870	2.77	3.67		31			6.32	192	1960	4.63	977			301	2.37	5.66	277	5840			11600	350	14.6		257			8.11	2.01	3.42		38.4			2.97	1.95	5.81	28.8	1460			865	.m																																																		294
SUB231457	Non-atopic	CSLRI	1.0	expected	420916	b	247	5.37	4.12	219	687			1140	3.7	3.1	11.7	48.1			210	58.5	687	68.7	113			590	6.35	55.2	782	1740			2900	121	187	473	253			587	2.59	2.2	12.4	59.3			12.4	7.86	49.5	157	215			37.7	.m																																																		247	5.52	5.9	236	775			1610	2.94	3.24	14.6	85.6			188																																				.m																																																		282
SUB231458	Atopic	CSLRI	1.0	expected	420180	b	250	4.51	1770	149	8440			3060	2.77	40.8	3.72	1060			1750	176	13900	59.3	1700			2900	2.8	5830	415	20600			21100	41.1	4560	332	1480			2140	3.85	33.1	3.46	2000			919	8.55	3860	15	7230			1530	.m																																																		250	5.26	2020	166	9260			2040	4.14	33.3	3.81	1110			1660	207	12400	61.8	1650			2360	3.01	8810	498	26300			23600	27.9	3270	316	1520			2420	2.67	21	3.5	1670			767	7.68	2430	14.7	8040			1570	.m																																																		291
SUB231459	Non-atopic	CSLRI	1.0	expected	409865	b	247	5.58	65.1	217	6450			2740	4.99	6.42	16.4	1560			1180	59.7	2640	61.8	3220			2510	4.4	560	1440	21100			9730	55.2	494	526	2200			2200	2.36	7.11	3.52	4060			160	1.88	92.9	12.5	7690			90.8	.m																																																		247	5.84	64.2	233	6640			2860	4.37	4.59	15.1	1350			817	52.1	3160	63.7	3390			2610	2.3	267	1330	20200			10800	47.5	494	476	2230			2540	6.83	6.8	3	3610			137	3.29	85.4	15.3	6460			69.3	.m																																																		279
SUB231460	Non-atopic	CSLRI	1.0	expected	409986	b	250	2.21	250	95	5330			3410		1.48		153			33.4	563	6150	9.99	1280			1060		1610	317	16000			22600	287	368	43.1	485			516			4.35	315			7.7	1.64	54.5	2.75	4730			78.3	.m																																																		250		150	84.3	5780			2950		2.31		127			32.1	611	9510	10.5	1360			951		1420	316	20300			27100	286	366	52.6	523			404		1.55	4.15	328			5.65		11.2	3.35	3750			78	.m																																																		280
SUB231461	Atopic	CSLRI	1.0	expected	443146	b	250	2.05	45.9	312	3280			3100	1.25	1.83	2.62	253			439	330	4460	117	722			1110	1.95	986	1330	11700			11200	21.2	200	289	514			690		1.66	6.18	770			141	10	1570	62.5	4800			2220	.m																																																		250	2.24	44.3	284	2560			3640	1.37		2.3	240			428	370	6130	128	657			1230	1.86	487	1290	13800			14100	12.2	236	262	455			790		2.18	5.5	649			130	1.7	577	51.2	4020			1630	.m																																																		273
SUB231462	Non-atopic	CSLRI	1.0	expected	405197	b	250	2.34	43.3	125	1680			1380	1.28	2.01		75.8			82.3	44.3	590	16.7	288			313	4.62	105	663	5760			13400	35	85.8	117	221			530			1.93	105			15.2	2.05	1200	5.45	3230			608	.m																																																		250	3.46	43.6	126	1570			1400	4.62	2.64		75.8			116	45.4	329	13.4	234			305	3.6	75.3	788	6140			14500	9.92	52.5	97.9	177			421	1.14	1.07	1.44	101			15	3.01	559		4440			280	.m																																																		320
SUB231463	Atopic	CSLRI	1.0	expected	456252	b	248	4.78	17.2	414	4780			1030	3			365			400	194	585	28.7	600			933	2.53	213	890	8570			10700	8.87	24.7	192	818			1110		1.08		604			64.2	1.77	38.3	41.3	5810			1390	.m																																																		248	4.54	15	298	5270			1260				432			359	182	403	27.9	565			925		232	1010	9590			11700	20.9	33.5	227	785			1030			2.79	614			82.9	3.53	6.79	36.2	6500			1660	.m																																																		251
SUB231464	Non-atopic	CSLRI	1.0	expected	441526	b	248	6.15	1830	287	5380			2290		1.25		42.1			43.8	690	1810	26	176			198	4.22	880	474	4630			3850	272	45.8	324	390			158			7.46	66.3			1.38		345	8.69	3120			283	.m																																																		248	6.65	1480	221	4000			1650				39.2			13.7	627	1650	22	192			158	5.31	3310	350	8240			7130	331	41.6	336	354			123		1.14	7.53	60.7			1.08	5.26	78.8	11.9	1830			80.5	.m																																																		246
SUB231465	Non-atopic	CSLRI	1.0	expected	438342	b	250	3.78	4.35	330	419			1310	2.37	3.36		30			10.9	151	66.2	23.2	90.3			63.5	5.19	5.9	242	494			1070	617	38.5	87.1	403			39.4	2.97	2.85		20.1			7.18	3.39	3.73	1.68	350			22.2	.m																																																		250	4.07	3.17	299	413			1140	1.73	4.04		28.8			8.99	157	84.9	24.3	92.2			52	3.29	5.14	327	669			1390	580	35.3	80.4	374			22.7	4.14	2.98		20.1			8.99	3.6	2.36		183			23	.m																																																		248
SUB231466	Atopic	CSLRI	1.0	expected	437823	b	250	4.14	3.92	51.5	375			706	1.25	2.52		21.1			15.7	140	34.1	13.4	60.9			95.1	4.58	20.4	177	3210			1340	24.6	23	143	202			94.3	2.87	3.58		28.8			2.62	2.74	257	17.1	1120			18.9	.m																																																		250	2.7	5.69	41	442			705	3.04	2.69		26.4			14.8	175	31.9	15.2	61.2			100	5.8	24.2	140	2750			1130	28.4	24.5	171	183			72.3	2.14	4.56		22.1			2.35	4	256	17.2	1210			19.7	.m																																																		246
SUB231467	Atopic	CSLRI	1.0	expected	450622	b	248	2.47		485	5260			712			4.87	495			7.76	756	410	131	1720			113	6.68	7.67	1900	10500			1410	48.1	32.2	131	1880			562			8.44	707				5.22	4.08	73.9	1470			8.9	.m																																																		248	1.92		408	5320			811				473			5.23	688	380	136	1540			114	6.38	18.4	1620	7540			1030	54.5	30.2	134	1780			549			6.98	689					11.4	59.2	1550			11.2	.m																																																		234
SUB231468	Atopic	CSLRI	1.0	expected	429831	b	248	1.06	59.9	203	1260			1160				38.4			22.4	242	4420	28.4	230			777	4.01	409	667	5160			4540	330	291	365	270			412			11.5	54.2					14	84	1200			129	.m																																																		248	2.6	38.4	180	1210			1040				25.7			26.7	221	5170	30.6	222			755	2.17	476	742	4450			3980	300	347	366	318			422			14.8	66.8			1.81		5.22	97.3	1160			117	.m																																																		224
SUB231469	Non-atopic	CSLRI	1.0	expected	444183	b	248	1.9	10.6	236	9040			644		1.64		1400			87.9	797	4930	67.6	4500			416	4.78	57.3	457	20000			2560	107	4.8	65.9	1360			146				1800			2.49		1.9		5800			10.5	.m																																																		248	4.59	21.8	272	11400			1040		1.56		1480			69.1	688	4410	58.7	3740			398	6.05	46.8	553	17600			3410	435	137	87.7	4900			427				1650			1.17		4.29		5750			10.5	.m																																																		217
SUB231470	Non-atopic	CSLRI	1.0	expected	434401	b	248	6.53	17.8	225	2090			990			3.01	262			102	208	14900	55.6	1290			581	4.01	143	915	4150			3950	250	3110	158	894			1040			11.1	405			12		2.33	25.8	1260			360	.m																																																		248	3.29	14	212	2010			910				188			8.14	186	15000	50.6	1230			727	4.01	132	917	5680			5980	229	2260	165	1040			887	1.92		16.6	629			23.5	1.58	11.9	33.5	1460			319	.m																																																		194
